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Genetic investigation of α4-containing GABAA receptors’ different 
roles in alcohol consumption and conditioned behaviours 
influenced by cocaine 
The GABAA α4-subunit is found co-assembled with δ subunits in extrasynaptic 
GABAA receptors (α4-GABAARs). Within the striatum α4-GABAARs are most highly 
expressed in the Nucleus Accumbens (NAc) where they mediate tonic inhibition 
thought to control the excitability of accumbal medium spiny neurons (MSNs). 
Experiments presented in this thesis use genetic techniques in mice to investigate 
the role of α4-GABAARs in modulating binge-like ethanol consumption and the 
potentiation of locomotor behaviours by cocaine. We have generated several 
transgenic mouse lines in which the Gabrα4 gene, encoding the α4 subunit, has 
been deleted either constitutively or within specific neural populations expressing 
D1 or D2 type dopamine receptors via cre/loxp recombination. Using quantitative 
rt-PCR and in-situ-hybridisation methods to compare Gabrα4 mRNA levels in brain 
sections from each genotype we confirmed that the α4 subunit was deleted either 
globally or in the expected cell type within conditional knockouts. We also 
generated an Adeno Associated Virus (AAV) carrying Cre-recombinase to 
knockdown α4 locally by infusing it into in specific brain regions of ‘floxed’-α4 
mice. 
Deletion of the α4 subunit in mice significantly reduced alcohol consumption in a 
pre-clinical model of binge-drinking, known as drinking in the dark (DID). 
Moreover, targeted deletion of Gabrα4 in the NAc was sufficient to mediate this 
effect. We did not observe any effects on alcohol consumption in mice where α4 
was deleted conditionally in D1 or D2 type neurons. This data indicates that α4-
GABAARs in the NAc are an important mediator of alcohol consumption. 
Deletion of GABAAR α4-subunits from dopamine D1-expressing neurons facilitated 
cocaine’s ability to potentiate locomotor activity and operant responding for 
natural rewards. Deletion of GABAAR α4-subunits from dopamine D2-expressing 
neurons had no such effects. Deletion of GABAAR α4-subunits from dopamine D1-
expressing neurons also accelerated the acquisition of behavioural sensitisation to 
cocaine. This effect was associated with increased cFos expression in the NAc core 
following acute cocaine, whilst in cocaine-sensitised mice it was associated with 
increased cFos in both the NAc Core and Shell. A similar altered pattern of cFos 
expression was observed in mice with a global knockout of α4 subunits however 
they showed no behavioural effects. This may imply that a balance of α4-GABAAR-
mediated inhibition in D1 and D2 neurons is required for normal behavioural 
sensitisation to cocaine. The data presented within this thesis indicate that α4-
GABAAR-mediated inhibition of D1- and D2-expressing neurons plays an important 
physiological role in controlling behavioural responses to cocaine. 
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Chapter 1 
General Introduction 
 
1.1. Drug and alcohol abuse/addiction  
The world health organisation (WHO) estimates that two hundred fifty million 
people used illicit drugs at least once in 2015, of which about 29.5 million of 
those drug users, or 0.6% of the global adult population, suffer from drug use 
disorders (WHO, 2017). Within the UK alone approximately 8.5% of adults used 
an illicit drug in 2015/16 (UK Home Office, 2017). Of these users, ~10-13% 
continue to be problem users with drug dependence and/or use disorders. 
Cocaine use appears to be increasing in the two largest markets, North America 
and Europe, and the global disease burden attributed to cocaine use disorders 
increased by ~37% from 2005 to 2015 (WHO, 2017). During 2013/14, an 
estimated 2.4% of adults, aged 16-59 in England and Wales, used powder 
cocaine; making it the second most commonly used illegal drug (UK Advisory 
Council on the Misuse of Drugs, 2015). 
Globally harmful use of alcohol has been estimated to cause 5.9% of annual 
deaths and account for 5.1% of the global health burden (WHO, 2017). In 
particular ‘binge drinking’, a pattern in which blood alcohol levels are raised to 
0.08 grams alcohol per decilitre blood (0.8mg/ml), is associated with a large 
portion of alcohol related deaths, diseases and social harms (NIAAA, 2004). In 
the UK 58% of the population (28.9 million people) drink alcohol regularly, of 
which 26.8% of binge-drink on their heaviest dinking days (UK Office for 
National Statistics, 2016). During 2015/16, in England alone, there were 333 
thousand estimated admissions where an alcohol-related disease, injury or 
condition was the primary diagnosis or there was an alcohol-related external 
cause. 
The majority of treatments available for addiction are psychosocial interventions 
and behavioral therapies. The US National Institute on Drug Abuse (NIDA) 
estimate in developed countries rates of relapse during treatment are around 
40-60% (NIDA, 2014). There are currently very few pharmaceutical treatments 
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available for addiction and they are not commonly used.  Most currently used 
medications either act to replace the abused drug (e.g. methadone and nicotine 
supplements) or to block or make uncomfortable the effects of the drug (e.g. 
naltrexone and disulfiram) (NIDA, 2012). There is therefore a need for pre-
clinical research into the cellular, molecular, genetic and behavioral etiology of 
addiction to identify targets for therapeutic treatments. 
1.2. Brain regions involved in addiction 
1.2.1. The Basal Ganglia 
The basal ganglia (BG) are a series of interconnected subcortical nuclei primarily 
responsible for motor control as well as wider roles in motor learning, executive 
function and emotions. BG dysfunction therefore underlies a multitude of 
neuropathologies (Alexander and Crutcher, 1990; Cohen and Frank, 2009). The 
BG includes the striatum, globus pallidus externa (GPe) and interna (GPi), 
substantia nigra pars compacta (SNc) and pars reticulata (SNr), and subthalamic 
nucleus (STN). 
The BG and related nuclei can be broadly categorized into three groups. Firstly, 
input nuclei receive incoming information from various sources, mainly the 
cortex, thalamus, VTA and Substantia Nigra, and consist of the Caudate, 
Putamen and Nucleus Accumbens (NAc). Output nuclei send basal ganglia 
information to the thalamus and consist of the internal segment of the globus 
pallidus (GPi) and the substantia nigra pars reticulata (SNr). Finally, intrinsic 
nuclei are located between the input and output nuclei in the relay of information 
and include the GPe, STN and SNc. 
Regions within the BG are anatomically linked to the cerebral cortex and 
thalamo-cortical motor system via a series of parallel cortico–basal ganglia–
thalamo–cortical ‘loops’ which are largely structurally and functionally distinct 
(Alexander and Crutcher, 1990; Haber, 2003). Specific regions of the cortex 
send excitatory glutamatergic projections to the input structures of the BG, 
following which BG output nuclei exert a tonic GABA-mediated inhibitory control 
over their target nuclei in the thalamus. The thalamus then sends excitatory 
glutamatergic projections back to the cortex, thus completing the ‘loop’. Via this 
structure cortical afferent activity is modulated by the basal ganglia, which 
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subsequently sends back a signal to the cortex to facilitate (or inhibit) motor 
activity (Mink, 1996; Nicola, 2007). 
Classically, BG ‘loops’ were classified according to the presumed role of their 
primary cortical projection areas; motor, oculomotor, limbic, associative, and 
orbitofrontal circuits (Alexander and Crutcher, 1990; Mogenson and Yang, 1991; 
DeLong and Wichmann, 2007).  
1.2.2. The direct and indirect pathways 
Between the cortex and thalamus neuronal afferents are modulated by three 
distinct relay circuits known as the ‘direct’, ‘indirect’ and ‘hyperdirect’ pathways. 
The direct pathway originates in striatonigral neurons which form monosynaptic 
inhibitory connections with SNr/GPi neurons, suppressing inhibition of the 
thalamus, and ultimately disinhibiting selected behaviours (Vincent et al., 1982; 
Christensson-Nylander et al., 1986; Chevalier and Deniau, 1990). The indirect 
pathway originates in striatopallidal neurons which project to the GPe and onto 
the SNr/GPi complex via a polysynaptic disinhibitory connection, and an indirect 
GPe-STN-GPi connection, ultimately inhibiting the thalamus and suppressing 
selected behaviours (Beckstead and Kersey, 1985; Gerfen et al., 1990; Albin, 
Young and Penney, 1995; Cohen and Frank, 2009). 
Additionally the cortico-subthalamo-pallidal “hyperdirect” pathway was 
discovered, in which cortical afferents bypasses the striatum altogether, 
projecting directly to the STN (Nambu et al., 2000). The STN sends diffuse 
excitatory projections to many GPi neurons, producing a global, rather than 
selective, suppression of responses (Frank, 2006; Cohen and Frank, 2009). This 
third pathway has been proposed to mediate premature response inhibition, and 
termination of initiated behaviours (Aron and Poldrack, 2006). 
1.2.3. The Striatum 
1.2.3.1. Architecture of the Striatum 
The largest structure in the BG is the Striatum which comprises of the Caudate, 
Putamen, Nucleus Accumbens (NAc) and olfactory tubercle. The striatum serves 
as the primary afferent structure to the rest of the BG, precisely modulating 
neuronal excitability in the BG nuclei to mediate action-selection.  
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The vast majority (~95%) of neurons within the striatum are GABAergic 
projection medium spiny neurons (MSNs) (Wilson, 1993) so named due to their 
medium size and extensive dendritic trees (Kemp and Powell, 1971). MSNs 
receive glutamatergic inputs from the cortex, ventral hippocampus, amygdala 
and thalamus which synapse at their ‘spines’, and midbrain dopaminergic 
projections which synapse at the dendrites and ‘spine necks’ (Smith et al., 
1994).  
MSNs of the direct and indirect pathway have different molecular profiles so they 
were initially identified as distinct subtypes using their releasable neuropeptides 
as cell-type specific markers (Gerfen and Scott Young, 1988; Le Moine and 
Bloch, 1995). Immunohistochemistry identified populations of striatal neurons 
expressing the neuropeptides dynorphin and substance P and others expressing 
enkephalin (Beckstead and Kersey, 1985; Christensson-Nylander et al., 1986). 
Subsequent experiments in 6-hydroxydopmaine (6-OHDA) lesioned mice used 
D1 and D2 specific agonists (SKF-38393 and quinpirole) in combination with 
retrograde tracing and mRNA profiling to demonstrate that dynorphin/substance 
P or enkephalin expression in MSNs were differentially associated with D1 or D2 
dopamine receptor (D1R or D2R) expression respectively (Gerfen et al., 1990).   
Dopamine exerts a dual effect on MSNs, inhibiting striatal D2R-containing 
neurons and exciting striatal neurons that express D1Rs through L-type calcium 
channels (Onn, West and Grace, 2000). Further studies confirmed that D1Rs and 
D2Rs are expressed in distinct MSN subtypes (Le Moine & Bloch 1995) which are 
segregated into discrete pathways. Classically D1R-containing (D1) neurons are 
the origin of the ‘direct pathway’ and whilst D2R-containing (D2) neurons form 
part of the ‘indirect’ pathway.  A large body of research has elucidated distinct 
and often opposing functions of these two populations, sometimes referred to as 
the go/no-go pathways due to their roles in action initiation/inhibition (Surmeier 
2013). 
1.2.3.2. Genetic Dissection of D1 and D2 pathways 
Using recombinant DNA techniques genetic constructs can be placed under the 
control of various cis-regulatory elements. These can encode molecules which 
allow easy identification of the cells in which they are expressed, i.e. ‘reporter 
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genes’ (Forss-Petter et al., 1990). This type of labelling is more reliable than 
immunohistochemistry which requires markers that were based on correlative 
data (Gerfen et al., 1990) rather than being genetically hard-coded.  The 
discovery and development of green fluorescent protein (GFP) as a marker for 
gene expression (Chalfie et al., 1994) has rapidly become a staple technique for 
mapping neural populations as it allows stable reporter expression with minimal 
perturbation to the cell. Constructs encoding several GFP variants with different 
optical properties (collectively named XFP) were inserted under different 
promoters to allow imaging of neuronal subsets based on their expression 
patterns (Feng et al., 2000). In a refinement of this gene-trapping method GFP 
was expressed under the control of regulatory elements which had already been 
defined as specific to certain cell types. This was achieved using Bacterial 
Artificial Chromosomes (BACs) as vectors for these reporters, allowing large 
regulatory sequences and buffering transgenes from local regulation (Gong et 
al., 2003). This included 20 lines which drove expression within the striatum, of 
particular importance GFP was expressed under the Drd1 or Drd2 dopamine 
receptor promoters. By generating a BAC transgenic line expressing a different 
fluorophore (tdTomato) under the Drd1 promoter and crossing it with one 
expressing GFP under the Drd2 promoter it was possible to definitively dissociate 
D1 and D2 MSNs as only ~1% of neurons co-expressed both D1 and D2 
receptors (Shuen et al., 2008). 
The bacteriophage P1 recombinase ‘Cre’ can be used to mediate recombination 
between short sequences called ‘loxP’ sites (Hoess and Abremski, 1985) and a 
Cre-lox recombination system has been developed for use in mammals (Sauer 
and Henderson, 1988). Transgenic mice expressing Cre can be crossed with 
mice carrying a sequence which has been flanked by loxP sites via homologous 
recombination (‘floxed’) which results in deletion of that intervening sequence in 
the offspring (Lakso et al., 1992). This system is used in mice carrying a ‘floxed’ 
gene of interest so that it will be knocked out in a compartmentalised, cell-
specific manner which is determined by the promoter under which Cre is 
regulated (Gu et al., 1994). As previously with GFP reporters a library of BAC-
Cre mice have been generated where Cre is expressed in genetically defined 
neural subtypes in over 250 driver lines (Gong et al., 2007). Again, this includes 
expression of Cre under the Drd1 or Drd2 dopamine receptor promoters. This 
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technique has been used to conditionally delete genes in D1 or D2 expressing 
neurons with different behavioural consequences. Conditional knock-out of the 
BDNF receptor Trkb in D1 or D2 neurons either increased or decreased cocaine 
conditioned place preference (CPP) respectively. Similarly, conditional deletion of 
DARP-32, a MSN marker and signalling molecule, in D1 MSNs resulted in 
hypoactivity and reduced psychostimulant response whilst in D2 neurons 
deletion of DARPP-32 caused the reverse (Bateup et al., 2010). DARP-32 is 
involved in a dopamine-triggered signalling cascade important for synaptic 
plasticity and related to drug induced neuroadaptations (Nairn et al., 2004). 
In optogenetic experiments a channelrhodopsin (ChR), a non-specific cation 
channel opened/activated by light, can be used to stimulate neurons (Boyden et 
al., 2005) whilst halorhodopsin (NpHR), a light-activated chloride channel, is 
used to inhibit action potentials (Zhang et al., 2007). As with other transgenes 
optogenetic constructs have targeted to D1 and D2 expressing neurons and 
localised transfection of ChR has been achieved using viral vectors. Cre-
dependent ChR constructs were transfected throughout the basal ganglia of BAC 
mice expressing Cre in D1 or D2 neurons. Optogenetic stimulation of D1-MSNs 
increased locomotion and rescued the phenotype in a 6-OHDA Parkinson’s 
model, whereas D2 activation caused freezing and bradykinesia (A. V. Kravitz et 
al., 2010). Using the same manipulation in the ventral striatum D1 excitation 
was used to induce long lasting CPP while D2-MSN stimulation induced short-
lived conditioned place aversion (Kravitz, Tye and Kreitzer, 2012). Additionally, 
operant responding was established for a lever triggering D1-MSN stimulation, 
whereas a lever triggering D2-MSN stimulation was avoided. 
The segregation of D1 and D2 receptor expression to the direct and indirect 
pathways respectively is well established in the dorsal striatum however recently 
evidence indicates that this is not so in the ventral striatum. Kupchik and 
colleagues (2015) used a Cre-dependent (‘floxed’) channelrhodopsin (ChR2), 
delivered via a viral vector, to optogenetically activate D1 or D2 neurons in the 
NAc core of Cre-expressing transgenic mice. They recorded GABAergic IPSCs 
from the Ventral Pallidum (VP) following optogenetic stimulation of either 
population and found that that up to 50% of dorsal VP neurons are innervated 
by both D1 and D2 MSN afferents. We must therefore exercise caution in 
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referring to D1 and D2 populations as the ‘direct’ or ‘indirect’ pathways within 
the ventral striatum. 
1.2.2.3. Electrophysiology of D1/D2 MSNs 
Historically MSNs were characterised electrophysiologically by their 
hyperpolarized resting membrane potential and low input resistance (Kita, Kita 
and Kitai, 1984). The development of BAC GFP transgenic mice under the control 
of promoters for D1 and D2 receptors has allowed separate electrophysiological 
characterisation of the two populations (Gong et al., 2003). Whole-cell patch-
clamp recordings revealed that D2 MSNs exhibit larger excitatory postsynaptic 
potentials (EPSPs) and greater repetitive spiking than D1 MSNs (Kreitzer and 
Malenka, 2007; Bevan, Kreitzer and Berke, 2011). This may be partly explained 
by the greater surface area of D1- MSNs to D2-MSNs due to a greater number of 
primary dendrites (Gertler, Chan and Surmeier, 2008). 
Early experiments using in vivo recordings of striatal MSNs also demonstrated 
pattern of spontaneous activity consisting of long periods of silence separated by 
brief episodes of firing i.e. ‘irregular burst firing’ (Wilson, 1993). MSNs also 
exhibited two preferred, subthreshold membrane potential states (C. J. Wilson 
and Kawaguchi, 1996). Membrane potentials alternate between a resting 
hyperpolarized ‘down’ state, between -90 and -70 mV, and a less hyperpolarized 
‘up’ state, between -60 and -40 mV, which is only a few millivolts (3-5mV) below 
the spike threshold. Irregular spike discharge and spontaneous burst firing are 
observed only during the up state (Wilson and Groves, 1981), therefore the 
transition from the down state to the up state is proposed to be critical for spike 
firing in MSNs.  Neurons may exhibit ‘two-state’ behaviour because of their 
intrinsic properties, because they are in a network that imposes it on them or 
both in combination. In MSNs ‘two-state’ behaviour arises from both their 
intrinsic membrane properties and phasic changes in the excitatory inputs they 
receive (Wilson and Kawaguchi, 1996). 
MSNs express two different groups of ion channels which maintain these states 
dependent upon excitatory input, or lack thereof, to the MSN. During the down 
state, when synaptic input is low, the input resistance of MSNs is low (10-30 
MOhms) creating a stable membrane potential that is relatively insensitive to 
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small synaptic inputs. This results from the high expression of hyperpolarization-
activated KIR2 potassium channels, which move the membrane potential closer 
to the potassium reversal potential and therefore limit membrane depolarization 
(Nisenbaum and Wilson, 1995).  
Shifting MSNs into the up state requires a strong, synchronous depolarizing 
input from cortical and thalamic afferents (Blackwell, Czubayko and Plenz, 
2003). The up state is then dependent upon sustained excitatory input and is 
modulated by depolarization-activated potassium channels, largely in the Kv1 
family (Shen et al., 2003). These channels tend to return the membrane 
potential to the Down state or in the presence of strong excitatory synaptic input 
limit the sensitivity of the neuron to those inputs. This maintains membrane 
potential within a relatively narrow range which is marginally below the spike 
threshold (Shen et al., 2003). 
The outwardly-rectifying K+ channels are highly active in the Up state 
(Nisenbaum et al., 1996), and consequently the membrane potential remains 
relatively constant and very large changes in synaptic input are required to 
achieve even small increases in depolarization.  It has therefore been questioned 
what kind of synaptic input can trigger spiking in the up state. Computer 
simulations have suggested that brief depolarisations following rapidly changing 
in synaptic current may provide a window during which large sudden inputs can 
trigger a spike before voltage-sensitive channels are recruited to oppose their 
action (Wilson, 1995). Another possibility is that GABAergic activity may 
synchronise with large excitatory inputs to enable spikes to be triggered. 
GABAergic activity has been revealed to be involved in the generation of the up 
state in striatal MSNs (Kita, 1996). Classically GABAergic inputs to MSNs have 
been considered inhibitory; however, activation of GABAARs has been 
demonstrated to produce excitatory effects under certain physiological conditions  
(Cherubini, Gaiarsa and Ben-Ari, 1991; Gulledge and Stuart, 2003). It was 
demonstrated that during the ‘up state’ MSN membrane potential is below the 
reversal potential of GABAA inputs, therefore inhibition from fast-spiking 
interneurons results in depolarisation of MSNs (Plenz and Kitai, 1998). 
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1.2.3.4. Striatal Interneurons 
Populations of interneurons constitute the remaining 5% of striatal neurons, 
these have been divided into four groups, outlined below, based on their 
anatomy and expression of specific histochemical markers (Kawaguchi et al., 
1995). 
Of these, cholinergic interneurons make up 1-2% of striatal cells and are 
currently the most well characterised. These interneurons are relatively large 
(20-50μm diameter cell body) and possess widespread dendritic and axonal 
fields (Wilson, Chang and Kitai, 1990; Kawaguchi et al., 1995). Cholinergic 
interneurons receive excitatory input from the thalamus and cortex, and 
inhibitory GABAergic inputs from MSNs (Bolam et al., 1986; Chang, 1988; Brown 
et al., 2012). Due to their varied inputs and widespread axonal fields cholinergic 
interneurons are able to integrate synaptic input over an extensive area. They 
and project to multiple MSNs each and, to a lesser extent, other striatal 
interneurons (Bolam, Wainer and Smith, 1984; Chang and Kita, 1992).  
Importantly cholinergic interneurons have been implicated in reward-based 
learning and by mediating of dopamine-dependent striatal plasticity (Wang et 
al., 2006). In vivo recordings have demonstrated that cholinergic interneurons 
are tonically active, exhibiting slow irregular spontaneous activity of 2-10Hz 
(Wilson, Chang and Kitai, 1990; Bennett, Callaway and Wilson, 2000). It has 
been discovered that reward related cues elicit pause in the tonic activity of 
cholinergic interneurons which is thought to provide a ‘temporal window’ during 
which phasic dopaminergic activity can be distinguished from tonic dopamine 
states (Morris et al., 2004; Cragg, 2006). Thus, GABA projection neurons from 
the ventral tegmental area (VTA), which synapse almost exclusively on NAc 
cholinergic interneurons, inhibit their activity to promote stimulus-outcome 
learning (Brown et al., 2012). Notably, cholinergic interneurons also express D2 
dopamine receptors postsynaptically and therefore must be considered when 
interpreting experiments which pharmacologically or genetically manipulate 
D2Rs (Dawson, Dawson and Wamsley, 1990). 
The remaining striatal interneurons are GABAergic and are further classified by 
their expression of (a) parvalbumin, (b) somatostatin, neuropeptide Y and nitric 
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oxide synthase, and (c) calretinin (Kawaguchi et al., 1995). Of these 
parvalbumin expressing interneurons make up 1% of the striatum (Berke, 2011) 
and are termed fast-spiking (FS) based on their fast-firing and short duration 
action potentials with a short-spike after-hyperpolarization. Less is known about 
the function of these neurons however they receive excitatory inputs from the 
cortex and thalamus, and inhibitory inputs from other interneurons and a 
subpopulation of neurons within the globus pallidus (Chang and Kita, 1992; 
Bevan et al., 1998; Sidibé and Smith, 1999; Ramanathan et al., 2002) and in 
turn act in synchrony to modulate MSNs via many GABAergic synapses (Bennett 
and Bolam, 1994; Tepper and Koós, 1999; Kubota and Kawaguchi, 2000; 
Fukuda, 2009). 
GABAergic interneurons expressing somatostatin, neuropeptide Y, and nitric 
oxide synthase exhibit low-threshold and persistent plateau depolarizations, high 
input resistance, and relatively depolarized resting potentials, and are termed 
low-threshold spiking (LTS) interneurons (Kawaguchi, 1993). LTS interneurons 
receive innervation from, cortex, thalamus and direct pathway MSNs and in turn 
project back to MSNs (Kubota et al., 1988; Vuillet et al., 1989). Finally, 
GABAergic interneurons expressing calretinin are found predominantly within the 
rostral-medial region of the caudate putamen, where they are proposed to act as 
‘calcium-buffers’ stabilising the concentration of free calcium ions within MSNs 
(Baimbridge, Celio and Rogers, 1992; Résibois and Rogers, 1992). Calretinin 
expressing neurons exhibit similar electrophysiological properties to LTS 
interneurons, of which they can be considered a sub-type, however they receive 
cortical but not thalamic input (Sidibé and Smith, 1999). The physiological role 
of LTS neurons in the striatum has yet to be elucidated.  
1.2.3.5. The Dorsal and Ventral Striatum 
Classically, the striatum has been divided into two subregions, dorsal and 
ventral, based on the different cortical, thalamic and dopaminergic afferents to 
each region (McGeorge and Faull, 1989). Broadly, the dorsal striatum comprises 
the caudate nucleus and putamen, whereas the ventral striatum incorporates the 
nucleus accumbens (NAc) core and shell, olfactory tubercle, and the 
ventromedial portions of the caudate and putamen. It has been difficult to 
clearly define anatomical boundaries between these subregions therefore a 
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functional delineation has been proposed leading to distinction between 
ventromedial and dorsolateral regions within the striatum (Voorn et al., 2004). 
This functional delineation is reflected structurally with cortical, thalamic and 
amygdaloid inputs into the striatum are predominantly arranged in a 
dorsolateral-to-ventromedial fashion.  
Premotor and motor cortical areas, the mediodorsal, ventroanterior and 
ventrolateral thalamus, and the central nucleus of the amygdala (CeA), primarily 
project to the caudate nucleus and putamen. Accordingly, the dorsal striatum 
mediates sensorimotor control and motor planning (Kemp and Powell, 1970; 
Aldridge, Anderson and Murphy, 1980; McFarland and Haber, 2000). The orbital 
and medial prefrontal cortex, midline and medial intralaminar nuclei, and 
basolateral amygdala (BLA), primarily project to the ventral striatum, 
particularly the NAc. Accordingly, the ventral striatum mediates reward-based 
learning and goal-directed behaviours  (Kunishio and Haber, 1994; Everitt et al., 
1999; Haber, 2003). The NAc also receives input from the ventral hippocampus, 
which mediates the development of context-based learning (Mattson et al., 
2007; Crombag et al., 2008). 
1.2.3.6. The Nucleus Accumbens (NAc) 
A large body of research has demonstrated that the Nucleus Accumbens (NAc), 
is a critical structure for mediating the rewarding and motivational properties of 
drugs of abuse (Caine et al., 2001; Everitt and Robbins, 2005). The NAc receives 
inputs from various BG nuclei, including the VTA and BLA, and from the 
prefrontal cortex (PFC), and in turn the NAc projects to various BG nuclei, and 
thalamic regions. The NAc has been proposed to be of central importance to the 
limbic-motor interface and thereby mediate goal-seeking actions in response to 
reward-predictive stimuli (Mogenson and Yang, 1991; Wise, 1998; Nicola, 
2007).  
All known drugs of abuse have been shown to increase dopamine release within 
the NAc, especially within the Shell sub-region (Wise, 1987, 1988; Di Chiara and 
Imperato, 1988; Pettit and Justice, 1989). Dopaminergic activity in the NAc 
underlies the ability of psychostimulants to increases locomotor activity. 
Selective lesion of dopaminergic neurons, induced by 6-OHDA, in the NAc 
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attenuated psychostimulant (amphetamine or cocaine) induced locomotor 
activity (Kelly, Seviour and Iversen, 1975; Kelly and Iversen, 1976; Joyce, 
Stinus and Iversen, 1983) as well as  attenuating cocaine, but not heroin, self-
administration (Pettit et al., 1984). Dopamine transmission in the NAc also 
modulates reward-based learning and conditioning. Direct injection of 
amphetamine into the NAc, thereby increasing dopamine transmission, enhances 
responding for reward-related stimuli (Taylor and Robbins, 1984) and this is 
blocked by 6-OHDA lesion of dopaminergic neurons in the NAc (Taylor and 
Robbins, 1986). 
The NAc can be divided into two sub-regions, the Core and Shell, which appear 
to have different roles in drug related behaviour. The efferent projections from 
the NAc differ between the Core and Shell (Heimer et al., 1991; Zahm and Brog, 
1992; Zahm and Heimer, 1993; Zahm, 1999). The NAc Core parallels basal 
ganglia circuitry by sending outputs through the ventral pallidum (dorsolateral 
district), subthalamic nucleus and substantia nigra, which in turn project via the 
motor thalamus to premotor cortical areas. In contrast, the Shell projects 
preferentially to subcortical limbic regions including the lateral hypothalamus, 
ventral pallidum and VTA (Zahm, 1999). Interestingly, there are also direct 
interconnections between core and shell neurons indicating that these NAc sub-
regions do not function completely independently, but rather comprise 
interacting neuronal networks (van Dongen et al., 2005). 
Rats will self-administer cocaine or alcohol into the NAc Shell but not Core 
(Rodd-Henricks et al., 2002; Engleman et al., 2009). Lesions of the NAc shell 
were sufficient to block cocaine- and amphetamine-CPP (Sellings and Clarke, 
2003; Sellings, McQuade and Clarke, 2006), whilst administration of cocaine in 
the NAc Shell, but not Core, facilitated psychostimulant-CPP (Liao et al., 2000). 
Similarly, infusion of amphetamine in the NAc Shell enhanced responding for 
sucrose-reward-related stimuli, but did so without increasing positive hedonic 
reactions to the sucrose (Wyvell and Berridge, 2000).  
The Nucleus Accumbens has also been found to be critical in mediating the 
phenomenon of behavioural sensitisation, i.e. increased behavioural effects of 
drugs including psychostimulants, ethanol and morphine following repeated 
administration (Tilson and Rech, 1973; Segal and Mandell, 1974; Cador, Taylor 
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and Robbins, 1991; Kalivas and Duffy, 1993; Hoshaw and Lewis, 2001). Lesions 
of the NAc Shell attenuated of the induction of, but not expression of, 
behavioural sensitisation to cocaine (Todtenkopf et al., 2002; Todtenkopf, Stellar 
and Melloni, 2002), and infusions of cocaine or amphetamine to the NAc Shell, 
but not Core, induced behavioural sensitisation (Pierce and Kalivas, 1997). 
Further, after repeated administration of drugs of abuse (including 
psychostimulants, opiates and alcohol) exposure to those drugs caused greater 
dopamine release with the NAc (Di Chiara and Imperato, 1988; Wise, 1998). In 
addition, D1 dopamine receptors in the NAc show enhanced sensitivity to 
dopamine following repeated cocaine administration (Henry, Greene and White, 
1989; Henry and White, 1991). Repeated exposure to psychostimulant drugs 
also produces enduring alterations in intracellular signalling pathways and 
structural changes in neurons within the NAc (Nestler, Barrot and Self, 2001). 
For example, cocaine administration increased spine density on dendrites of 
MSNs in the NAc Shell, but not core (Robinson and Kolb, 1999; Robinson et al., 
2001). The neural sensitisation of the NAc and corresponding behavioural effects 
are extremely robust, the enhanced behavioural response has been found to 
endure persistently up to a year after the final drug exposure, and possibly 
longer (Paulson, Camp and Robinson, 1991; Boileau et al., 2006). 
Robinson and Berridge (1993) have argued that repeated exposure also leads to 
sensitisation to the incentive motivational properties of drugs. They propose an 
‘incentive-sensitisation’ theory of addiction whereby neural substrates mediating 
the attribution of incentive salience, termed ‘wanting’, are sensitised by repeated 
drug exposure. In contrast substrates which mediate the hedonic experience of a 
drug, termed ‘liking’, are dissociable and remain unsensitised or diminished 
(Robinson and Berridge, 2008). Given the evidence of cross-sensitisation 
between drugs of abuse, it has been proposed that these effects may be 
mediated by common neural mechanisms (Horger, Shelton and Schenk, 1990; 
Kalivas and Stewart, 1991; Cunningham and Kelley, 1992; McDaid et al., 2005). 
Supporting this theory, it has been demonstrated that sensitisation with 
amphetamine, cocaine, morphine or ethanol has facilitated the subsequent 
acquisition of self-administration or CPP produced by the same drug, or by a 
different drug (Lett, 1989; Horger, Shelton and Schenk, 1990; Piazza et al., 
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1990; Mendrek, Blaha and Phillips, 1998; Hoshaw and Lewis, 2001; Camarini 
and Hodge, 2004; McDaid et al., 2005). A dissociation between ‘wanting’ and 
‘liking’ is evidenced by anatomically distinct substrates of the reinforcing effects 
of drugs compared with the hedonic properties of rewarding stimuli (Robinson 
and Berridge, 1993; Wyvell and Berridge, 2000).  
GABAergic activity in the NAc has been implicated in mediating the hedonic and 
reinforcing properties of natural rewards as well as drugs of abuse. Injections of 
GABAA receptor agonists directly into the NAc shell increased consumption of 
sucrose but did not affect water consumption (Basso and Kelley, 1999) whilst 
injection of GABAA antagonists is sufficient to reduce alcohol consumption 
(George F. Koob, 2004). Injection of the GABAA agonist muscimol into the rostral 
NAc shell induced CPP, whereas infusion into the caudal NAc Shell induced 
conditioned place aversion (Reynolds and Berridge, 2001; Reynolds, Hyland and 
Wickens, 2001) indicating that GABAergic receptors in those subregions of the 
NAc mediate important and opposing roles in associative conditioning. 
1.2.4. The Ventral Tegmental Area (VTA) 
The VTA is notable as the origin of dopaminergic input in the mesolimbic 
dopamine system. It projects to the striatum, in particular the NAc, as well as 
the amygdala, hippocampus and prefrontal cortex (Swanson, 1982; Albanese 
and Minciacchi, 1983; Ikemoto, 2007). The VTA also sends GABAergic and 
glutamatergic projections to the NAc and prefrontal cortex. 
By various mechanisms drugs of abuse increase activation of dopamine neurons 
in the VTA which release dopamine to downstream targets, primarily the NAc 
(reviewed, Oliva and Wanat, 2016). Rodents readily self-administered cocaine, 
morphine, nicotine or ethanol directly into the VTA (Bozarth and Wise, 1981; 
Corrigall, Coen and Adamson, 1994; David et al., 2004; Rodd et al., 2004), and 
correspondingly, lesions of the VTA attenuate or abolish self-administration of 
cocaine and heroin (Roberts and Koob, 1982; Bozarth and Wise, 1986).  
The repeated administration of cocaine, amphetamine or dopamine re-uptake 
inhibitors directly into the VTA initiates behavioural sensitisation (Vezina, 1996; 
Cornish and Kalivas, 2001). It has therefore been proposed that 
neuroadaptations of the VTA predominantly mediate the initiation of behavioural 
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sensitisation, while the NAc is required for the expression of sensitisation (White 
and Kalivas, no date; Kalivas and Stewart, 1991; Pierce and Kalivas, 1997). 
Cocaine-evoked dopamine release was enhanced in the VTA of cocaine-
sensitized animals (Parsons and Justice, 1993) and dopamine neuron excitability 
was enhanced in the VTA of animals with a history of repeated exposure to 
amphetamine, cocaine, or ethanol (White and Wang, 1984; Henry, Greene and 
White, 1989; Brodie, 2002). Electrophysiological studies have demonstrated that 
single or repeated exposure to drugs of abuse, including cocaine, amphetamine, 
ethanol, morphine, and nicotine, induced long-term potentiation (LTP) of VTA 
dopamine neurons (Ungless et al., 2001; Saal et al., 2003; Borgland, Malenka 
and Bonci, 2004). 
VTA neurons have also been found to increase their firing rate in response to a 
conditioned stimulus previously paired with primary rewards (Schultz, Dayan 
and Montague, 1997; Fiorillo, Tobler and Schultz, 2003). Injection of the GABAA 
agonist muscimol into the VTA abolished the ability of conditioned cues to 
increase instrumental responding in a test of Pavlovian to instrumental transfer 
(PIT), as well as decreasing cocaine-seeking maintained by conditioned 
reinforcers (Di Ciano and Everitt, 2004; Murschall and Hauber, 2006). In-vivo 
recordings of rats responding in an operant task revealed that injection of 
dopamine agonists into the VTA blocked NAc neuronal firing responses to 
incentive cues and behavioural responding; indicating VTA dopaminergic input to 
the NAC is required for goal directed behaviour (Yun et al., 2004). 
GABAARs within the VTA are likely to modulate reward processing. Ligands acting 
directly at GABAARs have been shown to be freely self-administered directly into 
the VTA (David et al, 1997). Within the VTA GABAARs are predominantly located 
on GABAergic neurons which provide tonic inhibitory inputs onto other, 
dopaminergic, VTA neurons as well as projecting to the NAc and pre-frontal 
cortex (Johnson and North, 1992). Firing of GABA neurons in the VTA is 
facilitated during cues that predict appetitive rewards (Cohen et al., 2012) and 
optogenetic experiments revealed that stimulation of VTA GABA neurons 
suppressed the release of DA within the NAc (van Zessen et al., 2012). Thus, 
activity at GABAARs will alter neurotransmission between GABA and DA neurons 
19 
 
 
within the VTA, as well as projections fibres to the NAc, thereby modulating 
reward processing.  
1.2.5. The Ventral Pallidum (VP) 
The ventral pallidum (VP) is a central convergent point for input from the NAc, 
orbitofrontal and prefrontal cortex, amygdala, lateral hypothalamus, ventral 
tegmental area, subthalamic nucleus, and other structures related to reward 
(Smith et al., 2009). The VP projects back to nearly all its input sources, 
including the NAc, for reciprocal information exchange and translates limbic 
motivation signals into motor output (Mogenson, Jones and Yim, 1980; 
Mogenson and Yang, 1991; Groenewegen, Berendse and Haber, 1993; Churchill 
and Kalivas, 1994). 
In particular NAc to VP projections have been proposed as a major mechanism 
of translation of motivational signals to motor output (Mogenson and Yang, 
1991). It has also been proposed that release of VP neurons from the tonic 
inhibition by GABAergic inputs from the NAc is a primary ‘downstream’ 
mechanism by which hyperpolarizations in the NAc stimulate reward and 
motivation (Smith et al., 2009).  
Lesions of the VP, or inactivation by the GABAA agonist muscimol, decrease 
voluntary food and drink consumption, in fact replacing positive hedonic taste 
reactions with aversive reactions (Cromwell and Berridge, 1993; Shimura, 
Imaoka and Yamamoto, 2006). Conversely, GABA blockade in the VP fails to 
elevate hedonic reactions to taste rewards (Smith and Berridge, 2005) indicating 
that baseline neuronal activity in VP has a necessary role in normal hedonic 
valuation, although depolarization induced by GABAergic disinhibition is not 
sufficient to enhance hedonic valuation of food.  
The VP is also involved in processing rewarding stimuli and motivated behaviour. 
In-vivo recordings have demonstrated that sucrose rewards and conditioned 
cues predicting sucrose both elicit phasic burst firing in the VP (Tindell, Berridge 
and Aldridge, 2004). Lesion or inactivation of the VP attenuated or abolished the 
reinforcing properties of natural rewards and drugs of abuse. This includes 
attenuated Pavlovian incentive learning, reducing instrumental responding for 
alcohol or cocaine, and blocking acquisition and expression of sucrose, 
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amphetamine or morphine CPP (Robledo and Koob, 1993; Harvey et al., 2002; 
June et al., 2003). Electrophysiological evidence suggests that VP neurons use 
separate population- and firing rate activity-patterns to distinguish enhancement 
of ‘liking’ vs ‘wanting’ by amphetamine and opiates (Smith et al., 2009). 
The VP is critically involved in the development and expression of morphine-
induced behavioural sensitization and there is some evidence that it mediates 
psychostimulant-sensitisation. Blocking μ-opioid receptors within the VP is 
sufficient to block the development of sensitized motor responding to 
systemically administered morphine (Johnson & Napier, 2000). Dopamine 
release in the VP is increased by sensitisation to methamphetamine where it also 
induced long-lasting upregulation of pCREB and ΔFosB expression. Cross 
sensitisation to morphine in cocaine sensitised rats correlated with increased 
sensitivity of VP neurons to morphine and decreased GABAergic activity there 
(McDaid et al., 2005). VP neurons projecting to the VTA show increased cFos 
expression following cue-induced reinstatement for cocaine (Mahler & Aston-
Jones, 2012) and silencing these neurons via DREADDs was sufficient to blocking 
cue-induced reinstatement (Mahler et al., 2014). 
1.2.6. The Prefrontal Cortex (PFC) 
The prefrontal cortex (PFC) projects to multiple sites within the mesolimbic 
dopamine system, including the VTA and NAc. These glutamatergic projections 
inducing burst firing of DA neurons in those regions (Sesack et al., 1989; 
Chergui et al., 1993; Carr and Sesack, 2000). GABAergic neurons within the PFC 
can also modulate NAc and VTA activity indirectly by inhibiting PFC 
glutamatergic afferents to various BG nuclei (Christie et al., 1987; Matsumura, 
Sawaguchi and Kubota, 1992). 
Clinically reduced volume and damage of the PFC are common features of people 
with addictions to illicit drugs (Liu, M.D. et al., 1998) and alcohol (Pfefferbaum et 
al., 1997). This damage is related to increased impulsivity associated with 
addiction (Crews and Boettiger, 2009). Neuroimaging studies reveal activation of 
the orbitofrontal cortex of addicted subjects during intoxication, craving, and 
bingeing, and deactivation during withdrawal (Goldstein and Volkow, 2002). 
Cognitive functions supported by neurons in the PFC are disrupted by acute and 
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chronic exposure to alcohol and ethanol inhibits persistent activity and spike 
firing of PFC neurons in-vivo (Tu et al., 2007). 
Cocaine elicits increased dopamine release in the medial PFC (mPFC) (Sorg and 
Kalivas, 1993). However, while the cocaine-induced increase in dopamine levels 
in the NAc and VTA is augmented following cocaine-sensitisation (Di Chiara and 
Imperato, 1988; Henry, Greene and White, 1989; Schultz, Dayan and Montague, 
1997), the response of extracellular dopamine levels in the mPFC is attenuated 
(Prasad, Hochstatter and Sorg, 1999). Interestingly, administration of low-dose 
methamphetamine to the mPFC abolished behavioural sensitisation indicating 
decreased mPFC dopamine release contributes to behavioural sensitisation. 
GABA is known to modulate dopamine and glutamatergic systems in the mPFC. 
In cocaine-sensitised rats a challenge injection of cocaine, but not saline, 
resulted in a significant increase in extracellular GABA levels in the mPFC at 1 
and 7 days but not 28 days following repeated cocaine exposure (Jayaram and 
Steketee, 2005). Morphine-induced CPP was potentiated or attenuated by 
GABAAR agonists and antagonists respectively (Rozeske et al., 2009). 
1.2.7 The Amygdala 
Classically the amygdala has been associated with the modulation of memory 
consolidation and emotional learning, including appetitive and fear conditioning 
(Everitt, Cardinal, Parkinson, & Robbins, 2003; Gallagher, Graham, & Holland, 
1990; McGaugh, 2002; McIntyre et al., 2003; Wilensky, Schafe, & LeDoux, 
2000).  
The Central Amygdala (CeA) has been highly implicated as a critical locus of 
neuroadaptation during transition to alcohol dependence (Roberto, Gilpin, & 
Siggins, 2012). The CeA is composed mostly of GABAergic projection neurons 
and interneurons (Sun & Cassell, 1993; Veinante & Freund-Mercier, 1998). 
Acute alcohol increases GABAergic synaptic transmission in the CeA (Roberto et 
al., and BLA (Zhu and Lovinger, 2006) via increased presynaptic GABA release. 
Further, in-vitro electrophysiological results show that chronic alcohol exposure 
augments baseline GABA release in the CeA (Roberto et al., 2004). Infusion of a 
GABAAR antagonists directly into the amygdala suppresses drinking by alcohol-
dependent rats without affecting intake by nondependent controls (Roberts, Cole 
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and Koob, 1996). Injection of GABAAR antagonists more specifically in the CeA 
suppressed alcohol drinking by nondependent rats as well (Hyytiä and Koob, 
1995). 
The BLA projects heavily to the NAc as well as the medial PFC (mPFC) and 
hippocampus, and is proposed to play an important role in mediating 
motivational behaviour (Balleine, Killcross, & Dickinson, 2003; Everitt et al., 
2003). The BLA forms a cortico-subcortico ‘loop’ with the mPFC which is 
proposed to be important for integrating affective information with stimulus 
properties, thus mediating stimulus-outcome associations (Everitt et al., 2003; 
Quirk et al., 2003). The BLA also sends glutamatergic projections to NAc MSNs 
which are proposed to modulate incentive motivational properties of reward-
associated stimuli (Quirk et al., 2003b; Stuber et al., 2011). 
Lesions of the BLA attenuate sucrose, cocaine or morphine CPP, as well as 
attenuating cue-induced reinstatement of cocaine self-administration (Everitt, 
Morris et al., 2002; Milekic et al., 2006; Nicola, 2004). In-vivo recordings during 
operant tasks have been used to demonstrate that BLA neurons fire phasically in 
response to reward-predictive cues (Tye & Janak, 2007; Uwano et al., 1995). 
Increased extracellular dopamine was observed in the BLA of rats during a 
discriminative operant task (Hori, Tanaka and Nomura, 1993; Weiss et al., 
2000) and injection of dopamine agonists into the BLA has also been shown to 
enhance appetitive Pavlovian conditioning in a discriminative approach task 
(Hitchcott, Bonardi and Phillips, 1997).  
Lesion of the BLA did not affect the development of normal conditioned 
responding to a stimulus paired with a food reward (Hatfield et al., 1996) 
however it abolished the ability of rats to adjust responding to the conditioned 
stimuli when the reward was devalued (Balleine, Killcross and Dickinson, 2003). 
This suggests that the BLA is necessary for encoding the value of a rewards 
associated with conditioned stimuli.  
Interestingly, D1- and D2-expressing neuronal populations in the BLA appear to 
mediate drug reinforcement via mechanisms which are dependent upon prior 
drug experience. Intra-BLA injection of D1 but not D2 receptor antagonists 
blocked morphine CPP in drug-naïve rats whereas the reverse, D2 but not D1 
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receptor antagonists, blocked CPP in drug-dependent and animals in drug 
withdrawal (Lintas et al., 2011). In this study the affective doses also reduced 
neuronal firing in the NAc shell suggesting this is an important pathway in opiate 
reinforcement. 
Lesions of the amygdala have had mixed effects on behavioural sensitisation to 
amphetamine, either blocking or having no effect on the development of 
sensitization (Cador et al. 1999; Wolf et al., 1995). The BLA may mediate 
adaptive changes in response to drug related stimuli. Cocaine-seeking behaviour 
elicited by cocaine-paired environmental stimuli was found to be associated with 
an increase in cFos expression in the BLA, as well as the NAc and hippocampus 
(Neisewander et al., 2000). 
1.2.8. The Hippocampus 
The hippocampus underlies learning of associations between environmental 
contexts and rewarding or aversive stimuli. Environmental ‘triggers’ are known 
to induce drug seeking behaviour and relapse (Robbins and Everitt, 2002). 
Lesion of the hippocampus shortly prior to foot-shock conditioning prevented the 
expression of conditioned fear in an associated environment (Kim and Fanselow, 
1992). This effect was observed when lesions were made 1 day, but not at 28 
days, after training which indicates formation but not expression of the 
association is affected. 
Similarly, lesions or pharmacological inactivation of the hippocampus abolish 
both the acquisition and expression of cocaine or morphine CPP (Meyers, Zavala, 
& Neisewander, 2003; Meyers et al., 2006; Milekic et al., 2006) and impair 
acquisition of operant cocaine self-administration (Caine et al., 2001). Cocaine-
seeking behaviour elicited by cocaine-paired environmental stimuli was found to 
be associated with an increase in cFos expression in the hippocampus 
(Neisewander et al., 2000). 
Stimulation of the ventral subiculum of the hippocampus induced dopamine (DA) 
release within the NAc via increased firing of dopaminergic VTA projections 
(Brudzynski and Gibson, 1997; Legault, Rompré and Wise, 2000). Stimulation of 
the hippocampus also potentiated the ability of contextual cues to reinstate drug 
seeking behaviour following extinction of operant cocaine-self administration in 
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rats. Accordingly, this effect was blocked by pharmacological inactivation of the 
hippocampus (Luo, Callaway, & Svoboda, 2008; Vorel et al., 2001). Notably this 
effect was also dependant on glutamatergic input from the VTA. 
Lesion of the hippocampus abolished the potentiating effect of intra-NAc 
amphetamine on locomotor activity (Burns, Robbins and Everitt, 1993) and 
inactivation of the dorsal, but not the ventral, hippocampus blocked the 
expression of amphetamine sensitization (Degoulet et al., 2008). The dorsal and 
ventral hippocampus have been implicated in context- and cue-dependent 
reinstatement, respectively (Fuchs et al., 2005; Sun & Rebec, 2003) indicating 
this effect may be due to the modulating effect of environmental contexts in 
sensitisation.  
Behavioural sensitization to amphetamine has also been associated with 
enhanced ventral hippocampal modulation of dopamine neuronal activity (Lodge 
and Grace, 2008; Britt et al., 2012) demonstrated that long-term withdrawal 
from repeated cocaine administration produced an increase in synaptic strength 
selectively in the ventral hippocampal input to the NAc shell. Furthermore, 
inactivation of the said input to the NAc during attenuated cocaine-induced 
locomotion in a specific environment. 
1.3. GABAA Receptors 
1.3.1. The Structure of GABAA receptors 
GABA receptors fall into two classes: GABAA and GABAB. GABAA receptors 
(GABAARs) are ligand gated ion channels i.e. ionotropic receptors, whereas 
GABAB receptors (GABABRs) are G protein-coupled receptors i.e. metabotropic 
receptors. Here we will focus primarily on GABAARs. 
GABAARs are heteropentameric chloride channels, consisting of five 
heterogenous protein subunits arranged around a central pore. They belong to a 
large ‘super-family’ of evolutionarily and structurally related cys-loop ligand-
gated ion channels which includes nicotinic acetylcholine receptors, glycine 
receptors, and the 5-HT3 receptor (Goetzet al., 2007). These can be further 
classified into several isoforms based on the different combination of subunits 
present in each, i.e. their stoichiometry. 
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In humans there currently known to be 18 GABAAR subunits, which can be 
divided by sequence homology into seven subunit categories. There are six α 
subunits (α1-6), three β subunits (β1-3), three γ subunits (γ1-3), three ρ 
subunits (ρ1-3), and one each of the ϵ, δ, θ, and π subunits. Five subunits can 
combine in different ways to form GABAA receptors with the minimum 
requirement both α and β subunits (Baumann, Baur, & Sigel, 2001). Despite the 
potential for vast numbers of individual receptor isoforms GABAA receptors 
typically consist of two α-subunits, two β-subunits and either a γ- or δ-subunit 
(Whiting, McKernan and Wafford, 1995; Sieghart, 2006). 
GABAAR subunits consist of four hydrophobic transmembrane domains (TM1–4) 
made up of ~20 amino acids with both the N- and C-terminus located 
extracellularly. Of these, the TM2 domain lines the pore of the channel (Jacob, 
Moss and Jurd, 2008). GABA binds to a site at the large extracellular N-terminus 
at the interface between an α and β subunit where the binding of two GABA 
molecules induces channel opening (Baumann, Baur, & Sigel, 2003). The binding 
sites for several psychoactive drugs also fall within the extracellular N-terminus 
such as benzodiazepines (between α and γ) and barbiturates (between α and β) 
(Johnston, 2005).  
Selective assembly of GABAAR isoforms occurs within the endoplasmic reticulum 
and can therefore be selectively expressed and targeted to specific subcellular 
localities. Differences in subunit composition, i.e. subtype, confer differences in 
receptor, location, function, physiology and pharmacological properties (Goetz et 
al., 2007).  
1.3.2. Synaptic and Extrasynaptic GABAA receptors  
Historically it was observed that GABAARs mediate inhibition via fast ‘phasic’ 
transmission of activity occurring within the synapse. Subsequently, certain 
GABAAR isoforms have been physiologically characterised which are commonly 
located extrasynaptically, either perisynaptically or distant from synapses. 
Typically, synaptic GABAARs comprise of α1, α2, or α3 in combination with β2/3 
and γ2 subunits, whereas tonic extrasynaptic GABAARs predominantly comprise 
of α4, α5 or α6, coupled with β2/3 and δ subunits, although there is some 
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evidence of α1 and γ within extrasynaptic GABAARs (Barnard et al., 1998; 
Mortensen et al., 2010). 
Because GABAAR receptors are expressed in many different subcellular and 
anatomical locations the concentration of GABA each population is exposed to 
will also vary widely. Accordingly, the GABAAR sub-types have different 
pharmacological properties including sensitivity to both endogenous molecules, 
such as GABA and neurosteroids, and exogenous drugs (Baumann et al., 2001; 
Johnston, 2005; Mortensen et al., 2010). 
Since they are not located at the synapse, where high concentrations of GABA 
are available intermittently during phasic transmission, extrasynaptic GABAARs 
are adapted to be sensitive to low levels of ambient or ‘spill-over’ GABA which 
generates a sustained ‘tonic’ form of inhibition ( Brickley & Mody, 2012; Farrant 
& Nusser, 2005; Wei et al., 2003).  
The α subunit has been most highly implicated in GABA sensitivity of synaptic 
receptors. By combining radioligand binding and electrophysiology with 
mutagenesis it has been possible to identify four amino acids in the extracellular 
N-terminal region of α subunits which largely determine GABA sensitivity of 
typical αβ3γ2 GABAARs (Böhme, Rabe and Lüddens, 2004). Studies manipulating 
the α subunit reveal EC50 values (concentration of a drug that elicits half-
maximal response) of the GABA-induced chloride current to vary between <1 to 
>50 µM, with a rank order α6>α1>α2>α4>α5>α3 (Böhme, Rabe and Lüddens, 
2004; Minier and Sigel, 2004). Despite this ranking, sensitivity to GABA is 
increased in extrasynaptically located α4βδ extrasynaptic GABAARs compared to 
synaptic α4βγ2 GABAARs indicating that other subunits contribute to increased 
sensitivity of extrasynaptic receptors (Mortensen et al., 2010; Jensen et al., 
2013). 
Extrasynaptic receptors have a higher affinity to GABA and slower 
desensitisation in comparison to their synaptic counterpart (Belelli et al., 2009). 
Furthermore, α4β3δ extrasynaptic GABAARs are also differentially sensitive to a 
number of allosteric modulators and neurosteroids (Lambert et al., 2003).  
Compared with synaptic GABAARs, δ subunit-containing extrasynaptic receptors 
are highly sensitive to low, physiologically relevant concentrations of 
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neurosteroids. This has been demonstrated by experiments on recombinant 
receptors (Belelli et al., 2002; Wohlfarth, Bianchi, & Macdonald, 2002) and the 
reduced behavioural sensitivity of δ subunit knock-out mice to endogenous and 
synthetic neuroactive steroids (Mihalek et al., 1999). 
Similarly, the GABAA agonist muscimol has a higher potency at extrasynaptic 
α4β3δ GABAARs compared to synaptic α4β3γ2 and α1β3γ2 GABAARs, though this 
difference may be caused by reduced desensitisation (Mortensen et al., 2010).  
Extrasynaptic GABAARs are typically insensitive to benzodiazepine agonists 
(Belelli et al., 2009) but can be activated by low concentrations of drugs acting 
as super-agonists at the GABA-binding sites, as well as taurine and γ-
hydroxybutyrate (Jia et al., 2008; Halonen et al., 2009; Herd et al., 2009; 
Wafford et al., 2009; Absalom et al., 2012). 
Notably, Gaboxadol® (THIP; 4,5,6,7-tetrahydroisoxazolo-5,4-c]pyridin-3-ol), 
acts as a high-efficacy ‘super-agonist’ at δ-containing extrasynaptic GABAARs 
where it increases the frequency and duration of channel opening.  In contrast, 
on αβγ-type synaptic receptors THIP has only partial agonist activity (Ebert et 
al., 1994; Mortensen et al., 2004). 
More recently a novel, highly specific, positive allosteric modulator of δ-
containing GABAARs has been created: delta-selective compound 2 (DS2). An in-
vitro concentration-response curve indicates that DS2 produces a similar peak 
stimulated inhibitory current as THIP in α4βδ receptors; however, unlike THIP  
DS2 does not produce any response in α4βγ2 or α1βγ2 receptors even at high 
doses (Jensen et al., 2013; Mortensen et al., 2010). 
1.3.3. Differential targeting of Synaptic and Extrasynaptic GABAA 
receptors 
Subunit composition also appears to direct the sub cellular localisation of 
GABAARs. More than 20 intracellular or transmembrane proteins have been 
identified which interact with TM3–TM4 intracellular loops, often very specifically 
with a certain subunit, to regulate the surface expression of receptors (Uusi-
Oukari and Korpi, 2010). 
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Targeted deletion of γ2 results in reduced synaptic GABAAR clustering indicating 
its role in localising synaptic receptors. The γ2 subunit mediates this via complex 
interactions with synaptic scaffolding proteins gephyrin, collybistin and 
neuroligin-2 (Essrich et al., 1998; Poulopoulos et al., 2009). However, it appears 
that combination with other subunits in certain isoforms may nullify the synaptic 
anchoring properties of the γ2 subunit which has also been found to couple with 
α5 and α6 within extrasynaptic GABAARs in hippocampal and cerebellar granule 
cells, respectively (Crestani et al., 2002; Wisden et al., 2002). The δ subunit is 
expressed exclusively in extrasynaptic GABAARs (Belelli et al., 2009) however 
there are extrasynaptic receptors lacking δ subunits, such as α5βγ2 receptors. 
Together these receptors demonstrate that γ2 and δ subunits cannot be solely 
responsible for guiding GABAA-R targeting (Brünig et al., 2002; Glykys et al., 
2007; Serwanski et al., 2006). 
More recent studies found that different α subunits also direct GABAAR 
localisation. The α2 subunit has been demonstrated to bind directly to gephyrin 
(Tretter et al., 2008). When molecularly engineered to pair with the same 
chimeric δ-γ2 subunit, different α subunits (α2 versus α6) dictated synaptic 
versus extrasynaptic targeting respectively (Wu et al., 2012). Additionally, when 
they were engineered to interact with gephyrin α6βδ receptors were recruited to 
synaptic sites. Thus, synaptic GABAAR targeting is controlled by specific subunit 
composition and the ability to interact with gephyrin. 
As well as targeting GABAARs to the synapse accessory proteins are also able to 
modify channel kinetics. GABAA receptor-associated protein (GABARAP) binds 
and links the intracellular domains of γ2 subunits which promotes clustering of 
GABAARs and thereby induces cooperative opening and closing of channels 
(Chen et al., 2000). 
Comparatively, less is known about the targeting of extrasynaptic receptors. The 
extrasynaptic localization of receptors containing the α4, α5, and δ subunits 
appears to depend on structural motifs that either prevent interaction with the 
postsynaptic scaffolding molecule gephyrin or allow interaction with radixin - an 
actin-binding protein. Extrasynaptic receptors (α4βδ) do not colocalise with 
gephyrin (Crestani et al., 2002; Goetz et al., 2007; Kralic et al., 2006). α5-
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GABAARs were found to interact with radixin which thereby anchors them at 
extrasynaptic sites (Loebrich et al., 2006). 
1.3.4. Expression of GABAAR subunits in the mammalian brain  
Immunocytochemical and in-situ-hybridisation analysis has revealed that GABAA 
receptor subunit isoforms each exhibit unique distributions throughout the brain 
(Laurie, Seeburg, & Wisden, 1992; Laurie, Wisden, & Seeburg, 1992; Wisden et 
al., 1992). 
α1 and α2 subunits are found extensively throughout the brain, with α1 being 
the most abundantly expressed (Pirker et al., 2000; Wisden et al., 1991). The 
α3 subunit isoform is localised to the cerebral cortex, olfactory bulb and brain 
stem nuclei (Persohn, Malherbe, & Richards, 1992; Pirker et al., 2000; Wisden et 
al., 1991). The α4 subunit is most highly expressed in the thalamus and 
otherwise distributed throughout the NAc, hippocampus, neocortex and caudate-
putamen. Within the striatum it is most highly expressed in the NAc (Pirker et 
al., 2000; Schwarzer et al., 2001; Wisden et al., 1991). The α5 subunits is 
highly expressed within the hippocampus, moderately expressed within the 
hypothalamus, neocortex and olfactory bulb, and slightly expressed within the 
striatum (Ade et al., 2008; Laurie et al., 1992; Mendez et al., 2013; Persohn et 
al., 1992). Finally, the α6 subunit is expressed specifically in the cerebellar 
granule cells, hippocampal pyramidal neurons, and cochlear nucleus granule 
cells (Wisden et al., 2002; Wisden et al., 1991). 
All three β subunits are found throughout the brain and their distribution often 
overlaps (Pirker et al., 2000). β1 subunits are most highly expressed in the 
hippocampus and olfactory bulb, and to a lesser extent in the cerebral cortex, 
cerebellum, superior colliculus and substantia nigra (Persohn, Malherbe and 
Richards, 1992; Wisden et al., 1992). β2 subunits are widely expressed, most 
highly in the pallidum and thalamus, and their distribution often overlaps with 
the α1 subunit (Moreno, et al., 1994; Pirker et al., 2000; Wisden et al., 1992). 
Finally, the β3 subunit is most highly expressed in the striatum and its 
distribution often overlaps with the α2 subunit (Miralles, et al., 1999; Pirker et 
al., 2000). 
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γ1 subunit expression is minimally expressed throughout the brain and most 
highly expressed in the bed nucleus of the stria terminalis (Pirker et al., 2000). 
In contrast, γ2 subunits are highly expressed almost ubiquitously in the brain 
(Wisden et al., 1992; Pirker et al., 2000). The γ3 subunit is also expressed at 
low levels throughout the brain (Pirker et al., 2000).  
The δ subunit is most highly expressed in the cerebellar granule cells, and 
moderately expressed in the thalamus, striatum, hippocampal dentate granule 
cells and neocortex (Persohn et al., 1992; Schwarzer et al., 2001; Wisden et al., 
1992) . GABAAR δ subunits, which are expressed exclusively in extrasynaptic 
GABAARs, partner either with α6 or α4 subunits in the cerebellum and forebrain 
respectively (Jones et al., 1997; Peng et al., 2002).  
Expression of ρ subunits is restricted to cerebellum, colliculi and retina (Boue-
Grabot et al., 2002; Alakuijala et al., 2005). The θ and ε subunits show 
remarkably overlapping expression throughout the brain and typically form 
receptors with α3 subunits. They are most highly expressed in the dorsal raphe 
and the locus coeruleus (Bonnert et al., 1999; Pape et al., 2009). As yet, there 
is no evidence of π subunit expression within the mammalian CNS, but it is 
known to be highly expressed within the uterus (Hedblom and Kirkness, 1997). 
1.4. Ethanol 
1.4.1. Neurobiology of ethanol abuse 
The neurobiology of alcohol abuse has been difficult to dissect as alcohol 
mediates its effects via a wide range of molecular targets (Ron and Barak, 
2016). Studies suggest that dopamine also has a role in the incentive motivation 
associated with acute alcohol intoxication. For example, direct injections of 
dopamine antagonists into the NAc attenuate alcohol consumption (Hodge, 
Samson, & Chappelle, 1997; Rassnick, Pulvirenti, & Koob, 1992). Furthermore, 
voluntary alcohol consumption and alcohol predictive cues induce dopamine 
release in the NAc (Weiss, et al., 1993). However, lesions of the mesolimbic 
dopamine system do not completely abolish alcohol-reinforced behaviour, 
indicating that dopamine is an important, but not essential, component of 
alcohol reinforcement (Rassnick, Stinus and Koob, 1993). 
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Alcohol reinforcement is mediated in part by the release of endogenous opioids 
in the brain. Opioid antagonists acting either at all opioid receptor subtypes or 
only at specific subtypes suppress alcohol drinking in a variety of species and 
models (reviewed, Ulm et al. 1995). Furthermore, genetic deletion of the μ-
opioid receptor blocks alcohol self-administration in transgenic mice (Roberts et 
al., 2000). Naltrexone, a subtype-nonspecific opioid receptor antagonist, is 
currently used as a treatment for alcoholism. Opioid receptor antagonists 
interfere with alcohol’s rewarding effects by acting on sites in the VTA, NAc, and 
central nucleus of the amygdala (Koob, 2003, 2014). 
Research on two of the major neurotransmitter systems in brain, GABA and 
glutamate, has identified key pathways for ethanol-induced intoxication and 
reinforcement. Ethanol has been found to inhibit the function of NMDA receptors, 
in a selective manner, to reduce calcium entry into neurons. Electrophysiological 
assessment of the effects of ethanol on NMDA receptor-mediated demonstrated 
that in the hippocampus and striatum concentrations of ethanol as low as 10–
25mM were able to significantly inhibit NMDA receptor function (Hoffman et al., 
1989; Lovinger, White, & Weight, 1989; Woodward & Gonzales, 1990). The 
effect of ethanol on NMDA receptor function is only modestly influenced by 
subunit composition (Honse et al., 2004). Behaviourally injection of glutamate 
antagonists into the NAc have been found to reduce ethanol self-administration 
(Rassnick, Pulvirenti and Koob, 1992). 
1.4.2. GABAA receptors and Ethanol 
Historically, GABAergic systems were predicted as a mediator of ethanol’s action 
due to similarities between the behavioural effects of ethanol and 
benzodiazepines (reduced anxiety, sedation, anticonvulsant actions, produce 
tolerance/addiction), which are known to act through sites on GABAA receptors 
(Johnston, 2005). 
There is some convergence of pre-clinical evidence that agonism of GABAB 
receptors reduces alcohol consumption, motivation and withdrawal. 
Intraperitoneal (IP) injection of the GABAB receptor agonist baclofen dose 
dependently reduced ethanol consumption in rats (Colombo et al., 2000). IP 
baclofen and SKF 97541 (another GABAB agonist) also reduced operant self-
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administration of ethanol but also saccharin solution in mice (Besheer, Lepoutre 
and Hodge, 2004). 
In contrast opposite effects have been found using modulators of GABAA 
receptor activity. The GABAA antagonist RO15-4513 reduced ethanol self-
administration in alcohol preferring rats (Rassnick et al., 1993).  Ethanol 
consumption in rats was decreased by IP injection of the GABAA antagonist 
picrotoxin but was increased by the GABAA agonist THIP (Boyle et al., 1993) 
indicating bidirectional control of ethanol consumption via GABAARs. 
The effects of GABAergic compounds on ethanol consumption can be localised to 
specific brain regions. Alcohol drinking has been suppressed by GABAA and 
GABAB receptor antagonists when injected in the NAc, VP, bed nucleus of the 
stria terminalis (BNST), and amygdala (reviewed, Koob, 2004). Injections of the 
potent GABAA antagonist SR 95531 into the central amygdala (CA) or Nucleus 
accumbens (NAc) were sufficient to suppress responding in ethanol self-
administration (Hyytiä and Koob, 1995). Similarly, infusion of bicuculline or 
muscimol into the NAc supressed ethanol self-administration. 
 
1.4.3. Are GABAA receptors sensitive to ecologically valid doses of 
ethanol? 
Although GABAARs have been suggested to represent a primary target for 
ethanol, the direct effects of ethanol at postsynaptic receptors are achieved only 
at high concentrations (>40mM) unlikely to be achieved by social drinkers 
(Weiner and Valenzuela, 2006) which approaches the median lethal BEC in 
humans of ~72mM (Koski, Ojanperä and Vuori, 2002). Extrasynaptic GABA 
receptors were proposed as a target for ecologically valid doses of ethanol when 
it was observed that δ subunit-containing GABAARs are sensitive to much lower 
concentrations of ethanol (3 to 30mM) than GABAARs containing the γ subunit 
(Wallner, Hanchar and Olsen, 2003). As the γ subunit is necessary for the 
actions of benzodiazepines (Johnston, 2005) this presented a surprising 
differentiation of the actions of ethanol and benzodiazepines on GABAARs  
However, electrophysiological evidence for the effects of ethanol on α4βδ 
receptors is mixed. Early results found that low, ecologically valid doses of 
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ethanol enhanced GABAA gated current in Xenopus laevis oocytes expressing 
α4βδ receptors and that α4β3δ were uniquely sensitive to doses as low as 1mM 
(Sundstrom-Poromaa et al., 2002; Wallner, Hanchar and Olsen, 2003). This 
technique was also used to demonstrate that RO15-4513 blocked ethanol 
enhancement of α4βδ mediated current at doses that did not reduce GABA gated 
chloride current (Wallner, Hanchar and Olsen, 2006) suggesting a mechanism 
for the ability of RO15-4513 to reduce ethanol self-administration (Rassnick et 
al., 1993). These results are controversial as they are variable and have failed to 
replicate. Even in experiments which supported this model the ethanol 
concentration required for similar enhancement of current varied from 1mM 
(Sundstrom-Poromaa et al., 2002) to 30mM (Wallner, Hanchar and Olsen, 
2003). Independent experiments on Xenopus oocytes and human fibroblasts 
expressing rat, murine or human GABAA α4/b3/δ subunits reported that high 
doses of ethanol were required to enhance current; 100mM in oocytes and 
300mM in fibroblasts (Borghese et al., 2006). The Blood Ethanol Content (BEC) 
used to define ‘binge drinking’ equates to approximately 17mM (NIAAA, 2004) 
so these results are unlikely to be physiologically relevant.  
The function of GABAA receptors also is regulated by molecules known as 
neuroactive steroids (Lambert et al., 2003) that are produced both in the brain 
and in other, peripheral organs. Alcohol increases the brain levels of many 
neuroactive steroids (Morrow et al., 2001). Interestingly, this increased activity 
of neuroactive steroids in the brain following alcohol exposure is not dependent 
on their production by peripheral organs (Sanna et al., 2004). IP ethanol 
administration was found to greatly increase levels of the neurosteroid 
allopregnanolone (ALLOP) in the brain and this increase was much larger in 
alcohol-preferring relative to non-preferring rats (Barbaccia et al., 1999). IP 
injection of ALLOP has also been found to enhance ethanol consumption during 
operant self-administration and ‘two-bottle choice’ procedures in rats (Janak, 
Redfern, & Samson, 1998) and C57BL/6J mice (Sinnott, Phillips and Finn, 2002) 
respectively. Together, these findings suggest that neuroactive steroids are 
potential key modulators of altered GABA function during the development of 
alcohol dependence, likely acting directly at GABAA receptors. 
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The ability of alcohol to facilitate GABA neurotransmission may be limited by 
GABA feedback onto presynaptic GABABRs (Ariwodola & Weiner, 2004; Wan et 
al., 1996). For example, acute alcohol facilitates GABAergic transmission in 
hippocampus (Wu & Saggau, 1994) and NAc (Nie, Madamba, & Siggins, 2000) 
only if GABAB receptors are blocked. 
1.4.4. Different GABAAR isoforms affect alcohol consumption 
Specific, although low-efficacy, agonists of GABAARs containing the α1-subunit 
suppress alcohol drinking and seeking when they are injected into the CeA and 
VP (Harvey et al. 2002; June et al. 2003). In contrast, deletion of the α5 subunit 
had no effect on alcohol consumption or reinforcement (Stephens et al., 2005). 
Human genetic studies revealed that single nucleotide polymorphisms (SNPs) in 
the GABRA2 gene encoding the GABAA receptor α2 subunit are associated with 
alcohol dependence (Edenberg et al., 2004). In humans GABRA2 polymorphisms 
have been linked to the subjective response to ethanol, including the hedonic 
value of alcohol (Pierucci-Lagha et al., 2005; Haughey et al., 2008). In pre-
clinical studies deletion of the gabra2 gene in mice resulted in hypersensitivity to 
the acute effects of ethanol (sedation and ataxia) but did not alter ethanol self-
administration suggesting α2-GABAARs are not critically involved not in ethanol 
reinforcement but in its acute effects (Dixon et al., 2012). 
The selective α4βδ super-agonist THIP has been found to modulate ethanol 
consumption but with mixed results when injected IP, either reducing or 
increasing consumption (Boyle et al., 1993; Ramaker, Strong, Ford, & Finn, 
2012). When infused directly into the NAc THIP was found to attenuate drinking 
in mice; however, we have observed contradictory results under similar 
experimental conditions (Ramaker et al., 2015, MacPherson, Stephens and King 
unpublished data). Deletion of the GABAA δ subunit in mice reduced ethanol 
consumption (Mihalek et al., 2001) and several studies have found that α4βδ 
receptors in the NAc shell mediate alcohol consumption and reinforcement. 
Virally mediated knockdown of δ or α4 subunits in the NAc shell, but not core, 
reduced ethanol consumption and operant self-administration by rats (Nie, et al. 
2011; Rewal et al., 2009, 2012). Together these phenotypes strongly imply that 
α4βδ receptors in the NAc have a major role in the reinforcing effects of alcohol.  
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1.4.5. Ethanol regulation of GABAA gene expression 
Chronic alcohol exposure also leads to alterations in the GABAA systems. In 
some brain regions, alcohol affects the expression of genes that encode 
components of the GABAA receptors. This has been demonstrated by changes in 
the subunit composition of the receptor in those regions, the most consistent of 
which are decreases in α1- and increases in α4-subunits (Devaud et al., 1997; 
Mhatre et al., 1993). Analysis of post-mortem PFC tissue indicated increased 
GABRA2 mRNA levels in alcohol-dependent individuals (Haughey et al., 2008). 
Extrasynaptic α4βδ receptors were found to be rapidly upregulated GABA 
receptors following high-dose or chronic ethanol administration in rats (Liang et 
al., 2007). 
1.4.6. Investigating the role of for α4-GABAARs in binge drinking 
We wished to examine whether α4-GABAARs are also important in ‘binge-
drinking’ - a pattern in which more alcohol is consumed raising blood alcohol 
levels to >0.08 grams of alcohol per decilitre blood (0.8mg/ml). Binge-drinking 
is associated with alcoholism as well as a large proportion of alcohol related 
deaths, diseases and social harms (NIAAA, 2004). 
Previous experiments examining the role of α4-GABAARs in ethanol consumption 
(described above) have primarily focused on ‘two-bottle choice’ or operant self-
administration during which mice generally drink moderate amounts of alcohol 
(reviewed, Crabbe et al. 2011). Drinking in the Dark (DID) is a limited access 
procedure in which the water supply of a rat or mouse is exchanged for an 
ethanol solution (10 to 20% ABV) during a two-hour period in the dark phase of 
the light cycle and consumption is recorded (Rhodes et al., 2005; Ryabinin et al., 
2003). Ethanol consumption in these studies was high enough to reliably 
predicted BECs >1mg/ml in C57BL/6J mice. DID procedures have been used to 
distinguish differences in alcohol drinking phenotypes between different strains 
and genotypes of mice (Rhodes et al., 2007). 
The effects of these receptors may also depend on expression within different 
neuronal classes and subtypes. The D1 and D2 MSN pathways appear to have 
different and opposing roles mediating the rewarding properties of drugs 
(reviewed in Chapter 1/2 and Lobo and Nestler, 2011). Multiple experiments 
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have found that systemically D1 and D2 agonists reduce ethanol preference and 
consumption (Cohen, Perrault, & Sanger, 1999; Linseman, 1990; Silvestre, 
O’Neill, Fernandez, & Palacios, 1996). We therefore also wish to examine 
whether α4-GABAARs on D1 or D2 expressing neurons specifically have distinct 
roles in alcohol consumption. 
1.5. Psychostimulants  
1.5.1 Neurobiology of Psychostimulants  
Psychostimulants, such as amphetamine and cocaine, are psychoactive drugs 
which induce a variety of physiological effects within the central and peripheral 
nervous systems, ultimately increasing psychomotor activity. Psychostimulants, 
mediate their effects by increasing dopamine transmission within the NAc 
through a variety of mechanisms (Di Chiara and Imperato, 1988; Wise and 
Rompre, 1989). Amphetamines inhibit monoamine oxidase (MAO) thereby 
preventing the breakdown of excess dopamine (Mantle, Tipton and Garrett, 
1976). In addition amphetamine entering neurons indirectly causes 
phosphorylation of the dopamine transporter (DAT) resulting in reversal of 
dopamine transport (Miller, 2011). Cocaine binds to and inhibits the dopamine 
Transporter (DAT) (Beuming et al., 2008). This results in an increased 
accumulation of dopamine within the synaptic cleft prolonging stimulation of 
postsynaptic dopamine receptors that is thought to alter the influence of 
excitatory neuronal inputs.  
1.5.2. Behavioural Sensitisation to Psychostimulants 
Behavioural sensitisation is a phenomenon whereby the stimulant effects of a 
drug are enhanced following repeated, intermittent administration (Robinson & 
Becker, 1986; Segal & Mandell, 1974; Tilson & Rech, 1973). Psychostimulants 
are particularly robust in their ability to induce behavioural sensitisation and the 
neuroadaptations which underlie it. Behavioural sensitisation to amphetamine 
was demonstrated to persist undiminished for over a year (Robinson & Berridge, 
1993). 
Repeated exposure to psychostimulant drugs produces enduring alterations in 
intracellular signalling pathways and structural changes in neurons within the 
NAc (Nestler, Barrot, & Self, 2001). For example, cocaine administration 
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increased spine density on dendrites of MSNs in the NAc Shell, but not core 
(Robinson & Kolb, 1999; Robinson et al., 2001). Repeated intermittent cocaine 
administration is associated with an elevated basal extracellular level of 
dopamine within the NAc (Di Chiara and Imperato, 1988; Kalivas and Duffy, 
1990). In addition, D1 dopamine receptors in the NAc show enhanced sensitivity 
to dopamine following repeated cocaine administration (Henry, Greene and 
White, 1989; Henry and White, 1991). 
As outlined earlier, the NAc and VTA are critical in mediating the induction and 
expression of behavioural sensitisation respectively (Kalivas & Stewart, 1991; 
Pierce & Kalivas, 1997; White & Kalivas, 1998). Repeated intra-VTA, but not 
intra-NAc, injections of psychostimulants potentiate the locomotor stimulant 
effects of a systemic or intra-NAc challenge of the same or other such 
psychostimulants demonstrating the expression of sensitisation (Cornish & 
Kalivas, 2001; Dougherty & Ellinwood, 1981; Hooks et al., 1992; Kalivas & 
Weber, 1988). Lesions of the NAc Shell attenuated of the induction of, but not 
expression of, behavioural sensitisation to cocaine (Todtenkopf et al., 2002; 
Todtenkopf, Stellar, & Melloni, 2002), and infusions of cocaine or amphetamine 
to the NAc Shell, but not Core, induced behavioural sensitisation (Pierce, Duffy, 
& Kalivas, 1995). 
The increased basal concentration of dopamine in the NAc was found to 
gradually decline to the level of saline-treated controls following cessation of 
cocaine treatment (Heidbreder, Thompson, & Shippenberg, 1996; Johnson & 
Napier, 2000; Segal & Kuczenski, 1992; Weiss et al., 1992). Interestingly, 
despite the normalisation of basal dopamine levels, after extended periods of 
withdrawal expression of behavioural sensitisation is associated with increased 
dopamine transmission and a sensitised locomotor response higher than that 
found immediately following cessation (Weiss et al., 1992; Heidbreder, 
Thompson and Shippenberg, 1996). This implies other, long-term adaptive 
changes occur in response to psychostimulant sensitisation. 
A number of signalling molecules are known to be induced by psychostimulants 
including FosB (Hope et al., 1994), cFos (Robertson et al., 1991) and ERK 
(Bertran-Gonzalez et al., 2008).  In rats cFos is increased in the neurons in the 
NAc following behavioural sensitisation to cocaine (Crombag et al., 2002). 
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Further, following sensitisation to cocaine, cFos is increased preferentially in D1 
neurons (Young et al. 1991, Bertran-Gonzalez et al. 2008; Guez-Barber et al. 
2011) and conditional deletion of cFos in D1 neurons diminished cocaine 
sensitisation (Zhang et al., 2006). 
1.5.3. GABAA Receptors in behavioural sensitisation to psychostimulants 
It is also thought that repeated exposure to cocaine induces changes in GABA 
systems, resulting in a dysregulation of the neural circuitry mediating behaviour 
responses to drugs (Koob & Le Moal, 2001; Koob & Volkow, 2010). 
Following amphetamine-sensitisation a decrease in GABAAR α2-subunits is 
reported within the NAc shell and core (Zhang et al., 2006). Indeed, targeted 
deletion of the GABAAR α2 subunit, known to be highly represented within the 
NAc, blocked the development of behavioural sensitisation to cocaine (Morris et 
al., 2008). Similarly, selective activation of α2 receptors within the NAc using 
intra-NAc infusions of the GABAAR agonist Ro 15-4513, in α2(H101R) mutant 
mice, in which the mutation results in a change in efficacy of Ro 15-4513 from a 
negative allosteric action to a positive allosteric action, was sufficient to induce 
behavioural sensitisation (Dixon et al., 2010).  
Involvement of the GABAAR α4 subunit in mediating behavioural sensitisation to 
cocaine has also been suggested. The α4 subunit is genetically upregulated 
preferentially in D1 neurons following repeated or high dose cocaine 
administration (Heiman et al., 2008). Systemic administration of THIP blocks 
both the induction and expression of behavioural sensitisation to amphetamine 
(Karler et al., 1997). Constitutive deletion of the α4 subunit in mice did not 
affect behavioural sensitisation to cocaine but abolished the ability of systemic or 
intra-NAc THIP to attenuate sensitisation (Macpherson, 2013). These results 
indicate that activation of α4-GABAARs is likely to oppose sensitisation to 
cocaine, though they are not activated under normal conditions. 
1.5.4. Psychostimulant induced neuroadaptations 
Repeated exposure to psychostimulants results in neuroadaptations of the 
systems in which they produce their effects which can be maladaptive or 
homeostatic (Nestler, 1993). Neurophysiological changes are known to underlie 
behavioural sensitisation to psychostimulants following repeated exposure and 
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this has been proposed to mediate ‘incentive sensitisation’ (Robinson & Berridge, 
1993; Robinson & Berridge, 2008).  
Repeated administration of psychostimulants produces a variety of alterations in 
dopaminergic neurons, especially within key reward pathway structures such as 
the NAc and VTA (Nestler, 2005). Transient changes include reduction of 
inhibitory G protein levels (Nestler et al., 1990; Striplin and Kalivas, 1992), 
enhanced basal levels of extracellular DA (Kalivas and Duffy, 1993), and 
enhanced sensitivity of AMPA receptors on VTA DA neurons (White et al., 1995b; 
Zhang et al., 1997). These transient changes suggest enhanced basal activity of 
DA neurons. 
Intermediately, animals treated repeatedly with psychostimulants displayed 
enhanced responses of D1 dopamine receptors both pre- and post-synaptically 
(Henry, Greene and White, 1989; Higashi et al., 1989; Wolf, White and Hu, 
1994). Following repeated cocaine administration, a decrease in the density of 
glutamate but not GABA immunolabeling was observed within the NAc, 
indicating an increase in excitatory synaptic activity (Meshul et al., 1998). Long-
term, intermittent cocaine administration increased spine density on dendrites of 
MSNs in the NAc (Robinson and Kolb, 1999; Robinson et al., 2001). 
Chronic psychostimulant exposure alters expression of many genes (Nestler, 
2004). Perhaps most notable is the dramatic increase of the transcription factor 
protein ΔFosB, thought to act as an important molecular “switch” in the 
transition from drug abuse to addiction (Nestler, Barrot and Self, 2001; Nestler, 
2005). By artificially increasing or decreasing ΔFosB expression Nestler and 
colleagues (2001, 2004) examined its behavioural effects.  Mice with elevated 
ΔFosB in the NAc exhibited increased sensitivity to cocaine as well as increased 
self-administration and motivation for cocaine (Kelz et al., 1999). Conversely, 
blocking the build-up of ΔFosB in mice during a regimen of cocaine exposure 
reduced these behaviours. 
1.5.5. Psychostimulant induced neural ensembles in the reward 
pathways 
The neural substrates of behavioural activation and the perception of reward are 
often highly coincident or proximate, notably in the Striatum (Robbins and 
40 
 
 
Everitt, 2002; Koob, 2014). It has been proposed that neuronal ‘ensembles’ 
within the NAc may represent various stimulus-action associations which, when 
activated by conditioned stimuli, compete to control behavioural output 
(Pennartz, Groenewegen and Lopes da Silva, 1994; Nicola, 2007).  
A number of Immediate-Early-Genes (IEGs) genes have been identified which 
are upregulated following neural activation and therefore provide a histological 
marker for neural activity (Morgan and Curran, 1991). This has been used to 
identify spatial patterns of ‘neural ensembles’ which are activated by 
environmental stimuli, behavioural tests and drugs (Sheng and Greenberg, 
1990; Cruz et al., 2013). Notably, activation of the proto-oncogene cFos has 
been widely characterised and used to map neural activity (Sheng and 
Greenberg, 1990).  
Histochemical analysis has revealed that cFos is increased in striatal and cortical 
neurons in-vivo following injections of dopamine D1 receptor agonists, D2 
receptor antagonists as well as psychostimulants including amphetamine and 
cocaine (Robertson et al., 1991). Conditional deletion of cFos in D1 expressing 
neurons in ablated a number of persistent neuroadaptations normally induced by 
cocaine (Zhang et al., 2006). Loss of cFos in D1 neurons attenuated dendritic 
remodelling and behavioural sensitization after repeated exposure to cocaine; 
however, it increased persistent memory of cocaine-induced conditioned place 
preference. This indicates that cFos induced in D1 neurons integrates 
mechanisms to facilitate both the acquisition and extinction of cocaine-induced 
persistent changes. 
Neural ensembles within the NAc are activated by environmental cues paired 
with natural rewards or drugs (Pennartz, Groenewegen and Lopes da Silva, 
1994; Mattson et al., 2007; Cruz et al., 2013). Cocaine induced cFos is further 
increased in the NAc following repeated cocaine administration, i.e. behavioural 
sensitisation, in rats (Crombag et al., 2002). It was subsequently discovered 
that this effect occurred only when cocaine was administered in the conditioned 
environment, supporting the idea that that ensembles code stimulus-action 
associations (Mattson et al., 2007). Accordingly, selective inactivation of these 
neurons with the ‘Duan02 inactivation method’ attenuated cocaine-induced 
locomotor sensitisation in animals receiving cocaine in the drug-paired but not 
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non-paired environment (Koya et al., 2009). These results support a model in 
which drug-induced dopamine release in the NAc acts to increase the firing of 
neurons representing stimulus-action associations. 
Recently, cFos has been combined with new technologies in transgenic mice, for 
example tagging cFos with reporters such as GFP which allows 
electrophysiological recordings from neural ensembles (Koya et al., 2012; Cruz 
et al., 2013).  Electrophysiological recordings, enabled by cFos-GFP mice, reveal 
that ensembles activated by food-paired environments are found to exhibit 
increased intrinsic excitability relative to surrounding populations (Ziminski et 
al., 2017) whereas cocaine induced ensembles exhibit significantly attenuated 
glutamatergic synaptic strength or ‘silent synapses’ due to loss of AMPA receptor 
function. 
1.5.6. Psychostimulant modulation of GABAAR subunit expression 
GABAergic mechanisms also appear to play an important role in mediating the 
physiological and behavioural effects of psychostimulants. Early studies revealed 
systemic amphetamine administration resulted in reduced extracellular GABA 
concentration within the VP (Bourdelais and Kalivas, 1990). Similarly, it was 
observed that chronic cocaine administration selectively attenuated GABAAR 
function within the striatum (Peris, 1996). Evidence was mixed as other studies 
have found no effect of psychostimulant administration on either quantity or 
function of GABAARs within the striatum (Jung and Peris, 2001).  
By analysing expression of various GABAA receptor subunits and in specific cell 
populations psychostimulant effects on the expression of specific GABAAR 
isoforms has been revealed. Chronic cocaine treatment was found to induce 
robust up-regulation of α4 subunit gene expression selectively in D1-MSNs 
(Heiman et al., 2008). Acute cocaine administration resulted in decreased α1 
subunit expression in the striatum when measured 1-hour post-administration 
(Suzuki et al., 2000). In contrast, when measured following cocaine self-
administration, at both 1 day (acute) and 20 days (chronic), α1 subunit mRNAs 
were up-regulated, whereas α4, α6, β2, γ2, and δ subunits were downregulated 
in the VTA (Backes and Hemby, 2003).  
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In pre-clinical studies quantitative immunohistochemistry of GABAAR subunit 
proteins revealed a significant decrease in α2 subunits within the hippocampal 
dentate gyrus and CA1 regions following chronic cocaine administration (Lilly 
and Tietz, 2000). Furthermore, following methamphetamine-sensitisation a 
decrease in GABAAR α2 was also observed in the NAc shell and core (Zhang et 
al, 2006). Accordingly, reversal of cocaine-induced behavioural sensitisation by 
pergolide/ondansetron treatment normalises GABAAR α2 subunit expression 
within the NAc (Chen and Olsen, 2007).  
As previously discovered in alcoholism, genetic studies have linked the GABRA2 
gene with cocaine addiction (Dixon et al., 2010). It has further been proposed 
that some GABRA2 haplotypes may interact with experience of childhood trauma 
to influence risk of cocaine dependence (Enoch et al., 2010). A GABRA2 
haplotype, which was negatively associated with addiction, was positively 
associated with resilience to addiction following childhood trauma. 
1.5.7. Psychostimulants and conditioned behaviours 
It has been proposed that drug-associated cues, environmental or discrete, are 
able to trigger drug craving and therefore contribute to high rates of relapse in 
people with (Stewart, de Wit and Eikelboom, 1984; Robinson and Berridge, 
1993; Everitt, Dickinson and Robbins, 2001; Crombag et al., 2008). Cocaine-
associated cues were able to trigger increased physical arousal and craving for 
cocaine in abstinent cocaine users (Avants et al., 1995) and neuroimaging 
studies have demonstrated that exposure to cocaine-related stimuli resulted in 
an increase in striatal dopamine release (Volkow et al., 2006).  
Pre-clinical rodent models have been widely used to establish the role of the 
mesolimbic dopamine system in development and expression of associative 
learning. These procedures include cue-induced reinstatement of drug-seeking, 
conditioned place preference, conditioned reinforcement and second-order 
schedules of reinforcement (Everitt, Dickinson and Robbins, 2001; Tzschentke, 
2007; Crombag et al., 2008). Primarily these models rely on Pavlovian 
conditioning whereby repeated pairing of an unconditioned stimulus (US), i.e. 
contextual or discrete cues, with a reward, can result in the US acquiring the 
motivational properties of the primary reward and become a conditioned 
43 
 
 
stimulus (CS). Combining these models with genetic and pharmacological 
manipulation of specific anatomical and molecular targets can elucidate the 
neurobiological mechanisms by which drug-associated stimuli illicit drug-seeking.  
As well as mediating acute behavioural and primary reinforcing effects of drugs 
of abuse, the NAc is also implicated in the ability of reward-paired environmental 
cues to motivate drug-seeking behaviour (Everitt and Robbins, 2005). The NAc 
has been proposed to encode the predictive value of reward associated stimuli 
and to stimulate specific, goal-directed motor behaviours in. It has been 
proposed that NAc neurons encode sensory information associated with the 
consequences of different behaviours and that this activity promotes reward-
seeking behaviour. This was supported by the observation that NAc neurons 
excited and inhibited by cues showed larger firing changes in response to a CS 
than US, and larger changes when the animal made an operant response to the 
cue than when the animal failed to respond (Yun et al., 2004). Excitations during 
operant responding were not modulated by cues, whereas inhibitions during 
operant responding were larger if the operant response occurred during the 
reward-associated cue. 
1.5.8. GABAARs in the NAc mediate cocaine effects on reward-
conditioned behaviours 
A model has been proposed in which striatal neurons compete for control over 
basal ganglia output nuclei and are inhibited by GABAergic interneurons and 
collateral connections between neighbouring MSNs to facilitate action selection 
by the NAc (Nicola, 2006). Given these findings it is likely that specific GABAAR 
isoforms are responsible for modulating the activity of NAc MSNs which underlie 
behavioural responses to psychostimulants and reward-conditioned cues. 
GABAAR subunits that are expressed within the NAc, such as α2 and α4, are 
therefore targets of interest to modulate these behaviours. 
In a conditioned reinforcement (CRf) experiment deletion of the α2 subunit did 
not modulate instrumental responding for reward-conditioned cues; however, it 
abolished cocaine potentiation of responding (Dixon et al, 2010). This suggests 
that α2-GABAARs do not mediate learning of reward-associated cues, but they 
are necessary for cocaine to facilitate cue-induced behaviours.  
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In contrast, deletion of the α4 subunit, constitutively or specifically in the NAc, 
enhanced baseline and cocaine potentiated CRf responding. Further deletion of 
α4 in D2-, but not D1-, expressing neurons alone was sufficient to produce these 
effects. Thus, tonic inhibition of D2 MSNs in the NAc by α4-GABAARs opposes 
conditioned reinforcement and cocaine’s ability to facilitate cue-induced 
behaviours. 
1.6. Investigating the role of α4-GABAARs in mediating addiction-related 
behaviours 
As outlined above, α4βδ GABAAR subtypes are the most rapidly regulated in 
plastic mechanisms triggered by high-dose alcohol or chronic exposure to alcohol 
in rats (Liang et al., 2007), and within the NAc they are functionally associated 
with alcohol consumption and reinforcement (Boyle et al., 1993; Rewal et al., 
2009, 2012). These receptors are unlikely to be directly sensitive to ecologically 
valid doses of ethanol, although it may modulate them indirectly via 
neurosteroids. Alternatively, it is possible that α4-GABAARs play a more general 
role in reward learning and motivation. 
While the role of α4βδ GABAARs in alcohol related behaviour is highly studied, 
less is known about the possible involvement of α4-GABAARs in mediating the 
rewarding and reinforcing of drugs of abuse other than alcohol. Notably, within 
the striatum α4-GABAARs are most highly expressed within the NAc, where we 
have demonstrated they mediate a tonic form of inhibition that acts to control 
the excitability of MSNs (Maguire et al., 2014).  
Prior to the experiments presented in this thesis, investigators in our laboratory 
conducted a series of studies using genetic manipulations of the α4 subunit in 
mice to elucidate the role of α4-GABAARs in the acute effects of cocaine and 
cocaine conditioned behaviours (Macpherson, 2013), summarised below.  
Firstly, constitutive deletion of the α4 subunit did not affect baseline locomotor 
behaviour or its potentiation by cocaine; however, it abolished the ability of 
systemic or intra-NAc THIP to block cocaine potentiated locomotor activity. 
Secondly, we investigated the role of α4-GABAARs in natural- and cocaine-
conditioned behaviours using tests of behavioural sensitisation, cocaine-CPP with 
and without cocaine priming, and conditioned reinforcement (CRf) to natural 
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rewards with and without cocaine priming. Deletion of GABAAR α4-subunits did 
not alter the augmentation of locomotor activity observed following repeated, 
intermittent cocaine, indicating that unlike α2-GABAARs, α4-GABAARs are not 
involved in the development of behavioural sensitisation to cocaine. As with 
locomotor activity following acute cocaine, systemic THIP was able to reduce the 
sensitised increase in locomotor activity in wild type but not α4 knockout mice. 
Together these results indicate α4-GABAAR-mediated inhibition of NAc MSNs is 
able to attenuate the ability of cocaine to potentiate locomotor activity however 
under normal physiological conditions, there exists little tonic inhibition. Whilst 
constitutive deletion of the α4 subunit had no effect on CPP we demonstrated 
that a conditional deletion of α4 specifically on D1-, but not D2-, MSNs was 
sufficient to increase CPP and cocaine’s ability to potentiate CPP. Conversely, 
both constitutive, NAc specific and and D2-, but not D1-, specific deletion of the 
α4 subunit increased responding for conditioned reinforcers and further 
increased cocaine’s ability to potentiate responding in the CRf experiment. 
These experiments clearly demonstrate that α4-GABAARs modulate cocaine 
induced locomotor activity and conditioned behaviour. They also identify a 
dissociation between conditioning effects of by α4-GABAARs on D1- vs D2-MSNs 
whereby they modulate environmental conditioning and learning conditioning to 
discrete cues respectively. However, many questions remain to be answered. 
Firstly, we may hypothesize that whilst constitutive deletion of α4-GABAARs had 
no effect, D1- or D2-MSN specific deletion may affect baseline locomotor 
behaviour or its potentiation by cocaine. This is a very important consideration 
as it may underlie the expression of other behavioural differences in CPP and CRf 
experiments. Further, we wished to examine the roles that α4-GABAARs on D1- 
or D2-MSN may have on the development of behavioural sensitisation to 
cocaine. Given that chronic cocaine treatment was found to induce robust up-
regulation of α4 subunit gene expression selectively in D1-MSNs (Heiman et al., 
2008) we may expect altered behavioural sensitisation when this mechanism is 
removed. Finally, results from our CRf experiments indicate that α4-GABAARs on 
D2-MSNs oppose instrumental responding for reward-associated-cues, i.e. 
secondary reinforcers. We therefore wished to examine whether α4-GABAARs on 
D2-MSNs also influenced responding and motivation for primary reinforcers 
themselves. If correlated this may underlie responding for secondary reinforcers. 
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We tested these hypotheses in well-established behavioural tests, including 
behavioural sensitisation, and operant conditioning under fixed and progressive 
ratio schedules of reinforcement. 
1.7. Aims and Structure of the thesis 
Chapter 1  
General Introduction.  
Chapter 2 
We have generated several transgenic mouse lines in which α4 has been deleted 
either constitutively or within specific neural populations. In chapter 2 we aim to 
confirm the deletion of α4 has occurred in each line as expected. We used mice 
in which α4 had been deleted constitutively (α4-KO) or conditionally in D1 or D2 
type dopamine receptor expressing neurons via Cre-lox recombination (Gong et 
al., 2007). We performed PCR with primers targeting each transgene gene to 
genotype these animals. We then confirmed the deletion using quantitative rt-
PCR to and in-situ-hybridisation to compare gabra4 mRNA levels in brain 
sections from each genotype. Using sections from conditional knockouts we 
performed a multi-probe fluorescent in-situ-hybridization method (RNAScope) to 
confirm in which cell types Cre-recombinase was expressed and that deletion of 
α4 occurred in these populations specifically. We also generated an Adeno 
Associated Virus (AAV) carrying Cre-recombinase to knockdown α4 locally by 
infusing it into in specific brain regions of ‘floxed’-α4 mice. To verify the efficacy 
of this virus we infused it into the brains of those mice then sectioned their 
brains for immunohistochemical and rt-PCR analysis. Characterising these lines 
verified our transgenic manipulations and allows us to attribute behavioural 
differences to the activity of α4-subunits in further experiments. 
Chapter 3  
Chapter 3 explores the role of GABAARs containing α4-subunits in controlling 
binge-like alcohol consumption. We used a well-established experimental 
protocol called ‘Drinking in the Dark’ (DID) to monitor their voluntary alcohol 
consumption (Wise, 1973). In DID experiments mice typically consume relatively 
large volumes of alcohol in a short time making it a good model for binge 
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drinking (Crabbe, Harris and Koob, 2011). We compared constitutive α4-KO 
mice with wild-type littermates in a standard DID experiment to assess whether 
deletion of α4 would alter ethanol consumption. Following this we attempted to 
isolate the effects of this manipulation to the NAc where α4 is highly expressed. 
Using ‘floxed’ α4 mice we targeted the NAc with a virus transfecting Cre-
recombinase to delete α4 there specifically and observed the effect on DID. We 
also measured DID following pharmacological activation of α4-GABAARs by the 
drug THIP both systemically at various doses and delivered directly to the NAc. 
Finally, we compared DID in mice where α4 was deleted conditionally in D1 or 
D2 type neurons to see if α4 driven effects were mediated by either population. 
The aim of this chapter is to determine whether α4-GABAAR activity in the NAc 
controls ethanol consumption and identify which α4-expressing neural 
populations do so. This may provide pre-clinical evidence that α4-GABAARs are a 
target for therapies to treat alcoholism.  
Chapter 4  
Previously conditional deletion of α4 in D1 or D2 type neurons has had different 
effects on cocaine conditioned behaviour (Maguire et al., 2014). In chapter 4 we 
expand on these studies by exploring the role of α4-GABAAR in controlling 
locomotor activity and its potentiation by acute cocaine. We performed a cocaine 
dose response in D1 or D2 α4 conditional knockout mice to assess whether 
deletion of these receptors in either population alone altered the locomotor 
response to cocaine at various doses. This will also allow consideration for other 
behaviours that could be affected by changes in locomotor activity. Conditional 
deletion of α4 in D1 or D2 type neurons also differently altered responses to 
reward conditioned cues and their potentiation by cocaine (Macpherson et al., 
2016). We therefore examined the effect of α4-subunits in D1 or D2 type 
neurons on instrumental responding for primary rewards to identify whether this 
may underlie motivation for cues or if the effect of α4 on responding for cues 
was distinct from motivation for the primary reward. We trained D1 and D2 α4 
conditional knockout mice to lever-press for sucrose rewards under fixed and 
progressive ratio conditions and compared their responding. This informs 
previous findings and explores differential roles of D1 and D2 neurons in 
responding for primary vs secondary rewards.  
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Chapter 5  
α2-containing GABAARs have previously been shown to be crucial for behavioural 
sensitisation to cocaine (Dixon et al., 2010) whilst constitutive deletion of α4 did 
had no effect (Macpherson, 2013). The aim of chapter 5 was to investigate 
whether populations of α4 expressing neurons mediate behavioural sensitisation 
to cocaine. Constitutive α4-KO mice, D1 and D2 α4 conditional knockout mice 
and their wild-type littermates were given repeated, intermittent cocaine or 
saline over 10 sessions. Conditioned locomotor response to cocaine was explored 
by testing for conditioned activity following saline in the drug-paired context. 
Following these experiments mice were immediately sacrificed and brains were 
used in immunohistochemistry experiments to examine expression of the neural 
activity marker cFos throughout the striatum. We compared cFos expression in 
the Core and Shell sub-regions of the NAc which are known to play different 
roles mediating the effects of psychostimulants (Ito, Robbins and Everitt, 2004). 
We also used RNAScope methods on the brains of α4-KO mice to examine 
whether effects of cocaine sensitisation on cFos differed in D1 and D2 neural 
populations in these sub-regions. These experiments provide novel data into a 
possible role of neural populations modulated by extrasynaptic GABAARs in 
mediating behavioural responses to repeated cocaine administration. 
Chapter 6  
General Discussion. 
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Chapter 2 
Characterising transgenic-mice and viral-vectors used to manipulate α4-
containing GABAA receptors 
 
2.1. Introduction 
2.1.1. α4-GABAAR subunits in D1 and D2 striatal neurons  
The GABAAR α4 subunit is distributed throughout the thalamus, NAc, 
hippocampus, neocortex and caudate-putamen (Wisden et al., 1992; Pirker et 
al., 2000; Schwarzer et al., 2001). Within the striatum α4 is most highly 
expressed in the NAc. As GABAA receptor sub-types in the striatum and NAc 
have been implicated in addiction and drug abuse by numerous studies 
(Macpherson, 2013; Maguire et al., 2014; Stephens et al., 2017) we wished to 
investigate the role of α4-containing receptors (α4-GABAARs) in these disorders. 
In particular we wished to investigate the behavioural effects of manipulating 
α4-GABAARs in distinct regions and neural populations within the striatum.  
The majority of the striatum (~95%) is made up of GABAergic Medium Spiny 
Neurons (MSNs) so named due to their medium size and extensive dendritic 
trees (Kemp and Powell, 1971). MSNs have also been characterised 
electrophysiologically by their hyperpolarised resting membrane potential and 
low input resistance (C. Wilson and Kawaguchi, 1996). Historically MSNs were 
characterised by their morphology and divided into two populations, known as 
the direct and indirect pathways, based on their axonal projection targets 
(Bolam et al., 2000). 
The direct pathway originates in striatonigral neurons which form monosynaptic 
inhibitory connections with SNr/GPi neurons, suppressing inhibition of the 
thalamus, and ultimately disinhibiting selected behaviours (Vincent et al., 1982; 
Christensson-Nylander et al., 1986; Chevalier and Deniau, 1990). The indirect 
pathway originates in striatopallidal neurons which project to the GPe and onto 
the SNr/GPi complex via a polysynaptic disinhibitory connection, and an indirect 
GPe-STN-GPi connection, ultimately inhibiting the thalamus and suppressing 
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selected behaviours (Beckstead and Kersey, 1985; Gerfen et al., 1990; Albin, 
Young and Penney, 1995; Cohen and Frank, 2009). 
MSNs of the direct and indirect pathway have different molecular profiles so they 
were initially identified as distinct subtypes using their releasable neuropeptides 
as cell-type specific markers (Gerfen and Scott Young, 1988; Le Moine and 
Bloch, 1995). Immunohistochemistry identified populations of striatal neurons 
expressing the neuropeptides dynorphin and substance P and others expressing 
enkephalin (Beckstead and Kersey, 1985; Christensson-Nylander et al., 1986). 
Fluorescent retrograde tracing in combination with in-situ hybridisation were 
used to demonstrate that striatonigral neurons co-express neuropeptides 
substance P and dynorphin whilst striatopallidial neurons express enkephalin; 
this provided the first markers to define these distinct but co-localised neuronal 
populations (Gerfen and Scott Young, 1988).  Subsequent experiments in 6-
hydroxydopmaine (6-OHDA) lesioned mice used D1 and D2 dopamine receptor 
specific agonists (SKF-38393 and quinprole) in combination with retrograde 
tracing and mRNA profiling to demonstrate that dynorphin/substance P or 
enkephalin expression in MSNs were differentially associated with D1R or D2R 
expression respectively (Gerfen et al., 1990).  
MSNs can be therefore divided into two subtypes; D1 and D2 MSNs based on 
their expression of D1 or D2 class dopamine receptors. Previously D1 and D2 
receptors had been presumed to co-localize but this and further studies using 
sensitive cDNA probes (Le Moine and Bloch, 1995) strongly indicated that D1Rs 
and D2Rs are expressed in distinct MSN subtypes which are segregated into 
discrete pathways. A large body of research has elucidated distinct and often 
opposing functions of these two populations, sometimes referred to as the 
go/no-go pathways due to their roles in action initiation/inhibition (reviewed, 
Surmeier, 2013). 
The segregation of D1R and D2R expression to the direct and indirect pathways 
respectively is well established in the dorsal striatum however recently evidence 
indicates that this is not so in the ventral striatum. Kupchik and colleagues used 
a Cre-dependent (‘floxed’) channelrhodopsin (ChR2) viral vector to 
optogenetically activate D1 or D2 neurons in the NAc core of Cre-expressing 
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transgenic mice (Kupchik et al., 2015). They recorded GABAergic IPSCs from the 
Ventral Pallidum (VP) following optogenetic stimulation of either population and 
found that that up to 50% of dorsal VP neurons are innervated by both D1 and 
D2 MSN afferents. We must therefore exercise caution in referring to D1 and D2 
populations as the ‘direct’ or ‘indirect’ pathways within the ventral striatum. 
As these MSN subtypes heterogeneously populate the same regions dissecting 
the neurocircuitry of the striatum requires high-resolution techniques to 
investigate and maps its cytoarchitecture. It is important to target discrete 
neural populations within defined regions that may be anatomically but not 
functionally overlapping which has proved difficult using traditional methods. 
Traditional histochemistry and mechanically injected anterograde/retrograde 
tracers such as horseradish peroxidase (HRP), fluorescent dyes and labelled 
plant lectins are not heritable or specific to genetically defined neurons (Feng et 
al., 2000). While immunohistochemistry allows us to label neuronal subtypes it 
is based on markers which usually must first be genetically defined. New 
methods that genetically target expression of ‘reporter genes’ are able to 
overcome these problems and achieve greater anatomical resolution.   
Using recombinant DNA techniques genetic constructs can be placed under the 
control of various cis-regulatory elements, these can encode molecules such as 
beta-galactosidase (LacZ), which allow easy identification of the cells in which 
they are expressed, i.e. ‘reporter genes’ (Forss-Petter et al., 1990). This type of 
labelling is more reliable than immunohistochemistry which requires markers 
that are based on correlative data rather than being genetically hard-coded.  The 
discovery and development of green fluorescent protein (GFP) as a marker for 
gene expression has rapidly become a staple technique for mapping neural 
populations as it allows stable reporter expression with minimal perturbation to 
the cell (Chalfie et al., 1994).  
Transgenic mice expressing several GFP variants with different optical properties 
(collectively named XFP) under different promoters to allow imaging of neuronal 
subsets based on their expression patterns (Feng et al., 2000). This was 
particularly useful as it allows the imaging of multiple distinct populations, 
concurrently, based on optical properties of the fluorescent marker expressed. 
The method was not entirely reliable however as marker expression was found 
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to vary between founder lines.  Variation can be caused by variable regulatory 
elements in the integration site or other effects such as silencing due to nearby 
chromatin known as position effect variegation (Festenstein et al., 1996).  
In a refinement of this transgenic method GFP was expressed under the control 
of more regulatory elements. This was achieved using Bacterial Artificial 
Chromosomes (BACs) as vectors for these reporters (Gong et al., 2003). BACs 
are highly useful as they can carry large regulatory sequences and buffer 
transgenes from local regulation. This has given rise to over 250 driver lines 
including 20 lines that drove expression within the striatum. Importantly, GFP 
has been expressed under the Drd1 or Drd2 dopamine receptor. BAC mice were 
also generated carrying a red fluorescent protein under the Drd1 promoter 
(Drd1a-tdTomato) and crossed with BAC-Drd2-eGFP to allow simultaneous 
visualization of D1 and D2 populations (Shuen et al., 2008). Characterisation of 
these mice conclusively demonstrated that D1 and D2 receptors are expressed 
dichotomously in two distinct MSN populations, less than 1% of cells showed 
detectable expression of both fluorophores. 
2.1.2. Using conditional knock-outs to functionally differentiate D1 and 
D2 MSNs 
The bacteriophage P1 recombinase ‘Cre’ can be used to mediate recombination 
between short sequences called ‘loxP’ sites (Hoess and Abremski, 1985, see 
Chapter 1). The ‘Cre-lox’ recombination system has been further developed for 
use in mammals (Sauer and Henderson, 1988). Transgenic mice expressing Cre 
can be crossed with mice carrying a sequence which have been flanked by loxP 
sites via homologous recombination (i.e. ‘floxed’) resulting in deletion of that 
intervening sequence in the offspring (Lakso et al., 1992). This system is used in 
mice carrying a ‘floxed’ gene of interest so that it will be knocked out in a 
compartmentalised, cell-specific manner which is determined by the promoter 
under which Cre is regulated (Gu et al., 1994). Crucially this allows selective 
knockout of genes in defined cell types, such as D1 and D2 MSNs, so that their 
component function can be examined separately.  
As was previously done with GFP reporters a library of BAC-Cre mice have been 
generated where Cre is expressed in genetically defined neuron subsets in over 
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250 driver lines (Gong et al., 2007). These have successfully been used to 
knock-out receptors and signalling molecules significant to drug seeking 
behaviour in D1 and D2 MSN populations with behavioural consequences. 
Conditional KO of DARP-32 in D1 MSNs resulted in hypoactivity and reduced 
psychostimulant response and in D2 neurons had the reverse effect; 
hyperactivity and enhanced psychostimulant response (Bateup et al., 2010). 
Conditional knock-out of the BDNF receptor Trkb in D1 neurons decreased 
cocaine CPP but in D2 neurons increased CPP.  These results identify important 
mediators of plasticity in MSNs downstream of D1 and D2 neurotransmitter 
receptors which are of clinical significance. They also support findings in knock-
out mice that D1 or D2 expressing populations have different and opposing 
effects on movement and drug responses (see Chapter 1). Notably, cholinergic 
interneurons also express D2 dopamine receptors and therefore must be 
considered when interpreting experiments in which transgenes, such as Cre, are 
controlled by the Drd2 promoter, as in our experiments (Dawson, Dawson and 
Wamsley, 1990). 
We have therefore generated dopamine D1 and D2 neuron specific GABAAR α4-
subunit knockout mice and respective wildtypes in order to study the role of α4-
GABAARs in behaviours relating to drugs of abuse. We achieved this by breeding 
‘floxed’ α4 mice with BAC mice (Gong et al., 2007, described above) 
hemizygously expressing Cre in D1 or D2 neurons (Maguire et al., 2014; 
Macpherson et al., 2016). In a cocaine-conditioned place preference (CPP) 
experiment constitutive α4 knockout mice did not differ from WT mice however 
conditional knock-out of α4 in D1 neurons increased CPP whilst both constitutive 
and D2 neuron specific knockout enhanced conditioned reinforcement 
(Macpherson, 2013; Maguire et al., 2014). 
Whilst these experiments indicate that deletion of α4 in D1 or D2 neurons is 
having distinct behavioural outcomes we have yet to fully characterise these 
conditional D1/D2 α4 knockout mice. Here we use several genetic and 
immunological methods to demonstrate that the Cre transgene is being 
expressed in the correct D1/D2 MSN populations and that it is functionally 
deleting the α4 subunit. 
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2.1.3. Using viral vectors to achieve spatial resolution 
Transfection of genetic constructs by viral vectors provides the best combination 
of temporal and spatial resolution possible. This has the advantages of 
anatomical specificity and avoids developmental compensation observed in 
transgenic mice (Brickley et al., 2001). Disadvantages are poorer stability and 
efficiency relative to traditional transgenics and that constructs must not exceed 
the vectors capacity which varies from ~10kb to ~4.5kb depending on the type 
of virus (Betley and Sternson, 2011).  
RNA interference is an evolutionarily conserved gene silencing mechanism which 
has been co-opted as an experimental tool. The introduction of double stranded 
RNA sequences such as short hairpin RNA (shRNA) can result in cleavage of 
messenger RNA to which they are complementary and thereby ‘knock-down’ of 
genes of interest (Fire et al., 1998). Both ‘Cre-lox’ and inducible systems can be 
used to express RNAi with genetic, spatial and temporal control and viral 
transfection methods can be combined simply and effectively with RNAi as the 
small RNA constructs are easily packed into viral vectors (Ventura et al., 2004; 
Kappel et al., 2007). This has enabled RNAi knock-down of genes in vivo in the 
mammalian brain. RNAi was used to knock down tyrosine hydroxylase (TH), 
required for dopamine production, in midbrain neurons which resulted in 
locomotor deficits and reduced response to psychostimulants (Hommel et al., 
2003).  
Virally mediated RNAi has also been used to knockdown α4-GABAARs with 
consequences on drug-related behaviour. Knockdown of α4 in the NAc, by RNAi 
constructs delivered in a lentivirus, reduced voluntary self-administration of 
alcohol in rats (Rewal et al., 2009, 2012). Further, knockdown of α4 in the NAc 
using the same method in mice reduced conditioned reinforcement (CRf) and its 
potentiation by cocaine (Macpherson et al., 2016). Such lentiviral vectors are 
only transiently expressed, so RNAI knockdown of gene expression occurred 
during a small time-window (~5 days). This method is not suitable for 
experiments which require the observation of behavioural consequences of gene 
knockdown over longer periods. We therefore wished to develop a permanently 
expressed Adeno-Associated-Virus (AAV) to knockdown α4 in our experiments.  
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One major advantage of viral vectors is that they can be readily combined with 
any technique that makes use of small transgenes to augment them with 
regional specificity. Soon after development of Cre-reporter mice (Tsien et al., 
1996) viral expression of Cre could be used to generate knockouts with both 
spatial and temporal resolution in mice with ‘floxed’ gene-of-interest (Kaspar et 
al., 2002). This method has been used to knockout α4 in the thalamus of ‘floxed’ 
α4 mice which attenuated fear-conditioning behaviour (Paydar et al., 2014). 
Here we generated a similar AAV vector carrying the Cre transgene and 
demonstrate its ability to knockout α4 the NAc of ‘floxed’ α4 mice.  
 
2.2. Methods 
2.2.1. Animals 
2.2.1.1. α4-WT/Het/KO Mice 
Constitutive α4-subunit knockout mice were produced at Sussex University. 
“Floxed” α4-subunit homozygous mice (strain name; B6.129-Gabrα4tm1.2Geh/J, 
supplied by The Jackson Laboratory, ME, USA), were crossed with Cre-
recombinase expressing hemizygous transgenic mice (strain name; B6.FVB-Tg 
(Ella-cre)C5379Lmgd/J, supplied by The Jackson Laboratory, ME, USA). 
Offspring were genotyped and putative Gabrα4 heterozygous mice (carrying the 
CRE transgene (~50% of offspring)) were bred together to generate 
homozygous knockout, heterozygous (used for breeding) and wildtype 
littermates (Figure 2.1). 
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Figure 2.1. Production of α4-WT, α4-Het, and α4-WT mice. (F0) ‘Floxed’-α4 
homozygous mice were bred with Cre-recombinase expressing heterozygous 
mice. (F1) offspring were heterozygous for the α4 allele, which were bred to 
create (F2) offspring in approximate ratios, 25% α4-WT, 50% α4-Het, 25% α4-
KO. 
2.2.1.2. α4-D1/D2-KO Mice 
Conditional dopamine D1/D2 expressing neuron specific α4-subunit knockout 
mice were created by crossing 'Floxed” Gabrα4 homozygous transgenic mice 
(strain name; B6.129-Gabrα4tm1.2Geh/J, supplied by The Jackson Laboratory, 
ME, USA) with either dopamine receptor D1 or D2 neuron specific Cre-
recombinase hemizygous transgenic mice (strain name; α4D1-/- = B6.FVB(Cg)-
Tg(Drd1a-cre)EY217Gsat/Mmucd, α4D2-/- =  B6.FVB(Cg)-Tg(Drd2-
cre)ER44Gsat/Mmucd, supplied by Mutant Mouse Regional Resource Centers 
(MMRRC), ME, USA). Breeding was conducted as described in Figure 2.2.  
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Fig 2.2. Production of D1-neuron specific α4-subunit wildtype (α4-D1-WT), and 
knockout (α4-D1-KO) mice. Step 1: (F0) ‘Floxed’-α4 homozygous mice were 
bred with D1-expressing neuron specific Cre-recombinase expressing 
heterozygous mice. Step 2:(F0) offspring heterozygous for the ‘Floxed’-α4 
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allele, and heterozygous for D1-CRE were bred to create (F1) offspring of 
approximately; 25% heterozygous for the ‘Floxed’-α4 allele, and heterozygous 
for D1-CRE, 25% heterozygous for the ‘Floxed’-α4 allele, and homozygous for 
No-D1-CRE, 25% 25% homozygous for the ‘Floxed’-α4 allele/heterozygous for 
D1-CRE and 25% homozygous ‘Floxed’-α4 allele/homozygous for No-D1-CRE . 
Step 3: F(2) offspring homozygous for ‘Floxed’-α4 allele/homozygous no-D1-
CRE mice and homozygous ‘Floxed’-α4 allele/heterozygous D1-CRE mice were 
used to breed the experimental α4-D1-WT (50%) and α4-D1-KO (50%) 
experimental mice, respectively. The same strategy was used using D2-CRE 
mice.   
2.2.1.3. Animal Husbandry 
Male and female GABAAR α4-WT, α4-Het, α4-KO and dopamine D1- or D2-
expressing neuron specific α4 wildtype (α4-D1-WT/α4-D2-WT) and knockout 
(α4-D1-KO/α4-D2-KO) mice on a C57Bl/6J background strain, weighing between 
20-30g, were housed in groups of 2-3, or separately for those undergoing 
surgery, with food and water available ad libitum. A 12hr light/dark cycle was 
used (lights on at 7:00 A.M.) with holding room temperature maintained at 21 
2ºC and humidity 50 5%. All injections, infusions and behavioural testing 
were performed between 2:00 P.M. and 5:00 P.M. All procedures were 
conducted in accordance to Animals (Scientific Procedures) Act 1986, following 
ethical review by the University of Sussex Ethical Review Committee. 
2.2.2. Genotyping 
2.2.2.1. DNA Extraction 
Mouse ear punches were collected, and DNA extracted by digestion in a 20μl 
solution of a 1mg/ml proteinase K solution (50mg/ml; Roche Products Ltd., UK) 
and 20mM Tris HCl (Sigma-Aldrich, Dorset, UK) and 10mM EDTA (Sigma-Aldrich, 
Dorset, UK) lysis buffer. Solutions were overlayed with two drops of purified 
mineral oil (Sigma-Aldrich, Dorset, UK), then incubated at 55°C for 2 hours, 
then heated to 95°C for 15 minutes in a thermocycling PCR machine (G-Storm 
GS1, GRI Ltd., Somerset, UK). Extracted DNA samples were diluted to 100μl 
with purified PCR water, with gentle mixing. 
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2.2.2.2. Primers 
GABAAR α4-subunit PCR primer sequences were used from those presented in 
the supplementary text of (Chandra et al, 2006). Forward and reverse cDNA 
primers were designed to target and replicate a sequence within the wildtype 
gabrα4 gene and the shortened gene with a deletion of exon 3 in the α4-subunit 
knockout mouse. The wildtype primers consisted of a 156bp product (forward 
primer, AAGATCACCAAGCCAACAGG; reverse primer, 
TCTTTGGGGAGTTGAGGATG) containing the primary loxP site in the “floxed” 
mice, and part of the conserved region. The knockout primers consisted of a 
241bp product (forward primer, AAGATCACCAAGCCAACAGG; reverse primer, 
TGCACACTGTAATTCCCATC), which flanked the primary and secondary loxP sites 
either side of exon 3 of the gabrα4 gene.   
Forward and reverse cDNA primers were designed to target and replicate a 
sequence contained within the integrated Cre recombinase transgene. The Cre 
primer consisted of a 102bp product (forward primer; 
GCGGTCTGGCAGTAAAACTATC, reverse primer; GTGAAACAGCATTGCTGTCACTT). 
2.2.2.3. PCR  
For each reaction, 0.5μl of extracted DNA was mixed into a solution of 0.5μl of 
both forward and reverse primers (25uM) and 23.5μl of Megamix-Blue 
(Microzone Ltd., Haywards Heath, UK). Solutions were overlayed with two drops 
of purified mineral oil, then incubated at 95°C for 5 minutes, followed by 35 
cycles of the following; 95°C for 30 seconds, 55°C for 30 seconds and 72°C for 1 
minute, in a thermocycling PCR machine. Finally, PCR samples were held at 72°C 
for 10 minutes. 
2.2.2.4. Gel Electrophoresis and DNA Detection 
Following PCR amplification of the targeted DNA, samples were 
electrophoretically separated on a 1.5% agorose (AGTC Bioproducts Ltd., 
Leicestershire, UK) gel containing 0.004% ethidium bromide (50mg/ml solution; 
Sigma-Aldrich, Dorset, UK) in 1% TAE buffer (242g/L tris base (Sigma-Aldrich, 
Dorset, UK), 57.1ml/L acetic acid (Sigma-Aldrich, Dorset, UK), 0.5M EDTA 
(14.62g of EDTA (Sigma-Aldrich, Dorset, UK) in 100ml/L dH2O). Gels placed 
within a horizontal electrophoresis tank connected to a power supply (BioRad 
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Laboritories Inc., Hercules, CA, USA) were run at 120v for approximately 30 
minutes, and then observed under UV light for the presence of the wildtype and 
knockout primers (Figure 2.3). 
Figure 2.3. Genotyping of GABAAR α4-subunit wildtype and knockout mice 
requires two reactions per mouse. The first reaction contains the wildtype 
primers, and second reaction contains the knockout primers for detection of the 
gabrα4 gene. The presence of a band in the wildtype reaction, but not the 
knockout reaction indicates a wildtype mouse. A band in the knockout reaction, 
but not the wildtype reaction indicates a knockout mouse. A band in both 
reactions indicates a mouse heterozygous for both the wildtype and knockout 
gene. 
Figure 2.4. The first reaction contains the wildtype primers, which detect the 
‘Floxed’- α4 allele. Genotyping of dopamine D1/D2-expressing neuron specific 
GABAA α4-subunit wildtype and knockout mice requires a reaction for the 
detection of Cre. The absence of a Cre band indicates a wildtype mouse, whilst 
the presence of a Cre band indicates a knockout mouse. 
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2.2.3. Quantitative reverse transcription PCR (qRT-PCR) mRNA analysis  
2.2.3.1 Preparation of tissue lysates and phase separation  
Constitutive GABAA α4-subunit wildtype, heterozygous and knockout mice brains 
were dissected, and tissue samples collected from the nucleus accumbens using 
a 1.5mm biopsy punch (Kai Medical Inc., Seki, Japan). Tissue samples were 
homogenised in 600μl of Trizol (Life Technologies, CA, USA) and 200μl of RNase-
free H2O (Life Technologies Corp., CA, USA), then mixed with 160μl of 
chloroform (Thermo Fisher Scientific Inc., Waltham, MA, USA) and phase 
separated by centrifuging for 15 minutes (12,000g) in pre-spun peqGOLD 
PhaseTrap A phase lock eppendorf tubes (Peqlab ltd., Erlangen, Germany).  
2.2.3.2 RNA precipitation 
The aqueous layer of each sample was decanted into an eppendorf tube (Sigma-
Aldrich, Dorset, UK), then mixed with 0.5ml of isopropanol (Sigma-Aldrich, 
Dorset, UK), 50μl of sodium acetate (Sigma-Aldrich, Dorset, UK), and 4μl of 
glycoblue (Life Technologies Corp., CA, USA) and incubated at room temperature 
for 10 minutes. Samples were centrifuged (12,000g) at 4°C for 20 minutes until 
a RNA pellet formed, the supernatant was discarded and replaced with 1ml of 
75% EtOH (Sigma-Aldrich, Dorset, UK) wash then centrifuged (7500g) for 5 
minutes at 4°C. The wash was discarded, and pellets left to air dry for 30 
minutes, then resuspended in 87.5μl of RNase-free H2O (Sigma-Aldrich, Dorset, 
UK). 
2.2.3.3. RNA cleanup 
RNA was extracted using the RNeasy Mini Kit (RNeasy Mini Kit, Qiagen Ltd., 
West Sussex, UK). To each 87.5μl solution; 10μl of buffer RDD and 2.5μl of 
DNase I stock solution were added and incubated at room temperature for 10 
minutes. Then to this 100μl solution; 350μl of buffer RLT mixed with 3.5μl of β-
mercaptoethanol and 250μl of 96-100% EtOH were mixed and immediately 
transferred to a spin column in a 2ml collection tube, then centrifuged (13,000g) 
for 15 seconds. Each spin column was transferred to a new collection tube to 
which 500μl of buffer RPE was added then centrifuged (13,000g) for 15 seconds. 
Each spin column was again transferred to a new collection tube to which 500μl 
of 80% EtOH was added then centrifuged (13,000g) for 15 seconds. Finally, 
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each spin column was transferred to a new collection tube and centrifuged 
(13,000g) for 5 minutes with the lid open. The spin columns were transferred to 
new 1.5μl eppendorf tubes to which 14μl of RNase-free H2O was added and 
centrifuged (13,000g) for 2 minutes. Approximately 12μl of eluted RNA was 
retrieved.  
2.2.3.4. RNA calculation and cDNA production 
The concentration of RNA was determined using a NanoDrop 2000 micro-volume 
spectrophotometer (Thermo Fisher Scientific Inc., Waltham, MA, USA. A volume 
of RNA solution containing 1µg was added to the appropriate amount of RNase-
free H2O and 2l of oligo(dT) primer (Life Technologies, CA, USA) to make a total 
volume of 15l then incubated at 65°C for 5 minutes in a thermocycling PCR 
machine. Reactions were snap chilled on ice for 1 minute, after which 4l of 
5Xiscript select react mix (Life Technologies, CA, USA) and 1l of reverse 
transcriptase (Life Technologies, CA, USA) were added to each. Finally, reactions 
were mixed and incubated at 42°C for 60 minutes then 85°C for 5 minutes in a 
thermocycling PCR machine, to make 20l of cDNA. 
2.2.3.5. qRT-PCR reaction 
1l of each cDNA sample (≤500ng) was amplified by PCR in a 25l reaction 
mixture; 12.5l of SYBRGreen mastermix (Sigma-Aldrich, Dorset, UK), 0.6-l of 
forward primer (primer sequences were designed using BLAST search with the 
NCBI tool Primer-BLAST (www.ncbi.nlm.nih.gov/tools/primer-blast/), presented 
in Table 2.1), 0.6-l of reverse primer and 10.3l of RNase-free H2O, using an 
Mx4000 multiplex quantitative PCR sampler (Stratagene, La Jolla, CA, USA). 
Sample concentrations were calculated from serial dilution concentration curves, 
and each reaction was set up in triplicate, including GAPDH and 1l RNase-free 
H2O no template controls.  
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Primer Forward Reverse 
 
GABAAR α4-
Exon 3 
 
GAPDH 
 
 
 
5’ - 
CGTATTCTGGACAGTTTGCTGG
ATGGT -3’ (27) 
 
5’- 
TGCCCCCATGTTTGTGATG  
-3’ (19) 
 
5’- 
ACGGGCCCAAAGCTGGTGACAT
-3’ (22) 
 
5’- 
TGTGGTCATGAGCCCTTCC 
-3’ (19) 
Table 2.1. Primer sequences used for qRT-PCR analysis of constitutive and 
D1/D2-expressing neuron specific GABAAR α4-subunit knockout mice, 
heterozygous and relative wildtype controls. 
 
2.2.4. Production of Virus 
2.2.4.1. AAV Production 
Hek 293 Cells were cultured at 37 and 5% CO2 in 90% Minimum Essential 
Medium [Invitrogen/Gibco, Cat. No. 21099-022] with GlutaMAX 
[Invitrogen/Gibco, Cat. No. 35050-038] and 10% heat inactivated horse serum, 
1 mM Sodium Pyruvate (Invitrogen/Gibco, Cat. No. 11360-039), 0.1 mM non-
essential amino acids (Invitrogen/Gibco Cat.No. 11140-35). Passaging was 
carried out using treatment of 0.5 mg/ml Trypsin; 0.2 mg/ml EDTA in PBS at 
intervals of 80-90% confluency. 
Hek 293 cells were transfected at 70-80% confluency in 9cm plates. Plasmids 
were adjusted to 1mg/ml, then 10ug of pAAV-Cre or pAAV-GFP, pHelper and 
pRC plamisds were added to 1ml CaCl2 and 1ml 2xHBS. DNA/CaCl2/HBS mixture 
was applied to plates which were then incubated 6h at 37. 6h post transfection 
medium was aspirated and replaced with growth medium before incubation for a 
further 72h. 
2.2.4.2 Harvesting AAVs 
Cell/media suspension was decanted into a 50ml Falcon tube and cells were 
detached using a scraper into 2.5ml 1xDPBS then added to the same tube. 
Suspension was centrifuged at 20c for 5 minutes, then media was aspirated and 
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procedure to allow 4 plates per tube. Pellet was resuspended in 1068ul cell lysis 
buffer (3ml 5M NaCl, 5ml 1M Tris-HCl pH8, 80ml ddH2O) then freeze-thawed 2x 
using dry-ice/37 water bath. Benzonase was added to the cell lysate at a final 
concentration of 50units/ml and incubated 30  ins at 37. Lysate was centrifuged 
at 3670g for 45 minutes at 4°C. Supernatant containing virus was collected and 
stored at -80°C.  
2.2.5. Stereotaxic Viral Infusion 
C57BL/6J mice anesthetised with isoflurane were stereotaxically infused with 
AAV-GFP or AAV-Cre, bilaterally into the NAc (coordinates AP1.34; L+/− 1.40; 
DV −4.20, (Paxinos and Franklin, 2001)). A steel infuser (33ga) connected via 
polyvinyl tubing to a (5μl) Hamilton Gastight syringe was used to infuse 1ul 
(0.5μl per side) of virus at a rate of 0.2μl/min for 5 minutes, then left to settle 
for an additional 5 minutes. Following surgery mice were singly housed and 
allowed to recover for 7 days.  
2.2.6. Immunohistochemistry 
Following experiments mice were euthanised by IP injection of Sodium 
Pentobarbital (10ml/kg). Mice brains were perfused via the aorta with 25ml 
(5ml/min) of phosphate buffer solution (PBS) followed by 75ml (5ml/min) of 4% 
paraformaldehyde (PF) (Sigma-Aldrich, St. Lois, MO, USA) in PBS. After 
perfusion, brains were removed and post-fixed overnight in 4% PF in PBS at 
4°C, then transferred into 30% sucrose solution in PBS and left for 3 days at 4°C 
to cryoprotect. Coronal sections (30μm thick) were cut using a cryostat and 
collected in PBS-azide. 
Free floating sections were washed 3 times in PBS for 10 minutes then incubated 
in blocking solution, 3% Normal Goat Serum (Vectorlabs) in PBS-T, for 1 hour 
with gentle agitation. Sections were then immediately incubated overnight in 
rabbit anti-GFP ployclonal primary antibody (1:10,000, Abcam ab6556) or rabbit 
anti-mCherry antibody (1:10,000, Abcam ab167453) diluted in blocking solution 
at 4°C. Sections were washed 3 times in PBS for 10 minutes before incubation in 
fluorescently tagged Alexafluor 488/568 anti-rabbit secondary antibodies (1:600, 
Thermofisher) diluted in blocking solution for 2 hours at room temperature. 
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2.2.7. Fluorescent in situ hybridisation (RNAScope) 
2.2.7.1. Tissue Preparation 
Mice were euthanised by intraperitoneal injection of sodium pentobarbital 
followed by cervical dislocation to minimise rupturing of blood vessels. Brains 
were extracted and flash-frozen by submergence in isopentane maintained at -
50°C for 10 seconds then stored at -80°C prior to sectioning. 
Brains were sectioned in an RNAse free cryostat at -18°C. Brains were mounted 
on cryostat platforms using OCT mounting medium in -18°C chamber and left to 
equilibrate temperature for 1 hour prior to sectioning. Coronal sections of 10µm 
thickness were taken and mounted on SuperFrost Plus microscope slides 
(Thermofisher). Slides were stored at -80°C prior to in-situ-hybridisation. 
Sections were submerged in 10% Buffered Formalin for 20 minutes at 4°C. 
Slides were washed in 1xPBS for 2 x 1 minute with gentle agitation then 
dehydrated in a series of ethanol solutions. Slides were submerged in 50% 
ethanol for 1 x 5 minutes, 70% ethanol 1 x 5 minutes and 100% ethanol for 2 x 
5 minutes then incubated overnight in 100% ethanol at -20°C. 
2.2.7.2. Procedure 
In-situ-hybridisation was carried out using a manual RNAscope Fluorescent 
Multiplex Reagent Kit (Advanced Cell Diagnostics, Cat No. 320850) using 
instructions for fresh-frozen tissue and performing incubation steps using an 
ACD HybEZ™ Hybridization oven. We used RNAScope probes targeting: Mouse 
Gabrα4 (Cat No. 424261), Cre-recombinase (Cat No. 312281-C2), and either 
Drd1 (Cat No. 406491-C3) or Drd2 (Cat No. 406501-C3). We used the ‘Amp4 Alt 
A’ amplification reagent to label probes with fluorochromes as follows; Gabrα4 = 
Alexa-488, Cre-recombinase = Atto-647, and either Drd1 or Drd2 = Atto 550. 
Images were captured using a QI click camera (Qimaging) attached to an 
Olympus Bx53 microscope (Olympus). Images of the NAc taken at 20x 
magnification were analyzed using ImageJ software (NIH).  
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2.2.8. Statistics 
2.2.8.1. qRT-PCR 
Data was analysed using the Mx4000 data analysis software (Stratagene, CA, 
USA), then exported to an Excel worksheet. Reaction triplicates were averaged, 
and then a mathematical model used to calculate the fold change of the target 
gene using the delta-delta CT of the target sample versus a control, expressed in 
comparison to the GAPDH reference gene (Pfaffl, 2001). 
Expression of α4 subunit mRNA in the NAc or DStr of mice with intra-NAc 
expression of AAV-GFP or AAV-Cre were compared in an ANOVA using genotype 
as the between subjects variable and fold-change in expression relative to 
control as the dependant variable. In a subsequent, similar analysis α4-WT and 
‘Floxed’-α4 groups were removed. 
Expression of α4 subunit mRNA in the NAc and DStr of α4-WT, ‘Floxed’-α4 mice, 
and ‘Floxed’-α4 mice with intra-NAc expression of AAV-GFP or AAV-Cre were 
compared in a repeated measures ANOVA using brain-region as the within 
subjects factor, genotype as the between subjects variable and fold-change in 
expression relative to control as the dependant variable.  In a subsequent, 
similar analysis α4-WT and ‘Floxed’-α4 groups were removed. 
 
2.2.8.2. Fluorescent in-situ-hybridisation (RNAscope) 
We compared α4 mRNA expression in α4-WT (n=3) and α4-KO (n=3) mice. The 
amount of α4 mRNA probe signal was calculated as a percentage of the total 
image. This was averaged for each mouse and compared in a one-way ANOVA 
using genotype as the within subjects variable. 
We compared α4, Cre, and D1 or D2 mRNA expression in α4-D1-KO, α4-D2-KO 
mice and their respective controls. Initially α4-D1-WT and α4-D2-WT were 
treated separately however we observed no differences and therefore grouped 
them as ‘Floxed’-α4 mice in the presented analysis.  
For images with multiple probes (α4, Cre, and D1 or D2) signal was measured in 
individual cells (see microscopy) and we calculated Pearson’s correlation 
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coefficients to measure colocalization of signal from each probe. From these we 
calculated weighted mean correlations for each genotype using a Fisher-Z 
approach with Olkin and Pratt correction (as described by Olkin and Pratt, 1958; 
Alexander, 1990).  
In order to compare the level of colocalization between α4 and D1 or D2 in the 
different genotypes we compared correlation coefficients for each pair of probes 
using the Fisher r-to-Z transformation method (Lenhard and Lenhard, 2014) in 
each genotype. 
 
2.3. Results 
2.3.1. Characterising constitutive α4-KO mice 
2.3.1.1. qRT-PCR for GABAAR α4-subunit in α4-WT/Het/KO mice 
To confirm deletion of α4 mRNA transcript we performed a quantitative RT-PCR 
experiment using primers directed to exon 3. The qRT-PCR analysis revealed 
GABAAR α4-subunit mRNA levels to be reduced in NAc of α4-Het mice and 
completely absent in α4-KO mice when compared to α4-WT control mice, 
confirming the knockout of α4 (Table 2.2, Figure 2.5; significant main effect of 
genotype, F(2,9) = 666.42, p < 0.001). We therefore confirm complete deletion of 
exon 3 in α4-KOs and ~50% expression in α4-Hets.  
GABAAR α4-subunit mRNA levels were similarly reduced in the DStr of α4-Het 
mice and again completely absent in α4-KO mice when compared to α4-WT 
control mice, further confirming the knockout of α4 throughout the striatum 
(Table 2.2, Figure 2.5; significant main effect of genotype, F(2,9) = 44.406, p < 
0.001). We therefore confirm complete deletion of α4 in α4-KOs and ~50% 
expression in α4-Hets. 
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Figure 2.5. Fold change from WT controls of GABAAR α4 subunit mRNA 
expression in the NAc and DStr of α4-WT (n=4), α4-Het (n=4) and α4-KO (n=4) 
mice. GABAAR α4-subunit expression in the NAc and Dorsal Striatum was absent 
in α4-KO mice and reduced to ~50% in α4-Het mice (p<0.001*). Error bars 
represent SEM. 
 
Region Genotype Fold change % Change from WT Sig 
NAc α4-WT 
α4-Het 
α4-KO 
1 ± 0.02/0.02 
0.93 ± 0.02/0.05 
0.9 ± 0.09/0.07 
0% 
-54% 
-100% 
 
p<0.001 
p<0.001 
DStr α4-WT 
α4-Het 
α4-KO 
1 ± 0.12/0.09 
0.98 ± 0.07/0.04 
0.9 ± 0.09/0.07 
0% 
-47% 
-10% 
 
p<0.001 
p<0.001 
Table 2.2 NAc and DStr mRNA expression levels of GABAAR α4 subunit in α4-WT 
(n=4), α4-Het (n=4) and α4-KO (n=4) mice were compared in triplicate against 
α4-WT mice to give a measure of fold change. Fold change from WTs was tested 
statistically using Least-Square-Difference post hoc comparisons. 
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2.3.1.2. Fluorescent in situ hybridisation (RNAScope) for GABAAR α4-
subunit in α4-WT/KO mice 
In order to visualise expression of the GABAA α4 subunit within the striatum we 
performed a fluorescence in situ hybridisation on brain sections taken from 
wildtype (α4-WT, n=3) constitutive α4 knockout (α4-KO, n=3) mice.  
Surprisingly we detected α4 mRNA signal in both the α4-Wt and α4-KO mice 
(Figure 2.6). We therefore quantified the amount of signal in images of the NAc 
and compared this between α4-WT and α4-KO mice. The α4 mRNA signal was 
significantly reduced in α4-KO mice relative to α4-WT (Figure 2.6, significant 
main effect of genotype, F(1,5) = 19.21, P<0.05). Although we detected some 
background signal it is therefore possible to distinguish α4-WT and α4-KO mice 
via in situ hybridisation.  
 
 
Figure 2.6. In-situ-hybridisation for GABAAR α4 subunit mRNA in the NAc of α4-
Wt and α4-KO mice. Neurons are highlighted by DAPI staining (blue) and the 
probe targets α4 mRNA (green). Signal is significantly reduced in α4-KO mice 
compared with α4-WT (p<0.05). Error bars represent SEM. 
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2.3.2. Characterising D1/D2 specific α4 KOs 
2.3.2.1. Fluorescent in situ hybridisation (RNAScope) Cre and D1/D2 
To confirm that Cre was correctly expressed only in D1 or D2 neurons of α4-D1-
KO and α4-D2-KO mice respectively we performed a fluorescent in situ 
hybridisation using probes for α4, Cre-recombinase, and either D1R or D2R on 
NAc brain sections from ‘Floxed’-α4, α4-D1-KO and α4-D2-KO mice (Figure 2.7).  
In ‘Floxed’-α4 mice we found no expression of Cre as expected. We detected 
significantly greater expression of Cre in α4-D2-KO mice compared to α4-D1-KO 
mice (Figure 2.7).  
In α4-D1-KO mice (n=3) Cre was positively correlated with D1 (r=0.237, 
t(307)=4.271, p<0.001) but not with D2 (r=-0.0023, t(393)=-0.045, p = 0.096, 
NS) and not with Cre (r=-0.0, t(393)=-0.045, p = 0.096, NS). 
Conversely, in α4-D2-KO mice (n=3) Cre was negatively correlated with D1 (r=-
0.279, t(413)=-5.92, p<0.001, NS) but was positively correlated with D2 (r=0.74, 
t(411)=22.54, p<0.001). 
Genotype Correlation Pearson’s r Sig 
‘Floxed’-α4 α4 & D1 
α4 & D2 
+0.304 
+0.305 
p<0.001  
p<0.001 
α4-D1-KO Cre & D1 
Cre & D2 
Cre & α4 
α4 & D1 
α4 & D2 
+0.237 
-0.002 
+0.079 
+0.213 
+0.369 
p<0.001 
NS 
NS 
p<0.001 
p<0.001 
α4-D2-KO Cre & D1 
Cre & D2 
Cre & α4 
α4 & D1 
α4 & D2 
-0.279 
+0.74 
+0.08 
+0.484 
+0.182 
p<0.001  
p<0.001 
NS 
p<0.001 
p<0.001 
Table 2.3. Table of correlations between signal from probes targetting GABAA α4 
subunit, Cre-recombinase and either D1R or D2R in the NAc of each genotype.  
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 Figure 2.7. In-situ-hybridisation for Cre-recombinase and D1/D2 mRNA in the 
NAc of α4-D1-Ko, α4-D2-KO and ‘Floxed’-α4 mice. Neurons are highlighted by 
DAPI staining (blue) and probes target Cre-recombinase (cyan) and D1 (red, 
upper panels) or D2 (red, lower panels) mRNA by probes (green). In α4-D1-KO 
animals Cre positively correlates with D1 but not D2 (p<0.001). In α4-D2-KO 
animals Cre positively correlates with D2 (p<0.001) and negatively correlates 
with D1 (p<0.001). 
2.3.2.2. Fluorescent in situ hybridisation (RNAscope) for α4, Cre and 
D1/D2 
We did not observe a significant difference in α4 expression between ‘Floxed’ α4, 
α4-D1-KO and α4-D2-KO (non-significant main effect of genotype, F(2,20) = 3.25, 
p=0.13).   
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In ‘Floxed’-α4 mice α4 was positively correlated with D1 (r=0.304, t(282)=5.368, 
p<0.001) and with D2 (r=0.305, t(464)=6.88, p<0.001). Comparison of Pearson’s 
coefficients found that α4 colocalised to a similar degree with D1 and D2 (Table 
2.3, z=0, p=0.5). 
In α4-D1-KO mice α4 was positively correlated with D1 (r=0.213, t(309)=, 
p<0.001) and with D2 (r=0.369, t(393)=7.85, p<0.001) but not with Cre 
(r=0.0793, t(333)=1.394, p=0.16). Comparison of Pearson’s coefficients found 
that α4 was more strongly colocalised with D2 than D1 (Table 2.3, z=-2.22, 
p<0.05). 
In α4-D2-KO mice α4 was positively correlated with D1 (r=0.484, t(413)=11.25, 
p<0.001) and with D2 (r=0.182, t(411)=3.76, p<0.001) but not with Cre (r=0.08, 
t(413)=1.65, p=0.1001, NS). Comparison of Pearson’s coefficients found that α4 
was more strongly colocalised with D1 than with D2 (Table 2.3, z=5, p<0.001).  
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Figure 2.8. In-situ-hybridisation for GABAAR α4 subunit, Cre-recombinase and 
D1/D2 mRNA in the NAc of α4-D1-KO, α4-D2-KO and ‘Floxed’-α4 mice. Neurons 
are highlighted by DAPI staining (blue) and probes target α4 subunit (green) 
Cre-recombinase (cyan) and D1 (red, upper panels) or D2 (red, lower panels) 
mRNA by probes (green). Boxes highlight Cre expressing (solid arrows) and non-
cre-expressing (transparent arrows) neurons. GABAAR α4 subunit correlates 
equally with D1 and D2 in ‘Floxed’-α4 mice. GABAAR α4 subunit correlates less 
strongly with D1 in α4-D1-KO mice (p<0.001) and less strongly with D2 in α4-
D2-KO mice (p<0.001).     
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2.3.3 Characterising Cre virus in vivo 
2.3.3.1. Confirming AAV expression by Immunohistochemistry 
 
Figure 2.9. (A) Expression of AAV-Cre virus in the NAc of ‘Floxed’-α4 mice 
visualised by immunohistochemistry using antibody for mCherry marker. (A) 
Expression of AAV-Cre virus in the NAc of ‘Floxed’-α4 mice visualised by 
immunohistochemistry using antibody for GFP marker. 
 
2.3.3.2. Confirming AAV-Cre knockdown of α4 by qRT-PCR 
To test whether wildtype and ‘floxed’-α4 mice have similar levels of α4 subunit 
expression and whether the AAV-Cre virus was able to reduce α4 subunit mRNA 
expression in the NAc of ‘Floxed’-α4 mice we used a qRT-PCR experiment to 
compare α4-WT (n=4), ‘Floxed’-α4 (n=4) mice, and ‘Floxed’-α4 mice with intra-
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NAc expression of AAV-GFP (n=4) or AAV-Cre (n=4) to give a measure of fold 
change compared to α4-WT mice.  
In the NAc α4 expression was reduced in ‘floxed’-α4 + AAV-Cre mice but not in 
untreated ‘Floxed’-α4 or ‘Floxed’-α4 + AAV-GFP mice (Figure 2.10, Table 2.4, 
significant main effect of genotype, F(3,12) = 6.2, p < 0.05, post hoc WT vs 
Floxed + Cre, p < 0.05). In a control region, the DStr, α4 expression was similar 
to wildtypes in untreated ‘Floxed’-α4, ‘Floxed’-α4 + AAV-GFP or ‘Floxed’-α4 + 
AAV-Cre mice mice (Figure 2.10, Table 2.4, non-significant main effect of 
genotype, F(3,12) = 0.48, p = 0.985, NS). 
Further, to determine that α4 subunit expression was reduced by accurate 
injection of AAV-Cre in the NAc of Floxed-α4 mice we compared mRNA 
expression in both the NAc and control region, the DStr, of these mice in a 
repeated measures analysis. We found that α4 expression was reduced only in 
the NAc but not DStr of ‘Floxed’-α4 + AAV-Cre mice (Figure 2.10, significant 
region by genotype interaction F(1,12) = 19.07, p<0.001). 
 
Figure 2.10. Fold change from WT controls of GABAAR α4 subunit mRNA 
expression in the NAc and DStr of α4-WT (n=4) mice, ‘Floxed’-α4 (n=4) mice, 
and ‘Floxed’-α4 mice with intra-NAc expression of AAV-GFP (n=4) or AAV-Cre 
(n=4). ‘Floxed’-α4 mice with intra-NAc expression of AAV-Cre (n=4) show a 
decrease in α4 expression in the NAc (p<0.05*) but not DStr. Error bars 
represent SEM. 
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Region Genotype Fold change % Change from WT Sig 
NAc α4-WT 
‘Floxed’-α4 
AAV-GFP 
AAV-Cre 
1 ± 0.08/0.06 
0.93 ± 0.13/0.09 
0.9 ± 0.09/0.07 
0.38 ± 0.06/0.04 
0% 
-7% 
-10% 
62% 
 
NS 
NS 
P = 0.023* 
DStr α4-WT 
‘Floxed’-α4 
AAV-GFP 
AAV-Cre 
1 ± 0.16/0.1 
0.98 ± 0.17/0.11 
0.9 ± 0.09/0.07 
0.89 ± 0.1/0.07 
0% 
-2% 
-10% 
-11% 
 
NS 
NS 
NS 
Table 2.4. NAc and DStr mRNA expression levels of GABAAR α4 subunit in α4-
WT, ‘Floxed’-α4, and ‘Floxed’-α4 mice with intra-NAc expression of AAV-GFP 
(n=4) or AAV-Cre (n=4) were compared in triplicate against α4-WT mice with to 
give a measure of fold change. Fold change from WTs was tested statistically 
using Least-Square-Difference post hoc comparisons. 
 
‘Floxed’-α4 + AAV-GFP mice provide the best physiological control for ‘Floxed’-α4 
+ AAV-GFP mice and, as outlined above, did not differ significantly from wildtype 
or ‘Floxed’-α4 mice. We therefore performed a subsequent analysis in which we 
compared α4 subunit fold change in the NAc or DStr of ‘Floxed’-α4 + AAV-Cre 
compared with ‘Floxed’-α4 + AAV-GFP controls. In the NAc α4 expression was 
reduced in ‘Floxed’-α4 + AAV-Cre mice (Figure 2.11, Table 2.5, significant main 
effect of genotype, F(1,6) = 20.16, p < 0.005). In the DStr α4 expression was 
similar in ‘Floxed’-α4 + AAV-GFP and ‘Floxed’-α4 + AAV-Cre mice (Figure 2.11, 
Table 2.5, non-significant main effect of genotype, F(1,6) = 20.16, p < 0.005). We 
found that α4 expression was reduced only in the NAc but not DStr of ‘Floxed’-α4 
+ AAV-Cre mice (Figure 2.11, significant region by genotype interaction F(1,12) = 
33.46, p<0.001). 
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Figure 2.11. Fold change from ‘Floxed’-α4 + AAV-GFP controls (n=4) of GABAAR 
α4 subunit mRNA expression in the NAc and DStr of ‘Floxed’-α4 +AAV-Cre mice 
(n=4). ‘Floxed’-α4 mice with intra-NAc expression of AAV-Cre (n=4) show a 
decrease in α4 expression in the NAc (p<0.05*) but not DStr. Error bars 
represent SEM. 
 
Region Genotype Fold change % Change from Cntrl Sig 
NAc AAV-GFP 
AAV-Cre 
1 ± 0.13/0.09 
0.42 ± 0.08/0.05 
0% 
-58% 
 
P = 0.004 
DStr AAV-GFP 
AAV-Cre 
1 ± 0.11/0.08 
0.98 ± 0.12/0.09 
0% 
-2% 
 
NS 
Table 2.5. NAc and DStr mRNA expression levels of GABAAR α4 subunit in 
‘Floxed’-α4 mice with intra-NAc expression of AAV-GFP (n=4) or AAV-Cre (n=4) 
were compared in triplicate against ‘Floxed’-α4 + AAV-GFP (n=4) to give a 
measure of fold change. Fold change from WTs was tested statistically using 
Least-Square-Difference post hoc comparisons. 
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2.4. Discussion 
2.4.1. Constitutive GABAAR α4 subunit Knockout Mice  
Our genotyping procedure and qRT-PCR analysis of NAc and DS tissue samples 
confirmed the absence of GABAAR α4-subunit DNA and mRNA expression in α4-
KO mice, and a reduction of approximately 50% in α4-Het mice when compared 
to α4-WT controls. These data confirm cre/loxp cleavage of the gabrα4 gene. 
To visualise the expression pattern of α4, to enable investigation of 
colocalistation with other neural markers in subsequent analysis, we used a 
recently developed fluorescent in-situ-hybridisation method (RNAscope). This 
method has been useful in other studies of low expressing genes as it amplifies 
mRNA signal for clear visualisation (Wang et al., 2012). Unexpectedly, we 
appeared to detect signal from the probe targeting the gabrα4 gene in α4-KO 
animals where it should be absent.  
Both genotyping and qRT-PCR analysis confirmed absence of exon-3 of the 
gabrα4 gene in addition to previous studies which have demonstrated a lack of 
GABAAR α4 subunit protein in α4-KO mice from the same colony via both 
Western blot and immunohistochemistry (see figure 2.12. below), as well as 
electrophysiological differences (Macpherson, 2013; Maguire et al., 2014).  
 
Figure 2.12. Western Blot analysis of PFC, thalamus and NAc tissue from GABAA 
α4-WT (WT, n=3), α4-Het (HET, n=3) α4-KO (α4-/-, n=3) mouse tissue 
(Macpherson, 20313). (A) Representative images of western blot results for 
GABAA α4 and β-actin. Blots probed for β-actin show equal loading of samples. 
(B) Percentage change from α4-WTs of the protein GABAA α4 in the PFC, 
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thalamus and NAc. The expression of the GABAA α4 protein was lacking in all 
tested brain regions of the α4-KO mice and significantly reduced in α4-Het mice. 
We therefore suggest that α4 signal observed in α4-KO mice results from either 
non-specific binding of the probe or that that following deletion of exon-3 in α4-
KO mice there remains a truncated mRNA transcript which does not lead to 
expression of functional α4 protein but is able to bind the RNAscope probe. The 
primers used in genotyping and qRT-PCR analysis are targeted within the 
deleted exon-3 whereas the RNAscope probe targets a 1316 base-pair region 
(449 to 1765) surrounding exon-3 but encompassing upstream and downstream 
regions including exons 1-8. If a truncated mRNA is present it could therefore 
have a large amount of sequence homology with the α4 probe. Despite this 
problematic ‘background’ signal we observed higher levels of α4 mRNA specific 
signal in α4-WT mice and are therefore able to distinguish α4-WT and α4-KO 
neurons using this method. 
We attempted to investigate the possibility of a truncated transcript using qRT-
PCR with two pairs of primers directed either upstream or downstream of exon 
3. Unfortunately, these primers failed to replicate cDNA in either α4-KO or α4-
WT mice. Further work to develop effective qRT-PCR primers for exons 1/2 or 4-
8 may confirm or disprove the presence of a truncated α4 mRNA in α4-KO mice. 
Alternatively, a new gabrα4 RNAscope probe could be developed using, if 
possible, a smaller sequence or one further upstream of exon-3.  
2.4.2. D1- and D2- specific GABAAR α4 subunit Knockout Mice  
To confirm the D1- and D2-specific knockout of α4 in our conditional knockout 
α4-D1-KO and α4-D2-KO mice we performed in-situ-hybridisation using probes 
targeting Cre-recombinase, gabrα4, and either Drd or Drd2. No Cre was 
detected in ‘Floxed’-α4 mice (either α4-D1-WT or α4-D2-WT) which serve as 
controls for the conditional α4 knockout mice. In α4-D1-KO mice Cre was 
colocalized with D1 but not D2 whereas in α4-D2-KO mice Cre colocalized with 
D2 and was negatively correlated with D1. We have therefore confirmed that Cre 
is correctly expressed in the expected neural populations according to the 
original driver lines. Overall, Cre expression was higher in the NAc of α4-D2-KO 
mice than α4-D1-KO mice. This is also expected as Cre expression was higher in 
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the D1- than D2- BAC-Cre founder line used to breed our conditional knockouts 
(Gong et al., 2007). 
The difference in Cre expression may affect our interpretation of behavioural 
differences in these mice as the α4 subunit will be deleted in a smaller 
population of neurons in D1 than D2 mice which may result in a less severe 
phenotype. Further, in the D2 BAC founder line Cre is more broadly expressed 
throughout the Dorsal and Ventral striatum whilst in the D1 line it is more 
restricted to the NAc. This adds anatomical specificity to the D1 manipulation but 
makes comparisons of behaviour between D1- and D2- knockouts less readily 
attributable to D1/D2 neural dissociation and potentially partially attributable to 
anatomical differences. However, our previous studies and this thesis focus on 
drug potentiated behaviours and conditioning which are thought to be primarily 
mediated by the NAc where Cre is expressed in both lines. We should exercise 
some caution when interpreting behaviours mediated by the Dorsal Striatum, 
such as baseline locomotor activity. 
In ‘floxed-α4’, α4-D1-KO and α4-D2-KO mice, α4 was colocalized with both D1 
and D2. Our analysis revealed that in ‘floxed’-α4 mice this correlation was equal 
in D1 and D2 neurons. In contrast, we found that in α4-D1-KO mice α4 was 
more strongly correlated with D2 and less with D1, whereas in α4-D2-KO mice 
the reverse was true; α4 was more strongly correlated with D1 and less with D2. 
We therefore conclude that the presence α4 probe signal in both populations is 
due to the background signal (discussed above) and populations of D1 and D2 
neurons not expressing Cre in α4-D1-KO and α4-D2-KO mice respectively due to 
position effect variegation. Our results suggest a reduction of the α4 mRNA 
specific signal in D1 or D2 neurons of α4-D1-KO and α4-D2-KO mice 
respectively.  
The overall level of α4 mRNA signal was not significantly different between 
genotypes. We may have expected a reduction in α4 conditional knockouts 
relative to ‘floxed’-α4 controls based on previous qRT-PCR data (Macpherson, 
2013). The high level of signal amplification in the RNAscope method makes 
quantification difficult and may mask such smaller differences in expression 
(Wang et al., 2012). 
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2.4.3. AAV-Cre virus mediated NAc specific Knockout of the GABAAR α4 
subunit 
Finally, we used an AAV viral vector to deliver Cre to the NAc of ‘Floxed’-α4 mice 
and demonstrated its ability to reduce α4 subunit mRNA. Expression of the AAV-
Cre virus in the NAc was confirmed by immunohistochemistry for the mCherry 
marker. We were able to visualise mCherry expression within the targeted 
region of the NAc core to confirm localisation of the virus. Further qRT-PCR 
analysis demonstrated substantial knockdown (~60%) of GABAAR α4 subunit 
mRNA in the NAc but not in a nearby control region (Dorsal Striatum) when 
compared with the control AAV-GFP virus or untreated mice. Importantly, we 
also demonstrated similar α4 expression in ‘Floxed’-α4 animals as in α4-WT mice 
which verifies them as equally ecologically representative controls in 
experiments using manipulations of α4.  
One of the primary advantages of using viral vectors is to eliminate the 
compensatory mechanism observed in several GABAAR subunit knockout mice 
(Brickley et al., 2001; Sur et al., 2001; Vicini et al., 2001). However, under 
certain conditions, such as cocaine or alcohol treatment, expression of GABAAR 
subunits has been found to be rapidly modulated (Liang et al., 2007; Heiman et 
al., 2008). It would therefore be of interest to perform further qRT-PCR 
experiments analysing expression of various other GABAAR subunits in NAc 
tissue from ‘Floxed’-α4 mice treated with AAV-Cre. If other subunits are 
upregulated their compensatory effects could mask behavioural effects of the 
localised α4 knockout. 
The presented data, in addition to previous studies, demonstrate that the 
GABAAR α4 subunit is functionally deleted in α4-KO mice. Further, in D1- and 
D2- specific conditional knockout mice Cre/loxp deletion has reduced α4 
expression in D1 or D2 expressing neural populations respectively. We have also 
produced an AAV-Cre virus which can be used to locally knockdown α4 
expression when surgically injected into a region of interest, the NAc.   
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Chapter 3 
The role of α4-containing GABAA receptors in mediating binge-like 
alcohol drinking (Drinking in the Dark) 
 
3.1. Introduction 
3.1.1 Pre-clinical models of alcohol drinking 
Globally harmful use of alcohol has been estimated to cause 5.9% of annual 
deaths and account for 5.1% of the global health burden (WHO, 2014). In 
particular ‘binge drinking’, a pattern in which blood alcohol levels are raised to 
0.08 grams alcohol per decilitre blood (0.8mg/ml), is associated with a large 
proportion of alcohol related deaths, diseases and social harms (NIAAA, 2004). 
Pre-clinical animal models, typically rodent, allow the use of invasive 
pharmacological and genetic techniques in combination with behavioural tests to 
identify neuronal systems underlying the reinforcing effects of alcohol. A number 
of techniques have been developed in which ethanol consumption and 
preference can be measured (reviewed, Crabbe et al. 2011). Of these two of the 
most commonly used procedures are ‘Two-Bottle Choice’ and ‘Drinking in the 
Dark’ (DID). 
In ‘Two-Bottle Choice’ procedures an ethanol solution is presented alongside 
drinking water and can be provided continuously or under chronic, intermittent 
access conditions (24h access on alternating days) (Richter & Campbell 1940, 
Wise 1973). Drinking in the Dark (DID) is a limited access procedure in which 
the water supply of a rat or mouse is exchanged for an ethanol solution (10 to 
20% ABV) during a two hour period in the dark phase of the light cycle and 
consumption is recorded (Ryabinin et al. 2003, Rhodes et al. 2005). Ethanol 
consumption in these studies was high enough to reliably predicted blood alcohol 
concentrations (BACs) >1mg/ml in C57BL/6J mice. An obvious problem with DID 
is the lack of choice available however a 2h period of voluntary water deprivation 
is not nearly sufficient to challenge mice physiologically (Toth & Gardiner 2000, 
Crabbe et al. 2011). Under conditions of intermittent access (Wise, 1973) and to 
a greater extent limited access (Rhodes et al., 2005) animals show an increased 
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preference for alcohol and achieve higher BACs which makes them the best 
models of ‘binge drinking’ behaviour. 
These procedures are informative about alcohol consumption but not the 
motivation for ethanol consumption or its reinforcing properties. DID ethanol 
consumption and BACs are not changed by food deprivation or when peripheral 
leptin/ghrelin administration was used to decrease/increase feeding in C57BL/6J 
mice (Lyons et al., 2008) implying that increased consumption is not due to 
calorie seeking. Even so, these models only examine the consummatory phase 
of behaviour rather than the motivational or appetitive. Procedures have 
therefore been developed to train animals to respond for ethanol reinforcement 
in operant conditioning tasks where rodents are trained to press levers to 
receive small volumes of ethanol solution as reinforcers (Samson, 1986). Due to 
the aversive taste of alcohol this typically requires a ‘sucrose fading’ technique 
whereby food deprived animals are trained to respond for solutions in which 
sucrose content is incrementally reduced and ethanol content is increased over 
an ‘acquisition phase’ (Elmer, Meisch and George, 1986; Samson, 1986; 
Samson, Pfeffer and Tolliver, 1988). 
Although operant self-administration experiments provide insight into 
motivational behaviour sucrose fading introduces the confound of an additional 
rewarding stimuli and typically rodents do not reach such high BACs as in DID 
procedures (Elmer, Meisch and George, 1986; Rhodes et al., 2005; Crabbe, 
Harris and Koob, 2011; Doherty and Gonzales, 2015). Additionally studies that 
simultaneously recorded operant responses and volume/rate of subsequent 
ethanol consumption found that higher initial operant responses did not predict 
larger or faster drinking bouts therefore dissociating appetitive and 
consummatory aspects of drinking behaviour (Samson et al., 1998). This 
suggests that aside from appetitive mechanisms consummatory behaviour is an 
important component of binge-like drinking itself. 
3.1.2. GABA in ethanol consumption and reinforcement 
Alcohol can be described as lacking molecular specificity in comparison to other 
drugs of abuse which have specific molecular targets (e.g. heroin at opioid 
receptors or cocaine at dopamine transporters). Rather alcohol has low affinity 
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interactions with many different targets including neurotransmitters, receptors, 
enzymes and other molecules (Koob, 2014; Ron and Barak, 2016).  
Of the neurotransmitters and receptors affected by alcohol GABAeric systems 
appear to be a prominent target of alcohol (Davies, 2003). GABAergic 
components of ethanol related behaviour are varied as receptors mediate 
different effects depending on their class and sub-unit composition (George F 
Koob, 2004). Pharmacological manipulations of different GABA receptor classes 
have revealed different and often opposing roles of ionotropic (GABAA) and 
metabotropic (GABAB) receptors in alcohol consumption and reinforcement 
(reviewed below). 
There is some convergence of pre-clinical evidence that agonism of GABAB 
receptors reduces alcohol consumption, motivation and withdrawal. 
Intraperitoneal (IP) injection of the GABAB receptor agonist baclofen dose 
dependently reduced ethanol consumption in rats during continuous access in 
the ‘Two-bottle choice’ procedure (Colombo et al., 2000) and operant self-
administration (Anstrom et al., 2003). IP baclofen and SKF 97541 (another 
GABAB agonist) also reduced operant self-administration of ethanol but also 
saccharin solution in C57BL/6J mice (Besheer, Lepoutre and Hodge, 2004) 
although this may have been due to potentiation of alcohol’s sedative effects.  
In contrast opposite effects have been found using modulators of GABAA 
receptor activity. The GABAA antagonist RO15-4513 reduced ethanol self-
administration in alcohol preferring Wistar rats (Rassnick et al., 1993).  
Voluntary ethanol consumption in rats (measured by Two-Bottle Choice) can be 
decreased by IP injection of the GABAA antagonist picrotoxin but is increased by 
the GABAA agonist THIP (Boyle et al., 1993) indicating bidirectional control of 
ethanol consumption via GABAA receptors. 
The effects of GABAergic compounds can be localised to specific brain regions. 
GABA receptors are expressed in many brain areas, including the mesolimbic 
dopamine system, associated with drug and ethanol reinforcement (reviewed; 
Koob 2004). Injections of potent GABAA antagonist SR 95531 into the central 
amygdala (CA) or Nucleus accumbens (NAc) were sufficient to suppress 
responding in ethanol self-administration (Hyytiä and Koob, 1995). Similarly, 
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infusion of bicuculline or muscimol into the NAc supressed ethanol self-
administration. The NAc is a major region involved in the reinforcing properties 
of drugs of abuse including alcohol (Koob and Volkow, 2010). Rats self-
administer ethanol directly to the NAc and alcohol preferring rats do so to a 
greater extent (Engleman et al., 2009) indicating that alcohol acts directly in this 
region to mediate its reinforcing properties. 
GABA may also mediate changes in striatal medium spiny neurons (MSNs) that 
are involved in the acquisition of alcohol dependence. Repeated ethanol 
exposure in a DID paradigm resulted in an increase in both consumption and 
drinking rate associated with a reduced frequency of GABAA receptor mediated  
inhibitory postsynaptic currents in striatal MSNs (Wilcox et al., 2014). These 
results indicate that synaptic GABAA transmission in MSNs is decreased following 
chronic or binge-like alcohol consumption.   
 3.1.3. α4-GABAARs in ethanol consumption and reinforcement 
Individual GABAA receptor (GABAAR) subunits have been implicated in NAc 
ethanol reinforcement using rodent models. The GABAA receptor subunit δ co-
assembles preferentially with α4 and β subunits in pentameric receptors with the 
configuration α4βδ (Sur et al., 1999a) which are located extrasynaptically 
(Nusser, Sieghart and Somogyi, 1998). The agonist THIP is preferential for α4βδ 
GABAA receptors (Ebert et al., 1994) and was found to increase ethanol 
consumption in rats via IP injection (Boyle et al., 1993).  
Extrasynaptic α4βδ receptors are also of particular interest in ethanol 
consumption as they were found to be the most rapidly upregulated GABA 
receptors following high-dose or chronic ethanol administration in rats (Liang et 
al., 2007). These receptors are located extrasynaptically on medium spiny 
neurons (MSNs) in the NAc where they mediate a tonic inhibition of MSNs 
(Maguire et al., 2014).  
C57Bl/6J mice with a constitutive deletion of the GABAA δ subunit (δ-KO mice) 
subunit show reduced ethanol consumption in a continuous-access ‘Two-bottle 
choice’ test (Mihalek et al., 2001). Transgenic mice with a deletion of the α4 
subunit (α4-KO mice) show reduced enhancement of GABAAR mediated tonic 
currents by THIP and a reduced sensitivity to its motor incoordinating effects 
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(Chandra et al., 2006) although they have not previously been reported to show 
reduced ethanol consumption. Mice carrying mutations of the gabrb1 gene 
encoding GABAA subunit β1, rendering β1-GABAARs tonically active, are less 
sensitive to the acute motor effects of alcohol and show increased ethanol self-
administration associated with enhanced tonic inhibition in the NAc (Anstee et 
al., 2013). 
Within the ventral striatum α4 is notably most highly expressed in the NAc 
(Schwarzer et al., 2001), an area which has been implicated in mediating the 
addictive properties of many drugs of abuse (Everitt and Robbins, 2005). 
Several studies have found that α4βδ receptors in the NAc shell mediate alcohol 
consumption and reinforcement. Virally mediated knockdown of δ (Nie et al., 
2011) or α4 (Rewal et al., 2009) subunits in the NAc shell, but not core, reduced 
ethanol consumption by rats during intermittent access in a ‘Two-bottle choice’ 
test. Knockdown of α4 in the NAc shell also reduced operant ethanol self-
administration in rats (Rewal et al., 2012). Together these phenotypes strongly 
imply that tonic inhibition via α4βδ receptors has a major role in the reinforcing 
effects of alcohol. 
Electrophysiological evidence for the effects of ethanol on these receptors is 
mixed. Early results found that low, ecologically valid doses of ethanol enhanced 
GABAA gated current in Xenopus laevis oocytes expressing α4βδ receptors and 
that α4β3δ were uniquely sensitive to doses as low as 1mM (Sundstrom-
Poromaa et al., 2002; Wallner, Hanchar and Olsen, 2003). This technique was 
also used to demonstrate that RO15-4513 blocked ethanol enhancement of α4βδ 
mediated current at doses that did not reduce GABA gated Cl- current (Wallner, 
Hanchar and Olsen, 2006) suggesting a mechanism for the ability of RO15-4513 
to reduce ethanol self-administration (Rassnick et al., 1993). These results are 
controversial as they are variable and have failed to replicate. Even in 
experiments which supported this model the ethanol concentration required for 
similar enhancement of current varied from 1mM (Sundstrom-Poromaa et al., 
2002) to 30mM (Wallner, Hanchar and Olsen, 2003). Independent experiments 
on Xenopus oocytes and human fibroblasts expressing rat, murine or human 
GABAA α4/b3/δ subunits reported that high doses of ethanol were required to 
enhance current; 100mM in oocytes and 300mM in fibroblasts (Borghese et al., 
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2006). The BAC used to define ‘binge drinking’ equates to approximately 17mM 
(NIAAA, 2004) so these results are unlikely to be physiologically relevant.  
It is also not clear whether direct or indirect action of ethanol at α4βδ receptors 
mediates its acute behavioural effects. Neither δ-KO nor α4-KO mice displayed 
different ethanol-related changes in anxiety or sedation when compared to wild-
type mice (Mihalek et al., 2001; Chandra et al., 2006) although this may be due 
to compensatory changes in transgenic mice whereby other voltage gated ion 
channels can be upregulated to counterbalance changes in neuronal excitability 
(Brickley et al., 2001). One possible mechanism by which ethanol may enhance 
GABAA current is via certain neurosteroids which act as positive allosteric 
modulators of GABAA receptors, even at low nanoMolar to microMolar 
concentrations (Lambert et al. 1995; Lambert et al. 2003). IP ethanol 
administration was found to greatly increase levels of the neurosteroid 
allopregnanolone (ALLOP) in the brain and this increase was much larger in 
alcohol-preferring relative to non-preferring rats (Barbaccia et al., 1999). 
Interestingly IP injection of ALLOP has also been found to enhance ethanol 
consumption during operant self-administration and ‘two-bottle choice’ 
procedures in rats (P H Janak, Redfern and Samson, 1998) and C57BL/6J mice 
(Sinnott, Phillips and Finn, 2002) respectively. 
Previous experiments examining the role of α4 in ethanol consumption 
(described above) have primarily focused on two-bottle choice or operant self-
administration. We wished to expand these studies using a DID protocol as 
under these conditions mice typically consume more ethanol and achieve higher 
BACs (Crabbe, Harris and Koob, 2011). This would be of interest as it may 
discover a role of α4 containing receptors in binge-like drinking specifically. Prior 
studies have also largely been conducted in rats therefore replication of these 
effects in murine models would provide convergent evidence from two species, 
which is more robust, and enables higher through-put experiments to which 
mice are more suited. 
Here we used the DID procedure to investigate the role α4-containing GABAARs 
play mediating ethanol consumption in mice. We compared transgenic C57BL/6J 
mice with a deletion of the gabrα4 gene encoding the α4 subunit (α4-KO mice) 
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to wild-type (α4-WT) and heterozygous (α4-Het) littermates (described in 
Chapter 2).  
IP injection of THIP has been found to modulate ethanol consumption but with 
mixed results (Boyle et al. 1993, Ramaker et al. 2012). This may be due to the 
sedative effect of THIP at higher doses (Ebert et al., 1994).  We administered 
THIP intraperitoneally at a range of doses (0, 4, 8, 16mg/kg) to α4-KO, α4-WT 
and α4-Het littermates directly prior to the drinking period to see whether THIP 
would affect ethanol consumption and whether deletion of α4 would disrupt this.  
In previous experiments we infused THIP directly into the NAc of wild-type 
C57BL/6J mice prior to the drinking period. This increased drinking relative to 
control sessions where saline was infused (Macphearson, Stephens and King, 
unpublished data). Here we attempt to replicate this study using α4-KO and α4-
WT mice to confirm whether α4-GABAARs are required for intra-NAc THIP to 
increase drinking. 
The effects of these receptors may also depend on expression within different 
neuronal classes and subtypes. MSNs throughout the basal ganglia, including the 
NAc, can be classified as ‘D1’ or ‘D2’ based on their expression of dopamine D1 
or D2 receptors respectively (Gerfen et al., 1990). The D1 and D2 MSN 
pathways appear to have different and opposing roles mediating the rewarding 
properties of drugs (reviewed in Chapter 1/2 and Lobo and Nestler, 2011). 
Deletion of either D1 or D2 type dopamine receptors in reduces ethanol 
consumption in transgenic mice (El-Ghundi et al., 1998; Phillips et al., 1998). 
Multiple experiments have found that systemically D1 and D2 agonists reduce 
ethanol preference and consumption (Linseman, 1990; Silvestre et al., 1996; 
Cohen, Perrault and Sanger, 1999).  
D1 antagonists or agonists injected into the NAc-shell but not core reduced or 
enhanced operant responding for ethanol respectively (Hauser et al., 2015) 
indicating that D1 activity in the NAc enhances motivation for ethanol. Intra-NAc 
injection of D2 antagonists also reduced responding for ethanol and this effect 
was enhanced by co-administration of D1 agonists suggesting that D1-like and 
D2-like receptors in the NAc interact in the regulation of ethanol self-
administration (Clyde W. Hodge, Samson and Chappelle, 1997). In the same 
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study moderate doses of the D2 agonist quinpirole (1μg) increased total 
responses and response rate, whereas higher doses (4 to 10μg) decreased total 
responding due to early termination. Co-administration of either D1 agonists or 
antagonists prevented the enhanced responding observed with the lower doses 
of quinpirole which suggests that an intermediate level of D1 activation is 
required to observe the D2 effect.  
D1 and D2 MSNs in the NAc also undergo different physiological adaptations 
following chronic alcohol consumption. Two weeks of daily DID sessions shifted 
D1 MSNs in the NAc from a state of Long Term Depression (LTD) to Long Term 
Potentiation (LTP) and did the opposite to D2 MSNs shifting them from LTP to 
LTD when compared to naive mice (Ji et al., 2017). Repeated ethanol drinking in 
a limited-access ‘two-bottle-choice’ upregulated synaptic glutamate transmission 
in striatal D1 neurons and inhibitory synaptic GABA transmission in D2 neurons 
(Cheng et al., 2017). This study further demonstrated that inhibition of D1-MSNs 
or excitation of D2-MSNs using DREADDs attenuated excessive alcohol 
consumption. Together these results indicate that D1 activation or D2 
inactivation in the striatum promotes drinking and this pattern of activity is 
reinforced by maladaptive changes in D1 and D2 MSNs. 
The Cre-lox recombination system allows conditional knock-out of a gene by 
crossing an animal carrying a ‘floxed’ allele with one expressing Cre under a 
desired promoter (Gu et al., 1994, see Chapters 1 & 2). We have used this 
technique to generate conditional knockout of the α4 subunit in D1 or D2 
expressing neurons in C57BL6J mice (see chapter 2). In a cocaine-conditioned 
place preference (CPP) experiment constitutive α4 knockout mice did not differ 
from WT mice however conditional knock-out of α4 in D1 MSNs increased CPP 
whilst both constitutive and D2 MSN specific knockout enhanced conditioned 
reinforcement (Maguire et al., 2014; Macpherson et al., 2016). 
As α4 appears to mediate different effects on cocaine conditioned behaviour via 
the D1 and D2 MSN pathways we wished to examine whether D1 or D2 specific 
manipulations of α4βδ receptors would differentially affect behaviours related to 
ethanol as well. We compared α4-D1-KO and α4-D2-KO with their α4-D1-WT 
and α4-D2-WT littermates (described in Chapter 2) in a standard DID 
experiment. 
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3.2. Materials and Methods 
3.2.1. Animals  
All mice were generated on C57BL/6J background strain. Mice homozygous for a 
null-mutation of the gabrα4 gene (α4-KO) and homozygous wild-type mice (α4-
WT) were generated by breeding heterozygous mice carrying one copy each of 
both the knock-out and wild-type allele (α4-Het) as described previously in 
chapter 2 (Chandra et al., 2006; Maguire et al., 2014).  
As described in chapter 1 we produced conditional knock-out lines we crossed 
‘floxed’ α4 mice [strain name; B6.129-Gabrα4tm1.2Geh/J; Jackson Laboratory] 
(Chandra et al., 2006) with BAC D1-CRE [MMRRC strain B6.FVB(Cg)-Tg(Drd1a- 
cre)EY266Gsat/Mmucd] or BAC D2-CRE [MMRRC strain B6.FVB(Cg)-Tg(Drd2-
cre)ER44Gsat/ Mmucd] (Gong et al., 2007) to result in cre-mediated deletion of 
α4 in either D1 or D2 expressing cells of the offspring. Mice hemizygous for the 
BAC D1-Cre transgene and homozygous for the ‘floxed’ α4 transgene were bred 
with homozygous ‘floxed’ α4 mice to produce α4-D1-KO and α4-D1-WT 
littermates whilst mice hemizygous for the BAC D2-Cre transgene and 
homozygous for the ‘floxed’ α4 transgene were bred with homozygous ‘floxed’ 
α4 mice to produce α4-D2-KO and α4-D2-WT littermates as previously described 
(Maguire et al., 2014).  
Male and female mice weighing between 20-30g and aged between 2-4 months, 
were removed from groups of 2-3 and housed separately 7 days prior to 
experiments, with food and water available ad libitum. During the habituation 
period and experiment a reversed 12hr light/dark cycle was used (lights on at 
11:00 P.M.) with holding room temperature maintained at 212ºC and humidity 
505%. 
3.2.2. Drugs 
THIP (4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol) was kindly donated by 
Bjarke Ebert (Lundbeck, Valby, Denmark). For IP injections THIP was dissolved 
in 0.9% saline to the required concentrations and administered at a volume of 
10ml/kg. Active doses for intracranial infusions were selected based on previous 
data. THIP was infused bilaterally at a concentration of 3mM and a volume of 
0.5µl per side. DS2 (4-chloro-N-[2-(2-thienyl)imidazo[1,2-a]pyridine-3-yl 
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benzamide) was dissolved in vehicle of 2% Tween-20 and 2% DMSO in 0.9% 
saline to a concentration of 0.3mM and infused bilaterally a volume of 0.5ul per 
side.  
3.2.3. Drinking in the Dark procedure 
Habituation phase: mice were singly housed and acclimatised to the reverse 
12hr dark/light cycle for 7 days. To habituate mice to experimental conditions 
over the following 5 days water bottles were replaced for 2 hours each day, at 3 
hours after lights-off, with sippers (North Kent Plastics, Kent, UK) attached to 
10ml serological pipettes, containing tap water, to allow us to record the volume 
of fluid consumed in each session.  
Test Phase: over 5 days with mice received daily 2-hour drinking sessions 
starting at 3 hours after lights-off. On days 1 and 2 water bottles were replaced 
with pipettes containing tap water. On days 3 to 5 water bottles were replaced 
with pipettes containing a 15% ethanol solution. This was selected as in pilot 
studies 15% was the highest concentration which did not reduce drinking due to 
taste aversion (data not shown). Consumption was recorded at the end of each 
session. 
α4-KO vs Heterozygote and WT littermates: Groups of naïve male and female 
α4-WT (n=7), α4-Het (n=7) and α4-KO (n=7) littermates were compared in the 
standard DID procedure. The number of males and females was balanced 
between groups (5 males, 2 females).  
α4-D1-KO vs α4-D1-WT littermates: Groups of naïve male and female α4-D1-KO 
(n=7), and α4-D1-WT (n=7) littermates were compared in a standard DID 
procedure. The number of males and females was balanced between groups (4 
males, 3 females). 
α4-D2-KO vs α4-D2-WT littermates: Groups of naïve male and female α4-D2-KO 
(n=7), and α4-D2-WT (n=7) littermates were compared in a standard DID 
procedure. The number of males and females was balanced between groups (4 
males, 3 females). 
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3.2.4. IP THIP administration dose response  
Following 2 days resting period the same mice were given IP injections of 0.9% 
saline at 3 hours after lights off over 5 days habituation, followed by another 2 
days resting period. The mice then underwent DID sessions as described above 
over the course of 8 days receiving IP injections directly prior to the drinking 
period. THIP was dissolved in 0.9% saline and administered at doses of 0, 4, 8 
and 16mg/kg and a volume of 10ml/kg. Doses were allocated in a Latin-square 
design so that each dose was given to at least one animal per day and animals 
received all doses prior to one water-available session and prior to one ethanol-
available session.  
3.2.5. Stereotaxic Cannulation 
Mice anaesthetised with isoflurane were implanted stereotaxically with bilateral 
guide cannulae (26 ga., 10mm) aimed at the NAc (coordinates AP1.34; L+/− 
1.00; DV −3.20, Paxinos and Franklin, 2001). Following surgery, mice were 
singly housed and underwent a one-week recovery/habituation period.  
 
Figure 3.1.  Target site for infusions of drug via indwelling cannulae. 
Coordinates AP1.34; L+/− 1.00; DV −3.20, from Bregma. 
3.2.6. Intra-NAc Infusions 
On alternate days mice were given an infusion of drug or saline to the NAc. A 
steel infuser (33ga., 11mm) connected via polyvinyl tubing to a (5µl) Hamilton 
Gastight syringe was used to infuse 0.5µl of either saline, THIP (3 mM) or DS2 
(0.03mM) bilaterally over 90 seconds and left to settle for 90 seconds before 
infusers were removed.  
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3.2.7. Histological Confirmation of Placements 
Location of cannulae was confirmed histologically following experiment. India ink 
(Windsor and Newton, UK) was infused bilaterally at a volume of 0.5ul. Mice 
were euthanised by IP injection of Sodium Pentobarbital (10ml/kg). Mice brains 
were perfused via the aorta with 25ml (5 minutes of 5ml/min) of phosphate 
buffer solution (PBS) followed by 75ml (15 minutes of 5ml/min) of 4% 
paraformaldehyde (PF) (Sigma-Aldrich, St. Lois, MO, USA) in PBS. After 
perfusion cannulae were removed then brains were extracted and post-fixed 
overnight in 4% PF in PBS at 4°C, then transferred into 30% sucrose solution in 
PBS and left for 3 days at 4°C to cryoprotect. Coronal sections (30μm thick) 
were cut using a cryostat and collected in PBS-azide. 
Sections were mounted to Superfrost slides (Thermofisher, UK) and air dried 
overnight. Sections were immersed in distilled water for 2 times 10 minutes then 
immediately dehydrated in an ethanol series immersed in 30% followed by 60%, 
90%, 95% and 100% ethanol for 2 minutes each then in clearing solution 
(Histoclear, National Diagnostics) for 10 minutes. Sections were re-hydrated in 
100% ethanol followed by distilled water for 2 minutes each then immersed in 
0.1% Cresyl Violet in 0.1M Sodium Acetate, 0.1M Acetic acid buffer solution for 
10 minutes. Slides were rinsed in distilled water followed by 70% ethanol then 
dehydrated in 30% followed by 60%, 90%, 95% and 100% ethanol for 2 
minutes each then in clearing solution (Histoclear, National Diagnostics) for 10 
minutes.  Coverslips were applied using mounting medium (Histomount, National 
Diagnostics). 
3.2.8. Stereotaxic Viral Infusion 
C57BL/6J mice anesthetised with isoflurane were stereotaxically infused with 
AAV-Cre-mCherry or AAV-GFP bilaterally into the NAc (coordinates AP1.34; L+/− 
1.40; DV −4.20, (Paxinos and Franklin, 2001)). A steel infuser (33ga) connected 
via polyvinyl tubing to a (5μl) Hamilton Gastight syringe was used to infuse 1ul 
(0.5μl per side) of virus (1 × 109 IU/ml) at a rate of 0.2μl/min for 5 minutes, 
then left to settle for an additional 5 minutes. Following surgery mice were singly 
housed and allowed to recover for 7 days. Viruses contained mCherry and GFP 
fluorescent tags respectively which allowed histological confirmation of the 
targeted area. 
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We used 17 ‘floxed’ α4 mice; 8 receiving infusion of AAV-Cre and 9 receiving 
infusion of AAV-GFP. Of these we excluded 1 AAV-Cre and 2 AAV-GFP from 
analysis due to inaccurate placement resulting in n=7 per group. 
 
Figure 3.2. Target site for infusions of AAV-Cre or AAV-GFP virus. Coordinates 
AP1.34; L+/− 1.4; DV −4.20, from Bregma. 
3.2.9 Immunohistochemistry 
Following experiments mice were euthanised by IP injection of Sodium 
Pentobarbital (10ml/kg). Mice brains were perfused via the aorta with 25ml (5 
minutes of 5ml/min) of phosphate buffer solution (PBS) followed by 75ml (15 
minutes of 5ml/min) of 4% paraformaldehyde (PF) (Sigma-Aldrich, St. Lois, MO, 
USA) in PBS. After perfusion, brains were removed and post-fixed overnight in 
4% PF in PBS at 4°C, then transferred into 30% sucrose solution in PBS and left 
for 3 days at 4°C to cryoprotect. Coronal sections (30μm thick) were cut using a 
cryostat and collected in PBS-azide. 
Free floating sections were washed 3 times in PBS for 10 minutes then incubated 
in blocking solution, 3% Normal Goat Serum (Vectorlabs) in PBS-T, for 1 hour 
with gentle agitation. Sections were then immediately incubated overnight in 
rabbit anti-GFP ployclonal primary antibody (1:10,000, Abcam ab6556) or rabbit 
anti-mCherry antibody (1:10,000, Abcam ab167453) diluted in blocking solution 
at 4°C. Sections were washed 3 times in PBS for 10 minutes before incubation in 
fluorescently tagged Alexafluor 488/568 anti-rabbit secondary antibodies (1:600, 
Thermofisher) diluted in blocking solution for 2 hours at room temperature. 
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3.2.10. Statistics 
All statistical analysis was carried out using IBM SPSS software v.24. All 
analyses were initially carried out including sex as an independent variable 
however we found no main effects or interactions with other variables and sex 
was therefore excluded in the presented analyses for clarity. 
3.2.10.1 Standard DID procedures 
Prior to the test phase the starting weight of mice was taken and we compared 
this between genotypes using a one-way ANOVA to ensure weight was similar 
between experimental groups. 
The mean volume of water or ethanol consumed was calculated from 2 and 3 
sessions respectively. Ethanol consumption as a function of mouse weight (g/kg) 
was calculated and averaged over 3 days.  
Mean fluid consumption (ml) of water and ethanol by each genotype was 
compared using a one-way repeated measures ANOVA. Mean ethanol 
consumption (g/kg) of each genotype was compared by one-way ANOVA and 
followed by a Tukey’s Least Square Difference (LSD) post hoc test where there 
were more than two groups. 
3.2.10.2 IP THIP administration 
Volume of water or ethanol solution consumption at each dose was averaged 
and compared between genotypes using multi-factor repeated-measures ANOVA 
where genotype was a between subjects factor. 
Ethanol consumption (g/kg) at each dose was averaged for each genotype and 
compared in a repeated-measures ANOVA where genotype was a between 
subjects factor. 
3.2.10.3 Intra-NAc THIP administration 
The volume of water or ethanol consumed by α4-WT and α4-KO mice 
administered either saline or THIP was averaged from 2 sessions per condition. 
Volume drunk was compared using a multi-factor repeated measures ANOVA 
where Drug-Treatment and Solution (water or ethanol) were the factors and 
genotype was the between-subjects variable. Ethanol consumption as a function 
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of bodyweight (g/kg) for each condition was compared using a repeated 
measures ANOVA. 
Similarly ethanol consumed by α4-WT and α4-KO mice administered either 
Vehicle or DS2 was averaged from 2 sessions per condition. Volume drunk was 
compared using a multi-factor repeated measures ANOVA where Drug-
Treatment and Solution (water or ethanol) were the factors and genotype was 
the between-subjects variable. Ethanol consumption as a function of bodyweight 
(g/kg) for each condition was compared using a repeated measures ANOVA. 
3.3. Results 
3.3.1. Gabrα4 deletion reduces ethanol consumption in drinking in the 
dark 
We compared α4-WT, α4-Het and α4-KO mice in a standard DID experiment in 
which we measured their water and ethanol consumption. 
α4-KO animals consumed less ethanol but similar volume of water to α4-WT and 
α4-Het littermates. All genotypes drank a lower volume of ethanol than water 
(F(1,18) = 63.4, p<0.001). There was a significant interaction between genotype 
and solution (F(2,18) = 2.6, p<0.05). The post hoc test revealed α4-KO mice drank 
significantly less ethanol (mean= 0.176, S.E.= 0.04, n=7) than their α4-WT 
(mean= 0.326, S.E.= 0.04, n=7) or α4-Het (mean= 0.331, S.E.= 0.04, n=7) 
littermates, p<0.05*. We found no significant difference in starting-weight 
between genotypes (F(2,18)= 0.46, p<0.5). 
Ethanol consumption as a function of mouse weight (g/kg) was significantly 
lower in α4-K) mice compared to α4-WT and α4-Het littermates. We found a 
significant main effect of genotype (F(2,18) = 3.78, p<0.05). The post hoc test 
found that α4-KO mice consumed significantly less ethanol (mean= 0.929, S.E. 
= 0.25, n=7) than their α4-WT (mean= 1.65, S.E. = 0.04, n=7) or α4-Het 
(mean= 1.55, S.E.= 0.04, n=7) littermates, p<0.05*. 
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Figure 3.3 α4-KO (n=7) drank significantly less 15% ethanol solution than their 
α4-WT (n=7) or α4-Het (n=7) littermates p<0.05*, however water consumption 
was similar between genotypes. Error bars represent SEM. 
 
 
 
Figure 3.4 α4 knockout mice (n=7) consumed significantly less ethanol as a 
function of bodyweight than their wild-type (n=7) or heterozygous (n=7) 
littermates, p<0.05*. Error bars represent SEM. 
 
3.3.2. IP THIP administration reduces both water and ethanol 
consumption in DID in α4-WT but not α4-KO mice 
We administered THIP intraperitoneally at various doses to α4-WT, α4-Het and 
α4-KO mice prior to drinking sessions in a DID experiment in which we 
measured their water and ethanol consumption under each dose. 
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At low doses (0,4,8mg/kg) IP THIP had no effect on either genotype however at 
16mg/kg IP THIP reduced consumption of both water and ethanol in α4-WT and 
α4-Het mice. In contrast α4-KO mice were unaffected by THIP although they 
drank significantly less ethanol at baseline.  
 
There was a significant main effect of THIP dose on water consumption (F(3,18) = 
8.797, p<0.001) and a significant interaction between genotype and THIP dose 
on water consumption (F(3,18) = 2.6, p<0.05) whereby the volume drunk was 
reduced at high doses in α4-WT and α4-Het but not reduced to the same extent 
α4-KO mice. There was a significant main effect of THIP dose on 15% ethanol 
consumption (F(3,18) = 15.5, p<0.001) and a significant interaction between 
genotype and THIP dose on 15% ethanol consumption (F(3,18) = 2.3, p<0.05) 
whereby the volume drunk was greatly reduced at 16mg/kg THIP in α4-WT and 
α4-Het but not to the same extent α4-KO mice.  
Similarly, at low doses (0,4,8mg/kg) IP THIP had no effect on ethanol 
consumption as a function of bodyweight (g/kg) in either genotype however at 
16mg/kg IP THIP reduced ethanol consumption in α4-WT and α4-Het but not to 
the same extent α4-KO mice. There was a significant main effect of THIP dose 
(F(3,18) =14.243, p<0.001) and a significant interaction between genotype and 
THIP dose (F(3,18) = 2.4, p<0.05) whereby the ethanol consumption was reduced 
at high doses in α4-WT and α4-Het but not reduced to the same extent α4-KO 
mice. 
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Figure 3.5 A) Volume of water consumption decreased in all genotypes at 
16mg/kg THIP (n=21, p<0.05). B) Volume of ethanol consumption was 
decreased by 16mg/kg THIP in WT (n=7) and Heterozygous (n=7) and to some 
lesser extent α4-KO mice (n=7) p<0.05. Error bars represent SEM. 
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Figure 3.6 α4-KO mice (n=7) consumed significantly less ethanol as a function 
of bodyweight than their wild-type (n=7) or heterozygous (n=7) littermates, 
p<0.05. Ethanol consumption was decreased by 16mg/kg THIP in WT (n=7) and 
Heterozygous (n=7), but not α4-KO mice (n=7) p<0.05. Error bars represent 
SEM. 
 
3.3.3 Effect of Intra-NAc THIP on water and ethanol consumption in α4-
KO and α4-WT mice 
We administered THIP or saline directly to the NAc of α4-WT and α4-KO mice 
prior to drinking sessions in a DID experiment in which we measured their water 
and ethanol consumption under each treatment. 
Both genotypes drank significantly less ethanol than water (F(1,14) = 94.03, p 
<0.01) whilst α4-KO mice drank a similar amount of water but significantly less 
ethanol than α4-WT littermates (F(1,14)=5.914, p<0.05). We did not find a 
significant effect of drug (F(1,14)=1.42, p=0.254; NS) or a significant drug by 
solution (F(1,14)=0.243, p=0.629; NS) or drug by genotype (F(1,14)=0.008, 
p=0.938; NS) interaction. The drug by solution by genotype interaction showed 
a trend whereby THIP increased volume of ethanol consumed in α4-WT but not 
α4-KO animals however this was non-significant (F(1,14) =4.293, p=0.057). 
Ethanol consumption (g/kg) was significantly lower in α4-KO than α4-WT mice 
(F(1,14)=67.9, p<0.001). We found no main effect of drug (F(1,14)=0.638, p = 
0.438; NS) or drug by solution interaction (F(1,14)=2.56, p=0.131) indicating that 
THIP did not significantly reduce ethanol consumption. 
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Figure 3.7. We found no effect of intra-NAc THIP on either water or ethanol 
consumed in either genotype. Error bars represent SEM. 
 
 
Figure 3.8 We found no effect of Intra-NAc THIP on ethanol consumption as a 
function of bodyweight (g/kg) in either genotype. Error bars represent SEM. 
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3.3.4. Effect of Intra-NAc DS2 on water and ethanol consumption in α4 
KO and α4-WT mice 
We administered DS2 or vehicle directly to the NAc of α4-WT and α4-KO mice 
prior to drinking sessions in a DID experiment in which we measured their water 
and ethanol consumption under each treatment. 
Both genotypes drank significantly less ethanol than water (F(1,14) = 97.53, p 
<0.01) whilst α4-KO mice drank a similar amount of water but significantly less 
ethanol than α4-WT littermates (F(1,14)=5.53, p<0.05). We did not find a 
significant effect of drug (F(1,14)=1.074, p=0.318; NS) or a significant drug by 
solution (F(1,14)=1.074, p=0.318; NS) or drug by genotype (F(1,14)=2.104, 
p=0.169; NS) interaction. The drug by solution by genotype interaction showed 
a trend whereby DS2 increased volume of ethanol consumed in α4-WT but not 
α4-KO animals however this was non-significant (F(1,14) =2.104, p=0.169). 
We found no main effect of drug on ethanol consumption (g/kg) (F(1,14)=1.274, p 
=0.278; NS) or drug by solution interaction (F(1,14)=2.22, p=0.158; NS) 
indicating that THIP did not significantly reduce ethanol consumption. 
 
 
Figure 3.9. We found no effect of intra-NAc DS2 on either water or ethanol 
consumed in either genotype. Error bars represent SEM. 
104 
 
 
 
 
Figure 3.10. We found no effect of intra-NAc DS2 on ethanol consumption as a 
function of bodyweight (g/kg) in either genotype. Error bars represent SEM. 
 
3.3.5. Effect of selective knockout of α4 in NAc on ethanol consumption  
In order to examine the effects of reduced α4 expression, specifically in the NAc, 
on ethanol consumption we used an AAV viral vector to express Cre in the NAc 
of ‘floxed’ α4 mice to knockdown α4. We compared these mice with ‘floxed’ α4 
mice which received a control AAV virus in a standard DID test. 
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Figure 3.11. Example of viral expression in the NAc of experimental animal at 
target site (upper panels) and diagram indicating actual injection sites for each 
animal (lower panels). 
We found no significant difference in starting-weight between virus groups 
(F(1,12)= 0.029, p = 0.87; NS). Both groups drank a lower volume of 15% 
ethanol than water (F(1,12) = 32.053, p<0.001). There was a significant 
interaction between virus and solution (F(2,18) = 10.283, p<0.05) as AAV-Cre 
treated mice drank less 15% ethanol solution than AAV-GFP treated mice. 
Ethanol consumption as a function of mouse weight (g/kg) was compared and 
we found a significant main effect of virus (F(2,18) = 12.13, p<0.005). 
 
106 
 
 
 
Figure 3.12. AAV-Cre mice (n=7) drank significantly less 15% ethanol than 
AAV-GFP treated mice (n=7) p<0.05*. Error bars represent SEM. 
 
 
Figure 3.13. AAV-Cre mice (n=7) consumed significantly less ethanol as a 
function of bodyweight than AAV-GFP treated mice (n=7) p<0.005*. Error bars 
represent SEM. 
 
3.3.6. D1 specific deletion of α4 does not affect ethanol consumption in 
DID 
We compared α4-D1-WT and α4-D1-KO conditional knockout mice in a standard 
DID experiment in which we measured their water and ethanol consumption. 
We found no significant difference in starting-weight between genotypes (F(1,14) 
< 0.001, p = 0.992; NS). Both genotypes drank a lower volume of 15% ethanol 
than water (F(1,14) = 52.9, p<0.001). There was no significant interaction 
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between genotype and solution (F(1,14) = 1.02, p = 0.33; NS) indicating both 
genotypes drank a similar amount of ethanol and water.  
Ethanol consumption as a function of mouse weight (g/kg) was compared and 
we found no significant effect of genotype (F(1,14) = 0.387, p = 0.54; NS).  
 
 
Figure 3.14. Both α4-D1-WT (n=8) and α4-D1-KO (n=8) drank significantly 
less 15% ethanol than water p< 0.001 and drank similar amounts of both water 
and 15% ethanol. Error bars represent SEM. 
 
 
Figure 3.15. α4-D1-WT (n=8) and α4-D1-KO (n=8) consumed a similar amount 
of ethanol as a function of bodyweight (g/kg). Error bars represent SEM. 
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3.3.7. D2 specific deletion of α4 does not affect ethanol consumption in 
DID 
We compared α4-D1-WT and α4-D1-KO conditional knockout mice in a standard 
DID experiment in which we measured their water and ethanol consumption. 
We found no significant difference in starting-weight between genotypes (F(1,14) 
= 0.4, p = 0.537; NS). Both genotypes drank a lower volume of 15% ethanol 
than water (F(1,14) = 232.22, p<0.001). There was no significant interaction 
between genotype and solution (F(1,14) = 1.457, p = 0.247; NS) indicating both 
genotypes drank a similar amount of ethanol and water.  
Ethanol consumption as a function of mouse weight (g/kg) was compared and 
we found no significant effect of genotype (F(1,14) = 0.065, p = 0.802; NS).  
 
 
Figure 3.16 Both α4-D2-WT (n=8) and α4-D2-KO (n=8) drank significantly less 
15% ethanol than water p< 0.001 and drank similar amounts of both water and 
15% ethanol. Error bars represent SEM. 
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Figure 3.17 α4-D2-WT (n=8) and α4-D2-KO (n=8) consumed a similar amount 
of ethanol as a function of bodyweight (g/kg). Error bars represent SEM. 
 
 
3.4. Discussion 
Several previous studies using rats have found that downregulation of 
extrasynaptic α4βδ receptors in the Nucleus Accumbens reduces ethanol self-
administration (Rewal et al., 2009, 2012; Nie et al., 2011). We have 
demonstrated a role of α4-GABAARs in mediating binge-like alcohol consumption 
in mice. Our data indicate that α4-GABAARs are necessary for the high level of 
alcohol consumption seen in C57-BL/6J mice as constitutive deletion of α4 was 
sufficient to reduce alcohol consumption in DID.  
In order to test whether the effect of α4 expression on DID was dose-dependent 
we included α4-Het mice in this study since they express α4 at ~50% relative to 
α4-WT littermates (Chandra et al., 2006; Macpherson, 2013, see Chapter 2). α4-
Het mice did not show any difference in ethanol consumption when compared to 
α4-WT littermates. This may be explained by the remaining α4 50% expression 
in combination with developmental compensation in constitutive knockouts 
(Brickley et al., 2001) or it is possible that the threshold for a measurable 
behavioural effect lies between 50% and 60% knockdown. In prior studies RNAi 
of α4 in the NAc in rats reduced ethanol consumption where efficiency of the 
knockdown was ~25% mRNA and ~40% protein levels relative to control (Rewal 
et al., 2009). Indeed, our manipulation using AAV-Cre virus in the NAc of 
‘floxed-α4’ produces a ~60% knockdown (see Chapter 2) and this was sufficient 
to significantly reduce ethanol consumption in our experiment (Fig 3.12). 
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Our finding that knockdown of α4 in the NAc reduces ethanol consumption 
agrees with those similar studies which used RNAi interference of α4 although 
we used a different species, viral-knockdown method and behavioural tests. By 
replacing ‘Two-Bottle choice’ tests with the DID procedure, which usually results 
in higher BACs, we modelled binge-like drinking behaviour rather than ‘moderate 
drinking’ (Rewal et al., 2009; Crabbe, Harris and Koob, 2011). Using this 
method, we have also confirmed a likely anatomical candidate for the effects 
observed α4-KO mice. 
Our virus placements are centred in the NAc Core based on the efficacy of this 
manipulation in previous studies on cocaine-related behaviour (Macpherson, 
2013). This is in contrast with those experiments which only found a similar 
effect when virus was infused into the NAc Shell but not Core of rats (Rewal et 
al., 2012). As we used mice in our experiments these sub-regions may be 
closer, where they are more distinct in the larger rat brain, and therefore both 
receive some virus. Although the rat and mouse brains are anatomically highly 
similar, many major functional and behavioural differences relating to addiction 
have been described (reviewed, Ellenbroek and Youn, 2016). 
Unfortunately using DID experiments we are unable to examine the 
motivational/appetitive changes underlying this behaviour. Food remained 
available ad libitum during drinking sessions, so it is unlikely that we are 
observing differences in calorie-seeking behaviour and we did not observe 
differences in water consumption. We therefore provide good evidence that 
differences between genotypes are specific to alcohol consumption.  
We suggest two opposing hypotheses; increased tonic inhibition mediated by α4-
GABAARs either reduces the “reward” value of ethanol or it enhances satiation 
such that mice are sated after drinking less alcohol. Time-course data for 
drinking is not available from our experiment but if gathered in future 
experiments may indicate whether α4-KO mice satiate faster than α4-WTs. As 
reviewed earlier, downregulation of α4 or δ reduced operant ethanol self-
administration (Rewal et al., 2012) however there was no difference between 
genotypes in the first 5 minutes of drinking sessions, following several 
reinforcers, which indicates that this is a difference in consummatory rather than 
appetitive behaviour. Conversely mice carrying a mutation of the β1 subunit 
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which potentiates GABAA receptor activity maintained high rates of responding 
throughout sessions whilst wild-types slowed their rate of as the session 
progressed consistent with them satiating on alcohol (Anstee et al., 2013).  
Given the upregulation of α4 following chronic ethanol administration (Liang et 
al., 2007) we may consider whether this represents a maladaptive or 
homeostatic response to ethanol. We found that reduction in α4-GABAAR activity 
opposes drinking suggesting upregulation of α4 is likely a maladaptive change. 
This may however be opposed by reduced synaptic GABA transmission in MSNs 
(Wilcox et al., 2014) acting as a homeostatic mechanism. 
It is necessary to establish whether this control of drinking by α4 receptors in 
the NAc is bidirectional if they are to be considered as a therapeutic target. 
Previous results using GABAA agonists would predict this (Boyle et al., 1993; 
Rassnick et al., 1993; Hyytiä and Koob, 1995). We sought to use α4-KO mice in 
similar experiments, as a negative control, so we can could more reliably 
attribute this the behavioural effects of GABAA agonists to α4-GABAARs (i.e. 
where agonists are effective in α4-WT but not α4-KO animals). 
Contrary to studies in rats (Boyle et al., 1993) we did not find any evidence that 
systemic administration of THIP specifically reduced ethanol consumption. We 
found a genotype specific decrease in consumption of both ethanol and water 
following a high dose (16mg/kg IP) of THIP therefore we hypothesise that it is 
due to a sedative effect of IP THIP at higher doses in mice. Notably, α4-KO mice, 
which did not show the THIP induced reduction in water consumption, are 
resistant to some of the motor incoordinating effects of THIP (Chandra et al., 
2006) and in previous studies in our lab we have observed that THIP dose-
dependently decreases locomotor activity in α4-WT but not α4-KO mice 
(Macpherson, 2013). 
Our data suggests that the reduced ethanol consumption was due to THIPs 
sedative effects rather than acting on receptors in the NAc which are likely to 
mediate the reinforcing properties of alcohol (Rewal et al., 2009). This replicates 
another study that reported IP THIP decreased both water and ethanol 
consumption in C57BL/6J mice in a DID test (Moore et al., 2007). Ramaker and 
colleagues (2012) examined the effect of IP THIP on C57BL/6J mice using a 
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limited-access ‘two-bottle choice’ test instead and found reductions in ethanol 
consumption, but not water, after 8mg/kg or 16mg/kg doses and thus concluded 
that THIP reduced ethanol preference. Strangely this indicates dissociated 
effects of THIP on ethanol consumption in ‘two-bottle-choice’ and DID. It is 
possible that THIP reduced ethanol but not water consumption at those doses 
because of compounding sedative effects of both THIP and ethanol itself. The 
authors reported that they observed sedative effects following the 16mg/kg 
dose. 
There are two problems with systemic dosing of THIP: a lack of anatomical 
resolution and the resultant off-target sedative effects. Since α4 downregulation 
in the NAc was sufficient to reduce ethanol consumption we attempted to 
demonstrate bidirectional control by α4-GABAARs in this region. Previously we 
have observed opposite effects of targeted intracranial THIP infusions compared 
to systemic THIP injection. Infusion of THIP directly to the NAc of WT C57BL/6J 
mice increased ethanol but not water consumption in DID (Macpherson, 
Stephens and King, unpublished data). By repeating this DID experiment in α4-
KO animals we hoped to demonstrate that this effect was specifically mediated 
by α4-GABAARs and not THIP acting non-specifically at other receptors in the 
NAc. 
If deletion of α4-GABAARS abolished the ability of THIP to increase drinking we 
could conclude that α4-GABAARs in the NAc bidirectionally modulate ethanol 
consumption. Our current study failed to replicate an intra-accumbal THIP 
induced increase in drinking in α4-WT mice, and thus a null effect in the α4-KO 
mice could not be interpreted. Notably we observed a trend towards THIP 
increased drinking (g/kg) in α4-WT (mean = 1.13, SEM = 0.013) but not α4-KO 
mice (mean = 0.2595, SEM =0.0207, p=0.131, Observed Power = 0.312). To 
further examine the role of α4-GABAARs we also used infusions of the GABAA 
agonist DS2 as it is also highly selective for α4βδ receptors (Wafford et al., 
2009).  Again, we did not demonstrate a significant increase in ethanol 
consumption following intra-NAc DS2 although we observed a trend towards 
increased ethanol consumption in α4-WT (mean = 1.0507., SEM =0.046) but not 
α4-KO mice (mean = 0.2886, SEM =0.021, p=0.158, Observed Power = 0.209). 
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It is notable that both α4βδ receptors agonist treatments trended towards 
increased ethanol consumption in α4-WT but not α4-KO animals. 
Together these results conflict with a previous study by Ramaker and colleagues 
(2015) in which intra-NAc THIP reduced ethanol consumption in a limited access 
‘Two Bottle Choice’ test. Again, we find a dissociation of ‘two-bottle-choice’ and 
DID whereby we observe the opposite effect of this manipulation on drinking 
(Macpherson, Stephens & King, unpublished data). Other notable experimental 
differences were a lower dose of THIP (200mg vs ~265mg), and infusion into 
the NAc-Shell rather than centred in the Core as in our experiments.  
Concentrations of THIP were chosen based on a previous study testing the effect 
of NAc core infusions of THIP in α4 knockout and wildtype mice (Maguire et al., 
2014). THIP is most selective for α4βδ receptors at between 1 and 10µm 
whereby it increases current by ~50-100% only at α4βδ receptors but not at 
other GABAAR isoforms (Mortensen et al., 2010). However, at higher doses of 
100 µm to 1mM it acts as a ‘superagonist’ increasing α4βδ current by 250% but 
also increasing current by 100% at other GABAAR isoforms (Mortensen et al., 
2010). We used high dose of THIP (0.5µl of 3mM) because this ‘superagonist’ 
concentration it has been behaviourally active in previous experiments on 
cocaine conditioned behaviour (Maguire et al., 2014; Macpherson et al., 2016) 
and we can control for the off-target effects by comparing α4-WT and α4-KO 
mice.  
It is unexpected that intra-NAc THIP in the shell would reduce drinking since 
downregulation of α4βδ receptors in the same region also reduced drinking. If 
α4-KOs are satiating faster due to less tonic inhibition (as suggested above) then 
THIP mediated inhibition would likely be opposing the ‘satiating’ effects of 
alcohol which may explain this result. To explain our conflicting finding we also 
suggest that infusion to the NAc-Core rather than NAc-Shell may have different 
effects.  
Studies in which the Core or Shell were pharmacologically inactivated prior to 
ethanol-rewarded PIT experiments revealed distinct roles for the sub-regions in 
ethanol reinforcement (Corbit, Fischbach and Janak, 2016). They reported that 
the NAc core was required for responding to ethanol-predictive cues whilst the 
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shell mediated the influence of environmental context. Since DID is a home-cage 
test environmental context is controlled any stimuli related to the presentation 
of alcohol (e.g. smell & taste) may be used as discrete cues which are influenced 
by α4-GABAAR activity in the NAc Core. Thus α4-GABAAR agonism there may 
reduce the reinforcing properties of ethanol-related sensory stimuli during 
consumption resulting in faster satiation. 
Previous studies have suggested that D1 and D2 MSN populations may have 
distinct roles in ethanol drinking. D1 antagonists/agonists in the NAc-shell but 
not core reduce/enhance operant responding for ethanol (Hauser et al., 2015) 
indicating that D1 activity enhances motivation for ethanol. These populations 
also display distinct neuroadaptations following binge-like drinking. Two weeks 
of DID sessions shifted D1 MSNs from a state of LTD to LTP and D2 MSNs from 
LTP to LTD (Ji et al., 2017). 
We therefore attempted to examine whether tonic inhibition by α4-GABAARs on 
D1 or D2 MSN populations specifically may mediate distinct effects on binge-like 
alcohol consumption. No effect on DID ethanol consumption was apparent in α4-
D1-KO or α4-D2-KO specific knock-outs. Thus, it appears α4-GABAAR activity is 
required in both D1 and D2 pathways to mediate ethanol DID. This differentiates 
these effects from the dissociable roles of α4 on D1 and D2 MSNs in cocaine CPP 
(Maguire et al., 2014) or conditioned-reinforcement respectively (Macpherson et 
al., 2016). It is possible that D1 MSN activity underlies motivational behaviour 
(Maguire et al., 2014; Hauser et al., 2015) whilst D2 MSN activity processes 
ethanol-predictive cues such as smell or taste (Macpherson et al., 2016; 
Owesson-White et al., 2016). In this case normal tonic inhibition in either 
population may compensate for disinhibition in the other.  
At present our results do not suggest α4 modulation of total ethanol 
consumption is D1 or D2 dependant. Systemic pharmacological manipulations of 
D2 receptors have resulted in changes to the time-course of drinking by 
reducing initial drinking earlier in sessions but increasing it later in sessions 
(Spoelder et al., 2016). We may therefore expect similar patterns in α4-D2-KO 
mice. Our experimental set-up was not equipped to detect differences in 
patterns of drinking within the DID trial period which might be present in α4-D1-
KO/α4-D2-KO mice. Further experiments using more sensitive measurements of 
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fluid consumption over time (e.g. using lickometers) could indicate at what rate 
mice drink and satiate over the course of each session. Similarly, operant self-
administration experiments could be used to investigate time-course of ethanol 
consumption or appetite based on rates of responding over time in a similar 
delayed then increased pattern.  
Time-course data may also indicate whether reduced consumption in α4-KOs is a 
result of faster satiation. This would be indicated if levels of drinking are similar 
early in the session but more rapidly decline. Notably operant ethanol self-
administration in rats following intra-NAc RNAi knockdown of α4 was similar to 
controls in the first 5 minutes of sessions but reduced overall (Rewal et al., 
2012). Operant self-administration may also be a useful model to isolate α4-
GABAARs role in motivational aspects of ethanol consumption rather than simply 
measuring consummatory behaviour. Our AAV-Cre viral method could be used to 
knockdown α4-GABAARs prior to similar operant self-administration studies in 
mice. 
Since α4-GABAARs in the NAc appear to be a significant modulator of ethanol 
consumption it may be of interest to investigate other regions in which α4 is 
expressed using similar methods. The thalamus is a good candidate as it is 
where α4 is most highly expressed (Sur et al., 1999b; Schwarzer et al., 2001) 
and ethanol is known to potentiate GABAergic tonic inhibition there in wild-type 
but not α4-KO mice (Jia, Pignataro and Harrison, 2007; Jia et al., 2008). If 
depression of the thalamus is necessary to promote ethanol consumption α4 
knockdown may result in reduced drinking. 
Additionally, the Dorsomedial Striatum (DMS) has been implicated in 
maladaptive increase of GABA transmission, as measured by slice 
electrophysiology in the presence of GABA, in D2 MSNs following chronic DID 
(Cheng et al., 2017). If this is disrupted by α4 knockdown this would implicate 
extrasynaptic GABAARs in mediating such changes and therefore as a therapeutic 
target for alcoholism. 
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Chapter 4 
The role of α4-containing GABAA receptors in locomotor behaviour and 
instrumental responding and their potentiation by cocaine 
 
4.1. Introduction 
4.1.1. Locomotor behaviour  
Locomotor activity, defined as movement from one location to another, is a 
crucial component of all animals’ behaviour. It underlies their ability to explore 
the environment which is critical for approaching salient stimuli, such as food or 
sex, and avoiding aversive stimuli, such as predators. Animals display an initial 
increased level of exploratory locomotor activity when placed in a novel 
environment or in response to novel stimuli however this activity rapidly 
decreases if the salience is determined to be neutral (Harris, 1943). To a lesser 
extent some spontaneous locomotor activity occurs in habituated environments, 
suggesting that animals also display a basal level of locomotor activity (Robbins, 
1977; Paulus and Geyer, 1993).  
It is well established that locomotor activity is enhanced by drugs that facilitate 
transmission at dopamine synapses, moreover it is reduced by dopamine 
antagonists or lesions of dopaminergic systems (Kelly, Seviour and Iversen, 
1975; Kelly and Iversen, 1976; Wachtel and Anden, 1978; Fray et al., 1980). 
Psychostimulant drugs, which potentiate dopamine transmission, dose-
dependently modulate locomotor activity in an inverted U-shaped function 
(Isaacson, 1978). Acute administration of psychostimulants potentiates 
locomotor activity until at high doses their effects become so intense as to 
disrupt organised locomotor behaviour and therefore induces severe behavioural 
stereotypy (Randrup and Munkvad, 1967; Bhattacharyya and Pradhan, 1979). 
When dopamine agonists were infused directly into various regions of the rat 
forebrain the behavioural outcomes suggested that locomotor stimulation was 
primarily mediated by the NAc, and stereotyped behaviours from the dorsal 
striatum (Costall et al., 1977; Campbell et al., 1997). Locomotor behaviour 
resulting from dopamine activity in the NAc is notable in the study of addiction 
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as all drugs of abuse increase dopamine release in the NAc (Wise, 1987, 1988; 
Di Chiara and Imperato, 1988; Pettit and Justice, 1989). Repeated 
administration of psychostimulants results in increased dopamine release in the 
NAc and increased locomotor activity (Di Chiara and Imperato, 1988; Kalivas 
and Duffy, 1990; Kalivas and Stewart, 1991). 
The predominant neuronal type within the NAc are GABAergic MSNs (Kemp and 
Powell, 1971) therefore it is likely that GABAergic transmission is involved in 
controlling baseline and psychostimulant-potentiated locomotor activity. 
Systemic injection of GABA agonists decreased locomotor activity although this 
appeared to be primarily via GABAB receptors (Agmo and Giordano, 1985). 
Systemic administration of drugs blocking GABA breakdown attenuated baseline 
and amphetamine-potentiated locomotor activity (Grimm et al., 1975; Cott and 
Engel, 1977). Direct injections of GABA into the NAc affected a bimodal response 
in locomotion, with low doses inducing a small increase, and larger doses 
producing a reduction (Wachtel and Anden, 1978; Jones, Mogenson and Wu, 
1981) indicating multiple, possibly conflicting, roles for GABA in mediating 
locomotor activity..  
Activation of GABAA receptors in the NAc appears to oppose locomotor activity 
and its potentiation by psychostimulants. Systemic administration of a GABA-
transaminase inhibitor, ethanolamine-O-sulphate, abolished the ability of intra-
NAc dopamine injections to potentiate locomotor activity, but has no significant 
effect on baseline locomotor activity (Pycock and Horton, 1976). Injection of the 
GABAA receptor agonist Muscimol in the NAc core reduced dopamine receptor-
mediated locomotor behaviour in mice (Akiyama et al., 2003; Akiyamaa et al., 
2004) whilst intra-NAc microinjections of the GABAAR antagonist picrotoxin 
enhanced baseline and intra-NAc amphetamine-potentiated locomotor responses 
(Pycock and Horton, 1976; Jones, Mogenson and Wu, 1981; Wong et al., 1991).  
There is also recent evidence that extrasynaptically located GABAARs specifically 
play a functional role in mediating locomotor activity. Systemic administration of 
THIP, a GABAA antagonist selective for α4βδ receptors, reduces baseline 
locomotor activity and attenuates enhanced locomotion following intra-NAc 
administration of the glutamate agonist 6,7-ADTN (Arnt, 1981; Agmo and 
Giordano, 1985; Herd et al., 2009; Vashchinkina et al., 2012). 
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Previously we have reported that constitutive deletion of the α4 subunit does not 
affect baseline or cocaine-induced locomotor activity. In wild-type mice intra-
NAc THIP reduced locomotor activity and attenuated cocaine-induced locomotor 
activity however these effects were abolished in α4-KO mice (Macpherson, 
2013). 
Manipulations of both D1 and D2 type striatal MSNs alter locomotor activity 
although effects vary depending on the sub-region. Systemic administration of 
D1 agonists increases locomotion (Schindler and Carmona, 2002). Evidence for 
the effects of D2 receptor agonists is mixed with some studies finding it 
potentiated and others that it attenuated locomotion depending on dose and 
timing (Schindler and Carmona, 2002; Stuchlik et al., 2007). Optogenetic 
stimulation of D1 or D2 MSNs in the dorsomedial striatum resulted in increased 
or decreased locomotion respectively (A. V Kravitz et al., 2010).  
Within the NAc D1- and D2- expressing neurons mediate similar effects on 
locomotor activity and its potentiation by cocaine although D1-expressing 
neurons are predominantly involved (Bruhwyler et al., 1991; Mazurski and 
Beninger, 1991). Injections of D1 agonists into the NAc of rats greatly increased 
locomotor activity whilst D2 agonists did so more modestly and when co-
administered their effects were additive (Dreher and Jackson, 1989; Gong et al., 
1999). Intra-NAc D1 and D2 antagonists attenuated cocaine-induced locomotor 
activity (Kita et al., 1999) whilst D1 agonists in the NAc Shell enhanced cocaine-
induced locomotion as did D2 agonists although to a lesser extent (Bachtell et 
al., 2005a). Similarly, targeted blockade of neurotransmission by a tetanus toxin 
in either Direct or Indirect pathway neurons within the NAc abolished locomotor 
potentiation by cocaine or methamphetamine in mice (Hikida et al., 2010).  
We therefore investigated the role of α4 containing GABAARs receptors, 
specifically on D1 and D2 neurons, in locomotor behaviour. Here we use α4-D1-
KO and α4-D2-KO conditional knock-out mice (see chapter 2) in a cocaine dose-
response experiment where locomotor activity was recorded following various 
doses of cocaine. 
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4.1.2. Progressive Ratio 
It has been suggested that potentiated locomotor responses following intra-NAc 
infusions of dopamine agonists may result from a general facilitation of 
approach-investigation behaviour which is subsequently directed by 
environmental conditions (Ikemoto and Panksepp, 1999). In a standard 
locomotor activity chamber, lacking interactive stimuli, increased NAc dopamine 
transmission may simply stimulate exploratory behaviour including locomotion 
and rearing. Alternatively, in other situations this general stimulation may 
facilitate other approach behaviours such as instrumental responding or 
conditioned activity in operant tasks (Taylor and Robbins, 1986; Cador, Taylor 
and Robbins, 1991; Kelley and Delfs, 1991). 
In instrumental responding experiments animals are required to perform a 
behaviour, such as lever-pressing, to attain a ‘reinforcer’ such as food or drugs. 
Schedules of reinforcement describe the number of responses required, for 
example in a Fixed Ratio schedule a specified number of responses is rewarded 
(e.g. FR4 = 4 lever-presses) (Ferster, 1957). Under a Progressive Ratio schedule 
the number of instrumental responses required is increased by a fixed increment 
each time a reinforcer is attained until the animal stops responding, i.e. reaches 
its ‘breakpoint’ (Hodos, 1961). This measure has been used to investigate 
motivation for natural rewards (Hodos, 1961) and drugs of abuse in self-
administration experiments including psychostimulants (Griffiths et al., 1975), 
alcohol (Ritz et al., 1994; Brown, Jackson and Stephens, 1998) and opiates 
(Hoffmeister, 1979; Roberts and Bennett, 1993).  
As with locomotor activity it has been observed that dopamine manipulations in 
the NAc are sufficient to affect instrumental responding and breakpoints during 
PR schedules. Lesion of dopaminergic cells in the NAc by 6-OHDA significantly 
reduced responding during high-increment, but not low-increment, PR schedules 
(Salamone et al., 1999, 2001). Intra-NAc Shell injections of amphetamine 
significantly enhanced the number of active lever responses during a food 
reinforced PR schedule (Zhang, Balmadrid and Kelley, 2003).  
Importantly, dopamine depletions or antagonism in the NAc do not impair 
appetite for food or disrupt of primary food motivation (Ungerstedt, 1971; Koob 
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et al., 1978; Bakshi and Kelley, 1991; Salamone et al., 1993). In dopamine 
deficient transgenic mice, restoration of dopamine production in caudate 
putamen, but not NAc, was sufficient to rescue feeding behaviour (Szczypka et 
al., 2001). It has therefore been suggested that NAc dopamine transmission 
increases instrumental responding by increasing the level of work that animals 
are willing to do for similar reinforcement (Salamone et al., 1999). 
Systemic and intra-NAc administration of psychostimulants, including cocaine, 
increases responding and breakpoints for food under progressive ratio schedules 
(Poncelet et al., 1983; Zhang, Balmadrid and Kelley, 2003). Similarly, cocaine 
increased breakpoints for self-administration of ethanol (Brown and Stephens, 
2002), cocaine (Roberts and Bennett, 1993) and opiates (Duvauchelle, 
Sapoznika and Kornetskya, 1998). It has therefore been cautioned that high 
breakpoints for psychostimulants relative to other drugs may be due to their 
stimulant effects rather than greater efficacy as primary reinforcers (Jones et al., 
1995; Brown and Stephens, 2002). The hypothesis that psychostimulants 
increase the efficacy of primary reinforcers cannot be discounted however, in the 
case of food, it appears unlikely since at the same dose cocaine both increases 
PR breakpoints whilst reducing consumption and preference for sucrose 
(Balopole, Hansult and Dorph, 1979; Brown and Stephens, 2002). 
Again, GABAerigc activity within MSNs is likely to modulate these behaviours. 
Specifically agonism of GABAA receptors in the NAc shell, and to a lesser extent 
NAc Core, directly promotes food consumption (Stratford and Kelley, 1997; 
Basso and Kelley, 1999) as well as instrumental responding for food under 
progressive ratio schedules (Wirtshafter and Stratford, 2010). To date no 
published studies have investigated whether GABAergic activity in the NAc 
modulates the ability of cocaine to facilitate instrumental responding for natural 
rewards under progressive ratio schedules. Previously we found no difference in 
instrumental responding for primary rewards under fixed or progressive ratio 
schedules in α4-KO mice (see chapter 2) either at baseline or following cocaine 
administration (Macpherson, 2013). 
Systemic or intra-NAc administration of either D1 or D2 receptor antagonists 
reduces the breakpoint of responding for food in progressively escalating 
schedules of reinforcement (Hubner and Moreton, 1991; Aberman, Ward and 
121 
 
 
Salamone, 1998; Barbano, Le Saux and Cador, 2009). Similarly optogenetic 
stimulation of either D1 or D2 MSNs in the NAc increases Progressive Ratio (PR) 
responses and breakpoints for food (Soares-Cunha et al., 2016). Systemic and 
intra-NAc D1 and D2 antagonists reduced breakpoints in a PR schedule of 
cocaine self-administration (Hubner and Moreton, 1991; Bari and Pierce, 2005). 
Previously we have reported that constitutive deletion of the α4 subunit or virally 
mediated RNAi knockdown of α4 subunits in the NAc are sufficient to increase 
rates of instrumental responding for reward-paired stimuli in a test of 
conditioned reinforcement (CRf). In addition we found a similar effect when the 
α4-GABAARs was conditionally deleted in D2 but not D1 MSNs (Macpherson et 
al., 2016). Further experiments on instrumental responding for primary 
reinforcers could determine whether these effects are general to approach-
investigation behaviour or specific to cue-driven responses. Additionally, given 
that GABAA receptor activity in the NAc appears to mediate primary 
reinforcement of food (Wirtshafter and Stratford, 2010), we wished to 
investigate whether this might underlie α4-GABAAR mediated effects on CRf 
(Macpherson et al., 2016). Comparing CRf experiments with progressive ratio 
schedules may allow us to dissociate effects resulting from increased efficacy of 
the primary reinforcer vs increased response to secondary-reinforcers. 
Despite their widespread use Progressive Ratio tests (PR) are subject to 
problems of interpretation. Increased breakpoint values may indicate increased 
motivation however perseveration may also result from impaired learning 
flexibility or facilitation of general locomotor output, as discussed above 
(Ikemoto and Panksepp, 1999; Brown and Stephens, 2002). Comparing similar 
manipulations in PR, locomotor and CRf experiments may also indicate whether 
differences in CRf responding result from such generalised behaviour. 
We therefore investigated the role of α4 containing GABAARs receptors, 
specifically on D1 and D2 neurons, in fixed and progressive ratio schedules of 
reinforcement by sucrose. Here we use α4-D1-KO and α4-D2-KO conditional 
knock-out mice (see chapter 2) in a cocaine dose-response experiment where 
instrumental responding and PR breakpoints were recorded at baseline and 
following various doses of cocaine. 
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4.2. Methods 
4.2.1. Animals 
Conditional dopamine D1/D2 expressing neuron specific α4-subunit knockout 
mice were created by crossing “Floxed” α4-subunit homozygous transgenic mice 
(strain name; B6.129-Gabrα4tm1.2Geh/J, supplied by The Jackson Laboratory, 
ME, USA) with either dopamine receptor D1 or D2 neuron specific Cre-
recombinase hemizygous transgenic mice (strain name; α4-D1-KO = 
B6.FVB(Cg)-Tg(Drd1a-cre)EY217Gsat/Mmucd, α4D2-KO =  B6.FVB(Cg)-
Tg(Drd2-cre)ER44Gsat/Mmucd, supplied by Mutant Mouse Regional Resource 
Centers (MMRRC), ME, USA). Breeding was conducted as described in Figure. 
1.2.  
Male and female GABAAR α4 D1- or D2-expressing neuron specific α4 wildtype 
(α4-D1-WT/α4-D2-WT) and knockout (α4-D1-KO/α4-D2-KO) mice on a C57Bl/6J 
background strain, weighing between 20-30g, were housed in groups of 2-3, or 
separately for surgery animals, with food and water available ad libitum. A 12hr 
light/dark cycle was used (lights on at 7:00 A.M.) with holding room 
temperature maintained at 21 +/-2ºC and humidity 50 +/-5%. All injections, 
infusions and behavioural testing were performed between 2:00 P.M. and 5:00 
P.M. All procedures were conducted in accordance to Animals (Scientific 
Procedures) Act 1986, following ethical review by the University of Sussex 
Ethical Review Committee. 
4.2.2. Drugs 
Cocaine Hydrochloride was obtained from Macfarlan Smith (Edinburgh, UK). 
Cocaine was dissolved to desired concentrations in 0.9% saline, and 
administered IP at an injection volume of 10 ml/kg. 
4.2.3.1 Locomotor Activity 
We recorded locomotor activity in 16 annular black Perspex runways, (diameter 
24cm, annula width 6.5cm), placed atop a clouded Perspex sheet on an elevated 
frame. A digital camera positioned beneath the sheet captured the silhouettes of 
the boxes’ edges and the mice within them, which was then relayed to a 
computer to be recorded. A MatLab (MathWorks, Cambridge, UK) video analysis 
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programme and Excel macro converted the video data into a measure of the 
distance travelled in metres.  
The locomotor response to acute cocaine at various doses was tested in and α4-
D1-WT, α4-D1-KO, α4-D2-WT and α4-D2-KO mice (n=8 per genotype). Prior to 
testing there were two habituation days, on the first day mice were habituated 
to the equipment for 60 minutes, on the second day mice received an i.p. 
injection of saline prior to being placed in the apparatus. All animals underwent 
five test days in a within-subjects, Latin square design, during which they were 
administered saline, 3, 10, 20, 30mg/kg prior to being placed in the apparatus. 
4.2.3.2. Progressive ratio test 
Instrumental responding was measured using 8 operant chambers (Med 
Associates Inc, Vermont, USA), each housed within a light-resistant, sound-
attenuating cubicle. The front wall was fitted with a liquid dipper, located 
between 2 ultrasensitive mouse levers. Head entries into the liquid dipper 
magazine were detected using an infrared beam. Each operant chamber 
possessed a single house light located on the wall opposite the levers. In all 
sessions both levers were presented but only one ‘active lever’ resulted in 
reinforcement, this was alternated between left and right to avoid side-bias. 
Liquid dippers presented 0.2ml of 10% sucrose solution as reinforcers. 
Mice were food deprived to 90% of free-feeding bodyweight and trained to press 
the active lever for 10% sucrose solution in operant conditioning chambers. On 
day 1 mice underwent a 15h training session which included the dark phase and 
during which 10% sucrose solution was available on an FR1 schedule. 
Fixed ratio – Mice were tested in daily one-hour sessions (between 9:00 A.M. 
and 1:00 P.M.) during which the FR was 1, 2 or 4 for three consecutive sessions 
each. 
Progressive ratio – Mice were then tested in one session using a high-
increment PR schedule in which the FR was doubled each time a reinforcer was 
attained (i.e. 1, 2, 4, 8, 16… etc.). On the following two days mice were tested 
in sessions where saline or cocaine (10mg/kg) was administered directly prior to 
being placed in operant chambers in a within-subjects, counterbalanced design 
with each mouse receiving both treatments. 
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Using the same PR schedule all mice underwent five test daily sessions before 
which they were administered saline, 3, 10 or 30mg/kg directly prior to being 
placed in operant chambers in a within-subjects, Latin-square design with each 
mouse receiving all doses. 
4.2.4. Statistics 
All analyses were initially carried out including sex as a between-subjects 
independent variable however we found no main effects or interactions with 
other variables and sex was therefore excluded in secondary analysis for clarity. 
4.2.4.1. Locomotor activity during Cocaine Dose Response 
Baseline locomotor activity was assessed by a multivariate ANOVA using 
genotype as the between subjects factor and locomotor activity during 
habituation sessions and initial I.P. saline session as the dependant variables. 
Locomotor activity data for the cocaine dose response study was assessed by a 
repeated-measures ANOVA using genotype as the between-subjects factor, 
cocaine dose as a within-subjects factor and locomotor activity as the dependent 
variable. 
4.2.4.2. Instrumental responding under Fixed Ratio schedules  
Accuracy of instrumental responding was assessed using a multi-factor repeated 
measures ANOVA using FR and lever as within subjects factors, genotype as 
between subjects factors and lever-presses as the dependent variable. 
Reinforced instrumental responding was assessed by an ANOVA using genotype 
as a between-subjects factor and reinforcers earned as the dependant variable. 
4.2.4.3. Instrumental responding under Progressive Ratio schedules 
PR instrumental responding data was assessed by a multivariate ANOVA using 
genotype as a between-subjects factor and PR breakpoint, active lever presses, 
and inactive lever presses as the dependant variables. 
4.2.4.4. Cocaine (10mg/kg) Potentiation of Progressive Ratio 
PR instrumental responding data for the cocaine dose response study was 
assessed by a repeated-measures ANOVA using genotype as a between-subjects 
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factor, drug treatment as the within-subjects factor and PR breakpoint, active 
lever presses and inactive lever presses as the dependant variables. 
4.2.4.5. Progressive Ratio Cocaine Dose Response 
Instrumental responding data for the cocaine dose response study was assessed 
by a repeated-measures ANOVA using genotype as a between-subjects factor, 
cocaine dose as the within-subjects factor and PR breakpoint, active lever 
presses and inactive lever presses as the dependant variables. 
 
4.3. Results 
4.3.1. Locomotor activity cocaine-dose-response in α4-D1-WT/α4-D1-KO 
mice 
Baseline locomotor activity during habituation was similar in both α4-D1-WT and 
α4-D1-KO mice (Figure 4.1; non-significant effect of genotype, F(1,14)= 2.172, 
p=0.163; NS) and baseline locomotor activity following I.P. saline administration 
was similar in both genotypes (non-significant effect of genotype, F(1,14)= 1.549, 
p=0.234; NS). 
Acute administration of cocaine dose-dependently increased locomotor activity in 
both α4-D1-WT and α4-D1-KO mice (Figure 4.1; significant main effect of dose, 
F(4,56)= 36.57, p < 0.001). We observed an increased response to cocaine in α4-
D1-KO mice relative to α4-D1-WT littermates (significant main effect of 
genotype, F(1,14)= 6.61, p < 0.05; non-significant dose by genotype interaction, 
F(4,56)= 1.16, p= 0.34; NS).  
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Figure 4.1. Effect of acute intraperitoneal cocaine on distance travelled over 60 
minutes in α4-D1-WT and α4-D1-KO mice. Cocaine dose-dependently increased 
locomotor activity in both α4-D1-WT (n=8) and, to a greater extent, in α4-D1-
KO mice (n=8) mice (p<0.05). Error bars represent SEM. 
 
Baseline locomotor activity was significantly greater in the first 15 minutes of the 
session (Figure 4.2; significant main effect of time-bin, F(11,65) = 92.73, p< 
0.001) and cocaine potentiation of locomotor activity occurred in the first 15 
minute of the session (Figure 4.2; significant time-bin by dose interaction F(11,65) 
= 6.48, p<0.001). We did not observe a difference in the timecourse of 
locomotor behaviour between genotypes (Figure 4.2; non-significant time-bin by 
genotype interaction F(11,65) = 0.705, p = 0.73, NS). 
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Figure 4.2. Timecourse of activity over 60 minutes following I.P. injections of 
saline and cocaine at 3, 10, 20 or 30 mg/kg to α4-D1-WT (n=8) and α4-D1-KO 
(n=8) mice. Error bars represent SEM. 
4.3.2. Locomotor activity cocaine-dose-response in α4-D2-WT/α4-D2-KO 
mice 
Baseline locomotor activity during habituation was similar in both genotypes 
(Figure 4.3; non-significant effect of genotype, F(1,14)= 1.564, p=0.232; NS) and 
baseline locomotor activity following I.P. saline administration was similar in 
both genotypes (non-significant effect of genotype, F(1,14)= 1.7, p=0.213; NS). 
Acute administration of cocaine dose-dependently increased locomotor activity 
equally in α4-D2-WT and α4-D2-WT mice (Figure 4.3; significant main effect of 
dose, F(4,56)= 72.09, p < 0.001; non-significant main effect of genotype, F(1,14)= 
0.001, p = 0.98 NS; non-significant dose by genotype interaction, F(4,56)= 0.87, 
p = 0.461, NS).  
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Figure 4.3. Effect of acute intraperitoneal cocaine on distance travelled over 60 
minutes in α4-D2-WT and α4-D2-KO mice. Cocaine dose-dependently increased 
locomotor activity equally in both α4-D2-WT (n=8) and α4-D2-KO mice (n=8) 
mice. Error bars represent SEM. 
Baseline locomotor activity was significantly greater in the first 15 minutes of the 
session (Figure 4.4; significant main effect of time-bin, F(11,65) =109.87, p< 
0.001) and cocaine potentiation of locomotor activity occurred in the first 15 
minute of the session (Figure 4.4; significant time-bin by dose interaction F(11,65) 
= 12.997, p<0.001). We did not observe a difference in the timecourse of 
locomotor behaviour between genotypes (Figure 4.4; non-significant time-bin by 
genotype interaction F(11,65) = 0.326, p = 0.61, NS). 
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Figure 4.4. Time-course of activity over 60 minutes following I.P. injections of 
saline and cocaine at 3, 10, 20 or 30 mg/kg to α4-D2-WT (n=8) and α4-D2-KO 
mice (n=8). Error bars represent SEM. 
 
4.3.3. Instrumental responding under Fixed Ratio schedules in α4-D1-
WT/α4-D1-KO mice 
Mice responded significantly higher on the active lever than inactive lever and 
this was similar in both genotypes (Table 1.1; significant effect of lever, F(2,12)= 
53.77, p < 0.001; non-significant effect of genotype, F(2,12)= 0.376, p= 0.55;  
non-significant genotype by lever interaction, F(2,12)= 0.417, p=0.53, NS).  
Higher FR requirements elicited more active lever presses, but not inactive lever 
presses, from both genotypes (Figure 4.5; significant effect of FR, F(2,12)= 24.49, 
p < 0.001; non-significant FR by genotype interaction, F(2,12)= 0.378, p= 0.69, 
NS;  significant FR by lever interaction F(2,12)= 24.59, p < 0.001; non-significant 
FR by lever by genotype interaction, F(2,12)= 0.321, p=0.728, NS). 
Mice of both genotypes earned fewer reinforcers under higher FR requirements 
(Figure 4.5, significant effect of FR, F(2,12)= 16.54, p < 0.001; non-significant FR 
by genotype interaction, F(2,12)= 0.052, p=0.95, NS; non-significant effect of 
genotype, F(2,12)= 0.35, p=0.56, NS). 
130 
 
 
 
Figure 4.5. Graph FR Reinforcers earned over 60 minutes under FR1, FR2 and 
FR4 schedules of reinforcement. Both α4-D1-WT (n=8) and α4-D1-KO (n=8) 
mice earned a similar number of reinforcers at each ratio. Higher FR 
requirements reduced reinforcers earned by both genotypes. Error bars 
represent SEM. 
 
4.3.4. Instrumental responding under Progressive Ratio schedules in 
α4-D1-WT/α4-D1-KO mice 
Mice responded significantly higher on the active lever than inactive lever and 
this was similar in both genotypes (Table 1.1, Figure 4.6; significant effect of 
lever, F(1,13)= 41.488, p < 0.001; non-significant effect of genotype, F(1,13)= 
3.43, p= 0.087;  non-significant genotype by lever interaction, F(1,13)= 3.43, 
p=0.087, NS). Both genotypes reached similar PR breakpoints before they 
stopped responding (non-significant effect of genotype, F(1,13)= 2.709, p = 
0.124, NS). 
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Figure 4.6. Progressive Ratio breakpoint (lever-presses) attained during 180-
minute sessions by α4-D1-WT (n=8) and α4-D1-KO (n=8) mice. PR breakpoints 
were similar in both genotypes. Error bars represent SEM. 
 
4.3.5. Cocaine potentiation of instrumental responding under 
Progressive Ratio schedules in α4-D1-WT/α4-D1-KO mice 
Mice responded significantly higher on the active lever than inactive lever and 
this was similar in both genotypes (Table 4.2; significant effect of lever, F(1,12)= 
57.72, p < 0.001; non-significant genotype by lever interaction, F(1,12)= 0.761, p 
= 0.4, NS). Cocaine dose-dependently increased active lever presses to a 
greater extent than inactive lever presses (Table 4.2; significant main effect of 
dose, F(3,10)= 29.02, p<0.001; significant dose by lever interaction, F(3,10)= 
40.85, p<0.001).  
While both genotypes made similar active lever presses following I.P. saline 
(Figure 4.8; non-significant main effect of genotype F(1,12)= 0.085, p = 0.776, 
NS) cocaine treatment increased active lever presses by α4-D1-KO mice 
significantly more than in α4-D1-WT mice (Figure 4.8; significant dose by 
genotype interaction F(3,36)= 7.97, p<0.001, significant dose by lever by 
genotype interaction, F(3,36)=6.91, p<0.001). 
Cocaine dose dependently increased PR breakpoints reached by mice of both 
genotypes (Figure 4.9; significant main effect of dose, F(3,36)= 18.44, p<0.001). 
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Both genotypes reached similar PR breakpoints following I.P. saline (non-
significant main effect of genotype F(1,12)= 0.929, p = 0.35, NS) cocaine 
treatment increased PR breakpoints reached by α4-D1-KO mice significantly 
more than in α4-D1-WT mice (Figure 4.9; significant dose by genotype 
interaction F(3,36)= 3.99, p<0.05). 
 
Figure 4.7. The effect of I.P. administration of cocaine (10mg/kg)/saline on PR 
breakpoints in 180-minute sessions for α4-D1-WT (n=8) and α4-D1-KO (n=8) 
mice. A challenge dose of cocaine significantly increased PR breakpoints in both 
genotypes (p<0.01). Cocaine enhanced PR breakpoints significantly more in α4-
D1-KO than α4-D1-WT mice (p<0.01). Error bars represent SEM. 
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Figure 4.8. Timecourse of active and inactive lever presses over 60 minutes 
following I.P. injections of cocaine (10mg/kg) and saline in α4-D1-WT (n=8) and 
α4-D1-KO (n=8) mice. Both genotypes responded significantly more on the 
active than inactive lever. α4-D1-KO mice responded significantly more on the 
active, but not inactive, lever following I.P. cocaine but not saline. 
 
Figure 4.9. Effect of acute I.P. cocaine on PR breakpoints during 180-minute 
sessions in α4-D1-WT (n=8) and α4-D1-KO (n=8) mice. AT 10mg/kg cocaine 
increased PR breakpoints in both α4-D1-WT (n=8) and α4-D1-KO (n=8) mice. 
This enhancement was greater in α4-D1-KO mice at 3 and mg/kg however they 
were impaired at 30mg/kg relative to α4-D1-WT mice. Error bars represent SEM. 
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4.3.6. Instrumental responding under Fixed Ratio schedules in α4-D2-
WT/α4-D2-KO mice 
Mice responded significantly higher on the active lever than inactive lever and 
this was similar in both genotypes (Table 1.1; significant effect of lever, F(2,12)= 
59.76, p < 0.001; non-significant effect of genotype, F(2,12)= 0.86, p= 0.37, NS;  
non-significant genotype by lever interaction, F(2,12)= 0.87, p=0.37, NS).  
Higher FR requirements elicited more active lever presses, but not inactive lever 
presses, from both genotypes (Figure 4.10; significant effect of FR, F(2,12)= 
52.99, p < 0.001; non-significant FR by genotype interaction, F(2,12)= 0.93, p= 
0.41, NS;  significant FR by lever interaction F(2,12)= 54.59, p < 0.001; non-
significant FR by lever by genotype interaction, F(2,12)= 0.87, p=0.37, NS). 
Mice of both genotypes earned fewer reinforcers under higher FR requirements 
(Figure 4.10; significant effect of FR, F(2,12)= 18.03, p < 0.001; non-significant 
FR by genotype interaction, F(2,12)= 0.85, p=0.451, NS; non-significant effect of 
genotype, F(2,12)= 0.35, p=0.56, NS). 
 
Figure 4.10. Graph FR Reinforcers earned over 60 minutes under FR1, FR2 and 
FR4 schedules of reinforcement. Both α4-D2-WT (n=8) and α4-D2-KO (n=8) 
mice earned a similar number of reinforcers at each ratio. Higher FR 
requirements reduced reinforcers earned by both genotypes. 
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4.3.7. Instrumental responding under Progressive Ratio schedules in 
α4-D2-WT/α4-D2-KO mice 
Mice responded significantly higher on the active lever than inactive lever and 
this was similar in both genotypes (Table 1.1; significant effect of lever, F(1,13)= 
21.01, p < 0.001; non-significant effect of genotype, F(1,13)= 0.82, p= 0.38;  
non-significant genotype by lever interaction, F(1,13)= 0.5, p=0.83, NS). Both 
genotypes reached similar PR breakpoints before they stopped responding 
(Figure 4.11, non-significant effect of genotype, F(1,13)= 0.252, p = 0.62, NS). 
 
Figure 4.11. Progressive Ratio breakpoint (lever-presses) attained during 180-
minute sessions by α4-D1-WT (n=8) and α4-D1-KO (n=8) mice. PR breakpoints 
were similar in both genotypes. 
 
4.3.8. Cocaine potentiation of instrumental responding under 
Progressive Ratio schedules in α4-D2-WT/α4-D2-KO mice 
Mice responded significantly higher on the active lever than inactive lever and 
this was similar in both genotypes (Table 4.2; significant effect of lever, F(1,12)= 
58.72, p < 0.001; non-significant genotype by lever interaction, F(1,12)= 0.029, p 
= 0.87, NS). Cocaine administration increased active lever presses to a greater 
extent than inactive lever presses (Table 4.2; significant main effect of drug, 
F(3,10)= 6.391, p<0.05; significant dose by lever interaction, F(3,10)=7.59, 
p<0.05).  
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Cocaine potentiation of active lever responding was similar in both genotypes 
(Figure 4.13; non-significant main effect of genotype F(1,12)= 0.76, p = 0.4, NS; 
non-significant drug by genotype interaction F(3,36)= 0.163, p = 0.69, non-
significant drug by lever by genotype interaction, F(3,36)=0.059, p = 0.813). 
Cocaine administration increased PR breakpoints similarly in both genotypes 
(Figure 4.12; significant main effect of drug, F(1,13)= 17.53, p<0.001; non-
significant main effect of genotype F(1,12)= 0.15, p = 0.7, NS; non-significant 
dose by genotype interaction F(3,36)= 0.035, p = 0.85). 
 
Figure 4.12. The effect of I.P. administration of cocaine (10mg/kg)/saline on PR 
breakpoints in 180-minute sessions for α4-D2-WT (n=8) and α4-D2-KO (n=8) 
mice. A challenge dose of cocaine significantly increased PR breakpoints 
(p<0.01) similarly in both genotypes. 
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Figure 4.13. Timecourse of active and inactive lever presses over 60 minutes 
following I.P. injections of cocaine (10mg/kg) and saline in α4-D2-WT (n=8) and 
α4-D2-KO (n=8) mice. Both genotypes responded significantly more on the 
active than inactive lever following either saline or cocaine (10mg/kg) and this 
was similar in both genotypes. 
 
Genotype Schedule Active lever Inactive lever 
α4-D1-KO FR1 
FR2 
FR4 
PR 
93 ± 18 
160 ± 46 
233 ± 51 
466 ± 69 
3 ± 0.4 
5.4 ± 0.8 
4.4 ± 0.9 
62 ± 28 
α4-D1-WT FR1 
FR2 
FR4 
PR 
83 ± 8 
134 ±20 
194 ± 30 
855 ± 203 
4.8 ± 0.6 
5.1 ± 0.6 
5 ± 0.9 
27 ± 9.4 
α4-D2-KO FR1 
FR2 
FR4 
PR 
77 ± 15 
181 ± 27 
252 ± 36 
482 ± 168 
4 ± 0.7 
4.9 ± 0.7 
4.9 ± 0.8 
30 ± 9.9 
α4-D2-WT FR1 
FR2 
FR4 
PR 
66 ± 17 
137 ± 29 
201 ± 44 
597 ± 99 
4 ± 0.5 
5.7 ± 0.7 
4.6 ± 1 
99 ± 26 
Table 4.1. Baseline Active vs Inactive lever presses under each schedule of 
reinforcement for each genotype (Mean ± SEM to two significant figures). 
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Genotype PR + Drug Active lever Inactive lever 
α4-D1-KO Saline 
Cocaine (3mg/kg) 
Cocaine (10mg/kg) 
Cocaine (30mg/kg 
622 ± 115 
849 ± 51 
1578 ± 87 
184 ± 66 
121 ± 53 
144 ± 47 
61 ± 15 
111 ± 33 
α4-D1-WT Saline 
Cocaine (3mg/kg) 
Cocaine (10mg/kg) 
Cocaine (30mg/kg) 
569 ± 102 
502 ± 139 
1041 ± 121 
513 ± 97 
83 ± 12 
55 ± 18 
63 ± 9 
10 ± 8 
α4-D2-KO Saline 
Cocaine (10mg/kg) 
482 ± 79 
904 ± 77 
23 ± 4 
58 ± 13 
α4-D2-WT Saline 
Cocaine (10mg/kg) 
597 ± 37 
882 ± 55 
99 ± 10 
102 ± 13 
Table 4.2. Active vs Inactive lever presses under PR schedules following 
different drug treatments (Mean ± SEM). 
 
4.4. Discussion 
The present data demonstrate that conditionally deleting GABAA α4βδ receptors 
on D1-MSNs, facilitates cocaine-potentiation of locomotor activity. This agrees 
with multiple studies in which genetic or pharmacological methods to activate D1 
MSNs increased cocaine-induced locomotion (Schindler and Carmona, 2002; 
Bachtell et al., 2005b; A. V Kravitz et al., 2010).  
Notably we did not observe any differences in baseline locomotor activity in α4-
D1-KO mice. We may have expected an increase as in other studies activation of 
D1 receptors potentiated locomotor activity in the absence of cocaine (Dreher 
and Jackson, 1989). We therefore suggest that D1 MSNs which express α4 are a 
sub-population which mediate the effects of psychostimulants but are not 
normally involved in initiation of locomotor activity (see Chapter 1). This may be 
due to the relatively high expression of α4 in the NAc, which is known to mediate 
the locomotor activating properties of cocaine, relative to the rest of the 
striatum (Costall et al., 1977; Robinson and Berridge, 1993; Campbell et al., 
1997; Schwarzer et al., 2001). 
Further we have identified a dissociation between the effects of α4βδ receptors 
on D1 and D2 MSNs on cocaine-induced locomotor activity since deletion of α4 in 
D2 MSNs had no such effect. Based on previous studies using injections of D2 
agonists in the NAc we might have expected an increase in cocaine potentiated 
139 
 
 
locomotor activity (Bachtell et al., 2005b), however those effects were smaller 
than those produced by D1 agonists therefore deletion of α4βδ GABAARs may not 
have a sufficiently strong effect on D2 MSNs to replicate such findings. Given 
that systemic administration of D2 agonists results in mixed outcomes (Schindler 
and Carmona, 2002; Stuchlik et al., 2007) it is also possible that more 
anatomically targeted D2 manipulations are required to due to confounding 
effects. 
Previously, deletion of either GABAAR α4-subunits or δ-subunits, often paired in 
extrasynaptic α4βδ GABAARs, had no influence on baseline locomotion (Herd et 
al., 2009; Macpherson, 2013) and constitutive GABAAR α4-subunit knockout 
mice showed no difference from wildtype mice in locomotor activity following 
various doses of cocaine. There is however evidence that when 
pharmacologically activated α4βδ receptors oppose the locomotor stimulating 
effects of cocaine. Intra-NAc injections of the agonist THIP attenuated cocaine-
induced locomotor activity and this effect was abolished in α4-KO (Macpherson, 
2013).  
These data suggest that α4-GABAARs are not important for the initiation of 
locomotion, but their activation is able to attenuate baseline and cocaine-
potentiated locomotor activity. Our results indicate that this is most likely 
mediated by activation of α4βδ receptors on D1 MSNs. This could be fully 
confirmed by intra-NAc administration of THIP to D1/D2 α4 conditional knockout 
mice in larger cocaine-dose-response study of locomotor activity. 
Cocaine potentiates locomotor activity by prolonging the action of dopamine 
which is released in the NAc by projections from the VTA (Costall et al., 1984). 
This subsequently increases the sensitivity of MSNs to glutamatergic inputs 
which they receive from other areas such as the frontal cortex, amygdala and 
hippocampus (O'Donnell and Grace, 1995). We hypothesise that deletion of α4-
GABAARs will attenuate tonic inhibition on D1 MSNs in the NAc (Maguire et al., 
2014) consequently increasing the impact of glutamatergic excitation which is 
facilitated by cocaine-enhanced synaptic dopamine. 
We did not observe difference in cocaine potentiation of locomotor activity or 
instrumental responding in the α4 constitutive knockout - i.e. it predominates 
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over the α4-D1-KO phenotype. This implies that concurrent disinhibition of D2 
MSNs, and/or α4-containing interneuron populations that express D2, is in some 
way compensatory for disinhibition of D1 MSNs; possibly through opposing 
effects on locomotor activity. This is supported by studies that observed 
decreased cocaine-potentiated locomotor activity following activation of D2 
MSNs in the NAc by optogenetic stimulation or DREADDs (Chandra et al., 2013; 
Zhu, Ottenheimer and DiLeone, 2016). If disinhibition of D1 and D2 MSNs has 
opposite effects we would expect that α4-D2-KO mice should show reduced 
cocaine-potentiation of locomotor activity and instrumental responding, which 
they do not. However, absence of α4-GABAAR-mediated inhibition in D2-MSNs 
may override the inhibition of D2-MSNs normally caused by cocaine-induced 
dopamine release, resulting in locomotor activity of α4-D2-KO mice remaining 
unaffected by cocaine. 
As α4-GABAARs on D1 MSNs oppose cocaine’s stimulant effects this may act as a 
homeostatic control to prevent excessive neuronal excitation by dopamine. The 
α4 subunit is epigenetically upregulated following high dose or chronic cocaine 
administration and this occurs preferentially in D1 MSNs (Heiman et al., 2008) 
indicating this may also act as a long-term, adaptive homeostatic mechanism.  
Further experiments on locomotor sensitisation in α4-D1-KO mice may provide 
insight on this possibility (see chapter 5). 
We have also demonstrated that conditionally deleting α4-GABAA receptors on 
D1 MSNs facilitates cocaine-potentiation of instrumental responding for natural 
rewards under a PR schedule, as it does with locomotor activity. Again, we did 
not observe any differences in baseline instrumental responding in α4-D1-KO 
mice. This contrasts with previous studies where activation of D1 or D2 MSNs 
systemically or in the NAc facilitated responding under PR schedules reinforced 
by food or sucrose (Aberman, Ward and Salamone, 1998; Barbano, Le Saux and 
Cador, 2009). This implies that, as with locomotor activity, α4-GABAAR 
containing MSNs are a subset of neurons which mediate effects of 
psychostimulants but do not alter behaviour under normal conditions. 
The similar pattern of effects on locomotor activity and instrumental responding 
we observed in α4-D1-KO mice indicates a ‘general increase in approach-
investigation’ behaviour may underlie behavioural outcomes in both tests 
141 
 
 
(Ikemoto and Panksepp, 1999). The alternative hypothesis is that cocaine 
increases efficacy of primary reinforcers in α4-D1-KO mice. This is unlikely as in 
previous studies similar doses of cocaine reduced preference for sucrose 
(Balopole, Hansult and Dorph, 1979) and baseline responding was unaffected 
which indicated changes in GABAergic activity do not modulate appetite (Zhang, 
Balmadrid and Kelley, 2003). Whilst α4-D1-KO show greater enhancement of PR 
breakpoints following 10mg/kg cocaine they are more severely impaired 
following 30mg/kg indicating that they are more prone to stereotypy at high 
doses due to hypersensitivity to the stimulant effects of cocaine.  
Several previous studies identified that psychostimulant potentiation of both 
locomotor and PR instrumental responding are mediated by the NAc shell and 
similarly modulated by dopamine agonists which links these behaviours to a 
common neural substrate and mechanism (Zhang, Balmadrid and Kelley, 2003; 
Bachtell et al., 2005b). We conclude that increased cocaine potentiation of PR 
responding in α4-D1-KO mice is likely due to the enhanced locomotor stimulant 
effects of cocaine. 
These results are significant to the interpretation of previous CRf experiments 
using constitutive and conditional α4 knockout mice. There is a dissociation 
between locomotor activity/instrumental responding and CRf in the different 
transgenic α4 lines. α4-D1-KO mice show facilitation of locomotor activity and 
instrumental responding which was absent in constitutive α4-KO or α4-D2-KO 
mice. Conversely α4-KO or α4-D2-KO mice show enhancement baseline and 
cocaine potentiated CRf which is absent in α4-D1-KO mice (Macpherson, 2013). 
Deletion of α4 in D2 MSNs does not seem to alter primary reinforcer efficacy as 
measured by fixed and progressive ratio responding, nor does it increase the 
locomotor stimulating effects of cocaine as measured in the dose-responses for 
locomotor activity and progressive ratio schedules. This supports the hypothesis 
that removal of tonic inhibition of D2 MSNs enhances efficacy of secondary 
reinforcers and further enhances cocaine’s potentiation of CRf independently of 
its locomotor activating properties (Macpherson, 2013).  
To conclude, deletion of GABAAR α4-subunits on D1 or D2 MSNs had no effect on 
baseline locomotor activity or instrumental responding. However, deletion of α4- 
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GABAARs on D1, but not D2, MSNs increased cocaine’s ability to potentiate both 
behaviours. We interpret this as an enhanced general stimulant effect of cocaine 
in α4-D1-KO mice which is not present in α4-KO or α4-D2-KO mice. These data 
indicate that α4-GABAARs specifically on D1 MSNs provide an efficacious target 
for control of the stimulant properties of cocaine. Investigation into the effects of 
GABAAR α4-subunit deletion in D1/D2 MSNs on locomotor sensitisation to 
cocaine in further experiments may elucidate a role of α4 in adaptive changes 
following chronic cocaine administration.  
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Chapter 5 
The role of GABAA α4 Receptor subunits on D1 and D2 expressing 
neurons in mediating behavioural sensitisation to cocaine 
 
5.1. Introduction 
Behavioural sensitisation is a phenomenon whereby repeated administration of a 
drug results in increased stimulant behavioural effects (Tilson and Rech, 1973; 
Segal and Mandell, 1974; Browne and Segal, 1977; Bailey and Jackson, 1978; 
Hirabayashi and Alam, 1981; Leith and Kuczenski, 1982; Robinson and Becker, 
1986). This has been reported following administration of many drugs, including 
cocaine (Post et al., 1987; Kalivas and Stewart, 1991), amphetamine (Robinson 
and Becker, 1986; Cador et al., 1999), opiates (Babbini and Davis, 1972; 
Shuster et al., 1975) , nicotine (Benwell and Balfour, 1992; Kita et al., 1992)  
and ethanol (Cunningham and Noble, 1992; Phillips et al., 1997).  
Robinson and Berridge (1993) have argued that repeated exposure also leads to 
sensitisation to the incentive motivational properties of drugs. Under this 
‘incentive sensitisation’ model neural substrates mediating the attribution of 
incentive salience, termed ‘wanting’, are sensitised by repeated drug exposure, 
whereas substrates which mediate the hedonic experience of a drug, termed 
‘liking’, remain unsensitised or diminished (Robinson and Berridge, 2008). This is 
supported by evidence that sensitisation with amphetamine, cocaine, morphine 
or ethanol has facilitated the subsequent acquisition of self-administration or 
conditioned place preference (CPP) produced by the same drug, or a different 
drug (Lett, 1989; Horger, Shelton and Schenk, 1990; Piazza et al., 1990; 
Mendrek, Blaha and Phillips, 1998; Hoshaw and Lewis, 2001; Camarini and 
Hodge, 2004; McDaid et al., 2005). 
Psychostimulants are particularly robust in their ability to induce behavioural 
sensitisation and the neuroadaptations which underlie it. Behavioural 
sensitisation to amphetamine was demonstrated to persist undiminished for over 
a year (Robinson and Berridge, 1993). Studies exploring the neurobiological 
basis of behavioural sensitisation to cocaine have largely focussed on the 
mesolimbic dopamine system due to the established role of this system in 
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mediating the locomotor activating properties of cocaine (Pierce & Kalivas, 1997; 
Robinson & Berridge, 1993). It is well established that locomotor activity is 
enhanced by drugs that facilitate transmission at dopamine synapses, moreover 
it is reduced by dopamine antagonists or lesions of dopaminergic systems (Kelly, 
Seviour and Iversen, 1975; Kelly and Iversen, 1976; Wachtel and Anden, 1978; 
Fray et al., 1980).  
When dopamine agonists were infused directly into various regions of the rat 
forebrain the behavioural outcomes suggested that locomotor stimulation was 
primarily mediated by the Nucleus Accumbens (NAc), and stereotyped 
behaviours from the Dorsal Striatum (Costall et al., 1977; Campbell et al., 
1997). The NAc has been found to be critical in mediating behavioural 
sensitisation to drugs including psychostimulants, ethanol and morphine 
following repeated administration (Tilson and Rech, 1973; Segal and Mandell, 
1974; Cador, Taylor and Robbins, 1991; Kalivas and Duffy, 1993; Hoshaw and 
Lewis, 2001). During development of cocaine-sensitisation, repeated intermittent 
cocaine administration elevated basal extracellular level of dopamine within the 
NAc (Di Chiara and Imperato, 1988; Kalivas and Duffy, 1990). In addition, D1 
dopamine receptors in the NAc show enhanced sensitivity to dopamine following 
repeated cocaine administration (Henry, Greene and White, 1989; Henry and 
White, 1991). Lesions of the NAc shell attenuated of the induction of, but not 
expression of, behavioural sensitisation to cocaine (Todtenkopf et al., 2002; 
Todtenkopf, Stellar and Melloni, 2002), and infusions of cocaine or amphetamine 
to the NAc shell, but not core, induced behavioural sensitisation (Pierce and 
Kalivas, 1997). 
As outlined in earlier chapters, the majority of the striatum (~95%) is made up 
of GABAergic MSNs which can be divided into two subtypes, D1R- and D2R-
expressing MSNs (Kemp and Powell, 1971; Gerfen et al., 1990).  Recent 
evidence indicates we must exercise caution in referring to D1 and D2 
populations as the ‘direct’ or ‘indirect’ pathways within the ventral striatum 
(Kupchik et al., 2015). A large body of research has elucidated distinct and often 
opposing functions of D1 and D2 neuronal populations, sometimes referred to as 
the go/no-go pathways due to their roles in action initiation/inhibition (Surmeier, 
2013).  
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D1 and D2 neurons of the ventral striatum/NAc have been implicated in 
mediating the acute and chronic effects of drugs of abuse (Lobo and Nestler, 
2011). Many studies have specifically manipulated D1 or D2 striatal populations 
to examine their roles in behavioural sensitisation. Pharmacological 
manipulations have had mixed effects depending on type of agonist/antagonist, 
method and timing of administration (Mazurski and Beninger, 1991; Lobo and 
Nestler, 2011). It was proposed that genetically targeted manipulations may be 
able to more accurately dissociate these pathways (Durieux, Schiffmann and de 
Kerchove d’Exaerde, 2011; Lobo and Nestler, 2011). 
Blockade of neurotransmission via viral expression of tetanus toxin in either D1- 
or D2-MSNs of the NAc attenuated the locomotor activating effects of acute 
cocaine injection in mice (Hikida et al., 2010). Furthermore, blockade of D1 
MSNs attenuated sensitisation to cocaine over six drug exposures, whereas 
blockade in D2-MSNs slightly delayed the acquisition of sensitisation. 
Importantly, these phenotypes were normalized by reversal of the blockade 
indicating that D1/D2 neurons mediate expression rather than acquisition of 
cocaine sensitisation. Designer Receptors Activated by Designer Drugs 
(DREADDs) were used to inhibit D1 neurons or D2 neurons during a regimen of 
amphetamine treatment (six drug exposures) which induced robust behavioural 
sensitisation in controls (Ferguson et al., 2011). Neither affected acute response 
to amphetamine in the first session, but inactivation of D2 neurons resulted in 
increased sensitization whilst inactivation of D1 neurons had no effect on the 
acquisition of sensitisation. Notably, in this experiment response to a challenge 
dose after a one-week withdrawal period was reduced or enhanced in the D1- or 
D2-DREADD groups respectively even in the absence of DREADD activation. This 
indicates that activation of D1 or D2 neurons during sensitisation facilitates or 
opposes subsequent expression of psychostimulant sensitisation respectively.  
A knock-in mutation which diminished NMDA receptor (NMDAR) conductance in 
D1 MSNs abolished acquisition of cocaine-induced CPP and locomotor 
sensitization, highlighting the necessity for NMDA signalling in D1 MSNs for the 
rewarding and sensitizing effects of cocaine (Heusner and Palmiter, 2005). 
Subsequently, it was found that deletion of NMDARs in D2 MSNs normalized 
sensitization in mice already lacking NMDARs in D1 receptors (Beutler et al., 
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2011). This demonstrates that a balance of D1 and D2 neuronal activity is 
critical for establishing sensitisation. Conditional knock-out of the acetylcholine 
receptor 4 (M4) , an inhibitory metabotropic receptor, in D1 neurons increased 
their firing and resulted in accelerated acquisition of sensitisation to both cocaine 
and amphetamine and increased overall locomotor response to those drugs 
across all 6 sessions (Jeon et al., 2010). Optogenetic stimulation of D1, but not 
D2, neurons enhanced locomotor activity in cocaine-sensitised but not naive 
mice (Lobo et al., 2010). Although effects vary slightly depending on the type 
and location of genetic manipulations, together they indicate that activation of 
D1 MSNs within the NAc mediate behavioural sensitisation to psychostimulants 
while activation of D2 in the NAc neurons may oppose it. 
Chronic cocaine administration results in physiological adaptations of neurons in 
the direct and indirect striatal pathways. For example, long-term, intermittent 
cocaine administration increased spine density on dendrites of MSNs in the NAc 
(Robinson & Kolb, 1999; Robinson et al., 2001). A number of signalling 
molecules are known to be induced by psychostimulants including FosB (Hope et 
al., 1994), cFos (Robertson et al., 1991) and ERK (Bertran-Gonzalez et al., 
2008).  The transcription factor protein ΔFosB, is thought to act as an important 
molecular “switch” in the transition from drug abuse to addiction (Nestler et al. 
2001; Nestler, 2005). Mice with elevated ΔFosB in the NAc exhibited similar 
phenotype to cocaine-sensitised mice, including increased locomotor response to 
cocaine, as well as increased self-administration and motivation for cocaine (Kelz 
et al., 1999; Nestler et al., 2001). Conversely, blocking the build-up of ΔFosB in 
mice during a regimen of cocaine exposure reduced these behaviours (Nestler et 
al., 2001; Nestler, 2004). Repeated cocaine exposure preferentially induces 
ΔFosB in D1 neurons specifically (Hope et al., 1994). 
Activation of the proto-oncogene cFos has been widely characterised and used to 
map neural activity (Sheng and Greenberg, 1990). In rats there is an increase in 
cFos expressing neurons in the NAc following behavioural sensitisation to cocaine 
(Crombag et al. 2002). Further, following sensitisation cFos is increased 
preferentially in D1 Neurons (Young et al. 1991, Bertran-Gonzalez et al. 2008; 
Guez-Barber et al. 2011). Manipulation of signalling molecules in D1 or D2 
populations also differentially affects cocaine sensitisation. Conditional deletion 
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of cFos in D1 neurons blunted dendritic remodelling and attenuated expression 
of cocaine sensitisation (Zhang et al., 2006). Similarly, D1 cell specific deletion 
of DARPP-32, a dopamine activated signalling molecule, diminished sensitisation 
whereas deletion of DARPP-32 from D2 neurons led to enhanced acquisition of 
cocaine sensitisation (Bateup et al., 2008). Conversely deletion of BDNF in D1 
MSNs enhanced sensitisation and cFos expression in the NAc Shell whilst 
deletion in D2 MSNs attenuated sensitisation, and both phenotypes were rescued 
by restoring BDNF expression in the NAc using viral vectors (Lobo et al., 2010).  
Chronic cocaine administration alters GABA receptor and other ion channel 
subunits specifically in D1 neurons (Heiman et al., 2008). It is thought that 
repeated exposure to cocaine induces changes in GABA systems, resulting in a 
dysregulation of the neural circuitry mediating behavioural responses to drugs 
(Koob and Le Moal, 2001; Koob and Volkow, 2010). Ex-vivo analysis of striatal 
slices from cocaine-sensitised rats demonstrated that behavioural sensitisation 
to cocaine decreased pre- and post-synaptic GABA transmission (Jung et al., 
1999), and reduced the function of GABAARs (Peris, 1996). Muscimol binding 
was unaffected indicating that overall GABAAR levels remain similar (Jung and 
Peris, 2001). Conversely, following withdrawal from cocaine sensitisation or 
repeated cocaine administration in mice, cocaine challenges increase GABA 
transmission in the mPFC (Jayaram and Steketee, 2005) and NAc  (Xi et al., 
2003).  
The GABAAR α2-subunit is the predominant alpha subunit within the NAc and 
thus is likely to play an important role in mediating behavioural responses to 
cocaine (Schwarzer et al., 2001). Following amphetamine-sensitisation a 
decrease in GABAAR α2-subunits is reported within the NAc shell and core (Zhang 
et al., 2006). Furthermore, targeted deletion of the GABAAR α2-subunit blocks 
the ability of cocaine to induce behavioural sensitisation (Dixon et al., 2010), an 
effect subsequently demonstrated to be mediated within the NAc. Selective 
activation of α2-containing GABAARs within the NAc using intracranial infusions 
of the atypical benzodiazepine Ro 15-4513, were sufficient to induce behavioural 
sensitisation in α2(H101R) mutant mice (Dixon et al., 2010). 
Involvement of the GABAAR α4 subunit in mediating behavioural sensitisation to 
cocaine has also been suggested. Systemic administration of THIP, an agonist 
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selective for extrasynaptic α4-GABAARs, blocks both the acquisition and 
expression of behavioural sensitisation to amphetamine (Karler et al., 1997). 
With regard to D1 and D2 pathway involvement, α4 is upregulated preferentially 
in D1 neurons following repeated or high dose cocaine administration (Heiman et 
al., 2008). 
In previous experiments we did not find any effect of constitutive deletion of the 
α4 subunit on behavioural sensitisation to cocaine (Macpherson, 2013), although 
systemic THIP supressed locomotor sensitisation in α4-WT but not α4-KO mice. 
We hypothesise that the lack of change in behavioural sensitisation to cocaine 
following global knockout of GABAAR α4 subunits could be explained by the 
dissociable effects in dopamine D1- or D2-expressing neurons cancelling each 
other out and resulting in no overall change, as in the case of NMDAR receptor 
deletion (Beutler et al., 2011).  
Here we used immunohistochemical/in-situ-hybridisation analysis of cFos 
expression in D1 and D2 MSNs to examine the effects of acute and chronic 
cocaine administration on neural activity in the NAc of α4-KO mice compared 
with wildtypes. To elucidate the role of α4-GABAARs D1/D2 expressing neurons 
in behavioural sensitisation we examined the effects of D1- or D2-specific 
deletion of α4 containing GABAA receptors on behavioural sensitisation to 
cocaine. We also performed immunohistochemical analysis of cFos expression to 
investigate the effects of these manipulations on neural activity. 
 
5.2. Materials and Methods 
5.2.1. Animals 
All mice were generated on C57BL/6J background strain. Mice homozygous for a 
null-mutation of the gabrα4 gene (α4-KO) and homozygous wild-type mice (α4-
WT) were generated by breeding heterozygous mice carrying one copy each of 
both the knock-out and wild-type allele (α4-Het) as described previously in 
chapter 2 (Chandra et al., 2006; Maguire et al., 2014).  
As described in chapter 2 we produced conditional knock-out lines by crossing 
‘floxed’ α4 mice [strain name; B6.129-Gabrα4tm1.2Geh/J; Jackson Laboratory] 
(Chandra et al., 2006) with BAC D1-CRE [MMRRC strain B6.FVB(Cg)-Tg(Drd1a- 
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cre)EY266Gsat/Mmucd] or BAC D2-CRE [MMRRC strain B6.FVB(Cg)-Tg(Drd2-
cre)ER44Gsat/ Mmucd] (Gong et al., 2007) to result in cre-mediated deletion of 
α4 in either D1 or D2 expressing cells of the offspring. Mice hemizygous for the 
BAC D1-Cre transgene and homozygous for the ‘floxed’ α4 transgene were bred 
with homozygous ‘floxed’ α4 mice to produce α4-D1-KO and α4-D1-WT 
littermates whilst mice hemizygous for the BAC D2-Cre transgene and 
homozygous for the ‘floxed’ α4 transgene were bred with homozygous ‘floxed’ 
α4 mice to produce α4-D2-KO and α4-D2-WT littermates as previously described 
(Maguire et al., 2014).  
Male and female mice weighing between 20-30g and aged between 2-4 months, 
were housed in groups of 2-3, with food and water available ad libitum. During 
the habituation period and experiment a reversed 12hr light/dark cycle was used 
(lights on at 11:00 P.M.) with holding room temperature maintained at 212ºC 
and humidity 505%. 
5.2.2. Drugs 
Cocaine Hydrochloride was obtained from Macfarlan Smith (Edinburgh, UK). 
Cocaine was dissolved in 0.9% saline, and administered IP at an injection 
volume of 10 ml/kg. 
5.2.3. Apparatus 
Behavioural sensitisation was measured by recording locomotor activity in 16 
annular black Perspex runways, (diameter 24cm, annula width 6.5cm), placed 
atop a clouded Perspex sheet on an elevated frame. A digital camera positioned 
beneath the sheet captured the silhouettes of the boxes’ edges and the mice 
within them, which was then relayed to a computer to be recorded. A MatLab 
(MathWorks, Cambridge, UK) video analysis programme and Excel macro 
converted the video data into a measure of the distance travelled in metres.  
5.2.4. Behavioural Sensitisation to Cocaine (10mg/kg) Procedure 
(Figure 5.1, 5.2) Prior to testing, mice were habituated to the locomotor 
runways in two sessions. On the first day mice were habituated to the 
equipment for 60 minutes, then, on the second day, mice received IP injections 
of saline followed by a 60-minute habituation session. Subsequently, mice 
received repeated, intermittent treatment of either cocaine (10mg/kg) or saline 
for 10 consecutive daily sessions. Activity was recorded for 60 minutes each 
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session. Before every session mice were allowed to habituate to the runways for 
30 minutes before being returned to their homecage. After 5 minutes, mice were 
dosed with either cocaine (10mg/kg) or saline and returned to runways. 
5.2.5. Conditioned Activity 
(Figure 5.2) After 10 days of cocaine or saline treatment mice were placed in the 
locomotor runways as described above, with all animals receiving 10ml/kg saline 
injections. Activity was recorded for 60 minutes.  
5.2.6. Response to a cocaine (20mg/kg) challenge in sensitised vs non-
sensitised animals 
(Figure 5.1, 5.2) Cocaine-sensitised and saline-treated mice were divided into 
two groups, counterbalanced by sex and genotype, half receiving cocaine 
(20mg/kg) and the other half receiving saline directly prior to initiation of the 
locomotor test. Activity was recorded for 60 minutes each session. 
               
 
 
  
Figure 5.1. Experimental Design for studies 1 and 2. Investigating the effects of 
20mg/kg cocaine challenge compared with saline in naive (study 1) or cocaine-
sensitised (study 2) α4-KO and α4-WT mice.  
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Figure 5.2. Design of studies which compare behavioural sensitisation to 
cocaine (10,g/kg) in constitutive or D1/D2 selective α4 GABAAR receptor subunit 
knockout mice compared with respective wildtype controls. Includes saline-
treated control groups which are used to directly compare sensitised and non-
sensitised animals with a challenge of cocaine (20mg/kg) or saline in the final 
session. 
 
5.2.7. Design of Experiments 
Study 1. Both α4-WT (n=8) and α4-KO (n=8) mice were habituated to 
locomotor runways in a 60minute session and habituated to saline injection in 
another 60-minute session (Figure 5.1). On the challenge day mice received 
either IP saline injection (n=4 per genotype) or IP cocaine (20mg/kg) (n=4 per 
genotype). 
Study 2. Both α4-WT (n=8) and α4-KO (n=8) mice underwent the behavioural 
sensitisation procedure as described (Figure 5.1) with all mice receiving daily 
10mg/kg cocaine injections. On the challenge day mice received either IP saline 
injection (n=4 per genotype) or IP cocaine (20mg/kg) (n=4 per genotype). 
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Study 3. Both α4-D1-WT (n=16) and α4-D1-KO (n=16) mice underwent the 
behavioural sensitisation procedure as described (Figure 5.2) with all half of the 
mice receiving daily saline injections (n=8 per genotype) and half cocaine (n=8 
per genotype). On the challenge day cocaine-sensitised mice received either IP 
saline injection (n=4 per genotype) or IP cocaine (20mg/kg) (n=4 per genotype) 
and saline-treated mice received either IP saline injection (n=4 per genotype) or 
IP cocaine (20mg/kg) (n=4 per genotype). 
Study 4. Both α4-D2-WT (n=16) and α4-D2-KO (n=16) mice underwent the 
behavioural sensitisation procedure as described (Figure 5.2) with all half of the 
mice receiving daily saline injections (n=8 per genotype) and half cocaine (n=8 
per genotype). On the challenge day cocaine-sensitised mice received either IP 
saline injection (n=4 per genotype) or IP cocaine (20mg/kg) (n=4 per genotype) 
and saline-treated mice received either IP saline injection (n=4 per genotype) or 
IP cocaine (20mg/kg) (n=4 per genotype). 
Study 5. Both α4-WT (n=16) and α4-KO (n=16) mice underwent the 
behavioural sensitisation procedure as described (Figure 5.2) with half of the 
mice receiving daily saline injections (n=8 per genotype) and half cocaine (n=8 
per genotype). On the challenge day cocaine-sensitised mice received either IP 
saline injection (n=4 per genotype) or IP cocaine (20mg/kg) (n=4 per genotype) 
and saline-treated mice received either IP saline injection (n=4 per genotype) or 
IP cocaine (20mg/kg) (n=4 per genotype). 
5.2.8. Immunohistochemistry 
At 90 minutes following the 20mg/kg cocaine administration mice were 
euthanised by IP injection of Sodium Pentobarbital (200mg/kg, 10ml/kg). Mice 
brains were perfused via the aorta with 25ml (5 minutes of 5ml/min) of 
phosphate buffer solution (PBS) followed by 75ml (15 minutes of 5ml/min) of 
4% paraformaldehyde (PF) (Sigma-Aldrich, St. Lois, MO, USA) in PBS. After 
perfusion, brains were removed and post-fixed overnight in 4% PF in PBS at 
4°C, then transferred into 30% sucrose solution in PBS and left for 3 days at 4°C 
to cryoprotect. Coronal sections (30μm thick) were cut using a cryostat and 
collected in PBS-azide.  
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Free floating sections were washed 3 times in PBS for 10 minutes then incubated 
in blocking solution (3% Normal Goat Serum, Vector Labs, in PBS-T) for 1 hour 
with gentle agitation. Sections were then immediately incubated overnight in 
rabbit anti-cFos polyclonal primary antibody (Cat No. SC-52, Santa Cruz biotech, 
US) diluted 1:800 in blocking solution at 4°C. Sections were washed 3 times in 
PBS for 10 minutes before incubation in biotinylated anti rabbit secondary 
antibody (1:600, Vectorlabs, Peterborough, UK) diluted in blocking solution for 2 
hours at room temperature. Sections were washed 3 times in PBS for 10 
minutes before incubation in ABC solution (ABC Kit, Vectorlabs, Peterborough, 
UK) for 1 hour at room temperature. Sections were washed 3 times in PBS for 
10 minutes then incubated in DAB solution with Nickel Ammonium Sulfate (DAB 
kit, Vectorlabs, Peterborough, UK) for 5-10 minutes until precipitate developed. 
Sections were washed 3 times in PBS for 5 minutes to stop reaction. 
 
Sections were mounted in PBS onto Superfrost plus slides (Thermofisher, US) 
and air-dried overnight. Sections were immersed in distilled water for 2 times 10 
minutes then immediately dehydrated in an ethanol series immersed for in 30% 
followed by 60%, 90%, 95% and 100% ethanol for 2 minutes each then in 
clearing solution (Histoclear, National Diagnostics, US) for 10 minutes. 
Coverslips were applied using mounting medium (Histomount, National 
Diagnostics, US). 
 
Images were captured at 10x magnification using a QI click camera (Qimaging) 
attached to an Olympus Bx53 microscope (Olympus). Sections at Bregma 
+1.18mm were selected for analysis. The number of cFos+ nuclei was quantified 
using ImageJ software (National Institutes of Health, MD, US). Sample areas of 
250 by 750µm were specified within the NAc Core and Shell (Figure 5.3). 
Images were converted to binary image using an entropy based threshold 
(Kapur, Sahoo and Wong, 1985). Number of cFos+ nuclei was automatically 
counted within sample areas using the analyze particles function (specified 
objects of 50 to 100% circularity, 200-600 pixels).  
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Figure 5.3.  Schematic of regions sampled within Dorsal Striatum, NAc Core 
and NAc Shell indicated by red rectangles. Section at Bregma + 1.18mm. 
 
5.2.9. Fluorescent in situ hybridisation (RNAScope) 
5.2.9.1. Tissue Preparation 
Mice were euthanised by intraperitoneal injection of sodium pentobarbital 
followed by cervical dislocation to minimise rupturing of blood vessels. Brains 
were extracted and flash-frozen by submergence in isopentane maintained at -
50°C for 10 seconds then stored at -80°C prior to sectioning. 
Brains were sectioned in an RNAse free cryostat at -18°C. Brains were mounted 
on cryostat platforms using OCT mounting medium in -18°C chamber and left to 
equilibrate temperature for 1 hour prior to sectioning. Coronal sections of 10µm 
thickness were taken and mounted on SuperFrost Plus microscope slides 
(Thermofisher). Slides were stored at -80°C prior to in-situ-hybridisation. 
Sections were submerged in 10% Buffered Formalin for 20 minutes at 4°C. 
Slides were washed in 1xPBS for 2 x 1 minute with gentle agitation then 
dehydrated in a series of ethanol solutions. Slides were submerged in 50% 
ethanol for 1 x 5 minutes, 70% ethanol 1 x 5 minutes and 100% ethanol for 2 x 
5 minutes then incubated overnight in 100% ethanol at -20°C. 
5.2.9.2. Procedure 
In-situ-hybridisation was carried out using a manual RNAscope Fluorescent 
Multiplex Reagent Kit (Advanced Cell Diagnostics, Cat No. 320850) using 
instructions for fresh-frozen tissue and performing incubation steps using an 
ACD HybEZ™ Hybridization oven. We used RNAScope probes targeting: Mouse 
cFos (316928), Drd1 (Cat No. 406491-C2) and Drd2 (Cat No. 406501-C3). We 
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used the ‘Amp4 Alt A’ amplification reagent to label probes with fluorochromes 
as follows; cFos = Alexa-488, Drd1 = Atto-647, and Drd2 = Atto 550. 
Images were captured using a QI click camera (Qimaging) attached to an 
Olympus Bx53 microscope (Olympus). Images of the NAc taken at 10x 
magnification were analyzed using ImageJ software (NIH).  
Sample areas of 250 by 750µm were specified within the NAc Core and Shell 
(Figure 5.3). Images were converted to binary image using an entropy based 
threshold (Kapur, Sahoo and Wong, 1985). Cell nuclei stained by DAPI were 
used to select ROIs using the analyze particles function (specified objects of 50 
to 100% circularity, 200-600 pixels). Pixel intensity for each probes signal was 
measured within each ROI representing a cell. Cells expressing cFos and either 
D1 or D2 were counted and compared in our analysis. 
5.2.10. Statistical Analysis 
All analyses were initially carried out using sex as a between subjects factor. Sex 
did not influence any outcomes and was therefore excluded from all analyses for 
clarity. All analyses were carried out using IBM SPSS software. 
5.2.10.1. Behavioural Sensitisation to Cocaine 
Behavioural sensitisation to cocaine was analysed using a mixed-factors ANOVA 
with genotype and treatment-drug as the between-subjects variables, session as 
the within-subject variable, and metres travelled in each session as the 
dependent variable. Following this treatment, behavioural sensitisation to 
cocaine was confirmed using a mixed-factors ANOVA with genotype and 
treatment-drug as the between-subjects variables, and difference in metres 
travelled between sessions 1 and 10 as the dependent variable.  
To investigate whether any differences were present in baseline locomotor 
behaviour before the test sessions, an ANOVA was conducted with genotype as 
the between-subjects variable, day as the within-subject variable, and metres 
travelled during the habituation session as the dependent variable.  
5.2.10.2. Conditioned Activity 
Conditioned activity following behavioural sensitisation to cocaine was analysed 
using a mixed factors ANOVA, with genotype and drug dose as the between 
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subjects factors and metres travelled following a saline injection as the 
dependent variable.  
5.2.10.3. Response to IP saline or cocaine (20mg/kg) challenge in 
sensitised vs non-sensitised animals 
Response to 20mg/kg cocaine or saline challenge in non-sensitised/saline-
treated mice was analysed using a mixed-factors ANOVA with genotype and 
challenge-drug as the between-subjects factors, and using metres travelled in 
the challenge session, and cFos expression in the NAc Core and Shell as the 
dependent variables.  
Response to 20mg/kg cocaine or saline challenge in cocaine-sensitised mice was 
analysed using a mixed-factors ANOVA with genotype and challenge-drug as the 
between-subjects factors, and using metres travelled in the challenge session, 
and cFos expression in the NAc Core and Shell as the dependent variables.  
Cocaine-induced responses in saline-treated and cocaine-sensitised mice were 
compared in a mixed factors ANOVA using treatment-drug and genotype as the 
between subjects factors, and using metres travelled in the challenge session, 
and cFos expression in the NAc Core and Shell as the dependent variables.  
5.2.10.4. cFos Response to IP saline or cocaine (20mg/kg) challenge in 
sensitised vs non-sensitised animals in D1 vs D2 Neurons 
Response to 20mg/kg cocaine or saline challenge in non-sensitised/saline-
treated mice was analysed using a mixed-factors ANOVA with genotype and 
challenge-drug as the between-subjects factors, neuron-type as the within 
subjects variable, and using metres travelled in the challenge session and cFos 
expression, in D1 or D2 expressing neurons, in the NAc Core and Shell as the 
dependent variables.  
Response to 20mg/kg cocaine or saline challenge in cocaine-sensitised mice was 
analysed using a mixed-factors ANOVA with genotype and challenge-drug as the 
between-subjects factors, using neuron-type as the within subjects variable, and 
using metres travelled in the challenge session, and cFos expression in the NAc 
Core and Shell the dependent variables.  
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Cocaine-induced responses in saline-treated and cocaine-sensitised mice were 
compared in a mixed factors ANOVA using treatment-drug and genotype as the 
between subjects factors, using neuron-type as the within subjects variable, and 
using metres travelled in the challenge session, and cFos expression in the NAc 
Core and Shell the dependent variables.  
5.3. Results 
5.3.1. Response to 20mg/kg acute cocaine challenge in α4KO vs WT 
animals 
Analysis of the habitation session (following IP saline) confirmed that there was 
no significant difference in baseline locomotor activity between α4-WT (n=8) and 
α4-KO (n=8) mice (non-significant effect of genotype F(1,16) = 0.02, p = 0.89, 
NS). Compared with saline, an injection of 20mg/kg cocaine (IP) significantly 
increased locomotor activity, and there was no significant difference between 
α4-WT (n=4) and α4-KO (n=4) mice (Figure 5.4, significant main effect of drug 
F(1,16) = 77.74, p < 0.001; non-significant effect of genotype F(1,16) = 0.424, p = 
0.527, NS; non-significant genotype by drug interaction F(1,16) = 1.84, p = 0.2, 
NS). 
 
Figure 5.4. Effect of acute administration of saline or cocaine (20mg/kg, IP) 
injection on locomotor activity in α4-WT (n=8) and α4-KO (n=8) mice (per 
genotype; saline n=4, cocaine n=4). There was no significant difference in 
baseline or cocaine potentiated locomotor activity between genotypes. Error bars 
represent SEM. 
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5.3.2. cFos induced by acute cocaine (20mg/kg) in α4-KO vs α4-WT 
animals 
Compared with saline, IP injection of cocaine (20mg/kg) significantly increased 
cFos expression in the NAc Core (Figure 5.5, significant main effect of drug F(1,8) 
= 82.15, p < 0.001). Cocaine increased cFos to a greater extent in the NAc core 
of α4-KO (n=4) than α4-WT (n=4) mice (significant genotype by drug 
interaction F(1,8) = 7.563, p<0.05).  
There was a significant main effect of genotype on cFos expression however this 
was driven by greater cocaine-induced cFos in α4-KO mice (significant main-
effect of genotype, F(1,8) = 9.48, p<0.05). Post hoc tests confirmed higher cFos 
expression in the NAc Core of cocaine challenged than saline challenged α4-WT 
mice (t(6) = 3.91, p<0.01) and higher cFos expression in the NAc Core of cocaine 
challenged than saline challenged α4-KO mice (t(6) = 4.1, p<0.01). Post hoc also 
confirmed that cFos expression in the NAc core was not significantly different in 
saline challenged α4-KO (n=4) and α4-WT (n=4) mice (t(6) = 0.327, p = 0.33, 
NS) whereas, cocaine induced cFos was greater in α4-KO (n=4) than α4-WT 
(n=4) mice (t(6)= 30.4, p<0.05).  
Cocaine challenge increased cFos in the NAc shell (Figure 5.5, significant main 
effect of drug F(1,8) = 47.66, p<0.001) and this was not significantly different in 
α4-KO (n=4) and α4-WT (n=4) mice (non-significant genotype by drug 
interaction F(1,8) = 0.055, p = 0.82, NS). Overall cFos expression was not 
significantly different in the NAc shell of α4-KO (n=8) and α4-WT (n=8) mice 
(non-significant main effect of genotype, F(1,8) = 0.275, p = 0.61, NS).  
Cocaine challenge increased cFos in the Dorsal Striatum (Figure 5.5, significant 
main effect of drug F(1,8) = 97.95, p<0.001) and this was not significantly 
different in α4-KO (n=4) and α4-WT (n=4) mice (non-significant genotype by 
drug interaction F(1,8) = 0.18, p = 0.68, NS). Overall cFos expression was not 
significantly different in the Dorsal Striatum of α4-KO (n=8) and α4-WT (n=8) 
mice (non-significant main effect of genotype, F(1,8) = 0.35, p = 0.56, NS).  
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Figure 5.5. Effect of acute IP saline or cocaine injection on cFos expression the 
Dorsal striatum and Nucleus Accumbens of WT and α4KO mice (per genotype; 
saline n=4, 20mg/kg cocaine n=4). Cocaine induced a greater level of cFos 
expression in the NAc Core (p<0.001) and did so to a greater extent in α4 KO 
mice (p<0.05). Cocaine induced a greater level of cFos in the NAc Shell 
(p<0.001) equally in both genotypes. Cocaine induced a greater level of cFos 
expression in the Dorsal Striatum (p < 0.001) similarly in both genotypes. Error 
bars represent SEM. 
5.3.3. Behavioural Sensitisation to Cocaine (10mg/kg) in α4-KO vs α4-
WT animals 
Locomotor activity during habituation session (following IP saline) revealed no 
significant differences in baseline activity between genotypes (Figure 5.7, non-
significant effect of genotype F(1,8) = 0.036, p = 0.855, NS). Comparison of 
locomotor activity in session 1 revealed that injection of cocaine (10mg/kg) 
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increased locomotor activity similarly in both genotypes (Fig. non-significant 
effect of genotype F(1,8) = 0.24, p = 0.88, NS).  
Repeated, intermittent injections of cocaine (10mg/kg) induced an increase in 
locomotor activity over the course of 10 sessions (Figure 5.7, significant effect of 
session, F(9,90) = 5.98, p < 0.001). There were no significant differences in 
activity between genotypes across the 10 sessions (Figure 5.7, non-significant 
main effect of genotype F(1,10) = 0.009, p = 0.93, NS; non-significant session by 
genotype interaction F(9,90) = 0.006, p = 0.94, NS). 
Comparison of the difference between session 1 and session 10 activity 
confirmed that both genotypes sensitised to cocaine by a similar magnitude 
(non-significant effect of genotype, F(1,8) = 0.001, p = 0.97, NS). 
 
 
Figure 5.7. Effect of repeated intermittent cocaine on locomotor activity in α4-
WT (n=8) and α4 KO mice (n=8). Locomotor activity increased over the course 
of 10 sessions (p<0.001), equally in both genotypes. Error bars represent SEM. 
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5.3.4. Response to cocaine (20mg/kg) challenge in cocaine-sensitised 
α4-KO and α4-WT animals 
Compared with saline, a challenge dose of cocaine (20mg/kg) significantly 
potentiated locomotor activity in cocaine-sensitised mice, and did so to a similar 
extent in both genotypes (Figure 5.8, significant effect of challenge-drug F(1,8) = 
196.51, p<0.001; non-significant effect of genotype F(1,8) = 0.063, p = 0.81, 
NS; non-significant genotype by challenge-drug interaction F(1,8) = 0.093, p = 
0.77). 
 
Figure 5.8. Effect of a challenge dose of 20mg/kg cocaine on locomotor activity 
in cocaine-sensitised WT and α4 KO mice (per genotype; saline n=4, cocaine 
n=4). Cocaine significantly increased locomotor activity (p<0.001) equally in 
both genotypes. Error bars represent SEM. 
 
5.3.5. cFos induced by cocaine (20mg/kg) in cocaine-sensitised α4KO vs 
WT animals 
Compared with saline, IP injection of cocaine (20mg/kg) significantly increased 
cFos expression in the NAc Core of cocaine-sensitised mice (Figure 5.9, 
significant main effect of drug F(1,8) = 48.03, p < 0.001). Cocaine challenge 
increased cFos to a greater extent in the NAc Core of α4-KO (n=4) than α4-WT 
(n=4) cocaine-sensitised mice (Figure 5.9, significant genotype by drug 
interaction F(1,8) = 18.37, p<0.01).  
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There was a significant main effect of genotype (significant main effect of 
genotype, F(1,8) = 9.98, p<0.05) but this was driven by increased cocaine-
induced cFos in α4-KO mice. Post hoc tests confirmed higher cFos expression in 
the NAc Core of cocaine challenged than saline challenged α4-WT mice (t(6) = 
2.85, p<0.05) and higher cFos expression in the NAc Core of cocaine challenged 
than saline challenged α4-KO mice (t(6) = 7.99, p<0.001). Post hoc tests also 
confirmed that cFos expression was similar in the NAc Core of saline challenged 
α4-KO (n=4) and α4-WT (n=4) mice (t(6) = 0.986, p = 0.38, NS) whereas, 
cocaine induced cFos was greater in α4-KO (n=4) than α4-WT (n=4) mice (t(6)= 
4.52, p<0.05). 
Compared with saline, IP injection of cocaine (20mg/kg) significantly increased 
cFos expression in the NAc Shell of cocaine-sensitised mice (Figure 5.9, 
significant main effect of drug F(1,8) = 82.49, p < 0.001). Cocaine challenge 
increased cFos to a greater extent in the NAc Shell of α4-KO (n=4) than α4-WT 
(n=4) mice (significant genotype by drug interaction F(1,8) = 20.4, p<0.01).  
There was a significant main effect of genotype (significant main effect of 
genotype, F(1,8) = 0.275, p = 0.61, NS), but this was driven by greater cFos 
expression in the NAc Shell of α4-KO mice. Post hoc tests confirmed higher cFos 
expression in the NAc Shell of cocaine challenged than saline challenged α4-WT 
mice (t(6) = 3.08, p<0.01) and higher cFos expression in the NAc Shell of 
cocaine challenged than saline challenged α4-KO mice (t(6) = 10.15, p<0.001).  
Post hoc tests also confirmed that cFos expression was not significantly different 
in the NAc shell of saline challenged α4-KO (n=4) and α4-WT (n=4) mice (t(6) = 
2.76, p = 0.17, NS) whereas, cocaine induced cFos was greater in α4-KO (n=4) 
than α4-WT (n=4) mice (t(6)= 4.22, p<0.05). 
Cocaine challenge increased cFos in the Dorsal Striatum in cocaine sensitised 
mice (Figure 5.9, significant main effect of drug F(1,8) = 84.54, p<0.001) and this 
was not significantly different in α4-KO (n=4) and α4-WT (n=4) mice (non-
significant genotype by drug interaction F(1,8) = 0.18, p = 0.68, NS). Overall cFos 
expression was not significantly different in the Dorsal Striatum of α4-KO (n=8) 
and α4-WT (n=8) mice (non-significant main effect of genotype, F(1,8) = 0.19, p 
= 0.68, NS).  
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Figure 5.9. Effect of acute IP saline or cocaine injection on cFos expression the 
Dorsal Striatum and Nucleus Accumbens of WT and α4KO mice (per genotype; 
saline n=4, 20mg/kg cocaine n=4). Compared with saline, cocaine induced a 
greater level of cFos expression in the NAc Core (p<0.01) and did so to a 
greater extent in α4 KO mice (p<0.05). Cocaine induced a greater level of cFos 
in the NAc Shell (p<0.001) and did so to a greater extent in α4 KO mice (p 
<0.01). Cocaine induced a greater level of cFos expression in the Dorsal 
Striatum (p < 0.001) similarly in both genotypes. Error bars represent SEM. 
 
5.3.6. Behavioural Sensitisation to Cocaine in D1-α4-KO vs D1-α4-WT 
animals 
Locomotor activity during the initial habituation session (following IP saline 
injection) revealed no significant differences in baseline locomotor activity 
between α4-D1-WT (n=16) and α4-D1-KO (n=16) mice (Figure 5.11, non-
significant effect of genotype F(1,28) = 0.847, p = 0.365, NS). 
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Comparison of activity in session 1 revealed that, relative to saline, acute-
cocaine injection (10mg/kg) significantly increased locomotor activity (Figure 
5.11, significant main effect of treatment-drug F(1,28) = 46.89, p < 0.001) and 
did so to a greater extent in α4-D1-KO (n=8) than α4-D1-WT (n=8) (Figure 
5.11, significant genotype by treatment-drug interaction F(1,28) = 4.19, p < 
0.05). 
Repeated, intermittent injections of cocaine, but not saline, induced an increase 
in locomotor activity over the course of 10 sessions (Figure 5.11, significant 
main effect of treatment-drug, F(1,28) = 199.097, p<0.001;  significant session by 
treatment-drug interaction, F(9,252) = 11.231, p < 0.001). Saline-treated α4-D1-
WT and α4-D1-KO mice showed a similar locomotor activity over 10 sessions 
(non-significant session by genotype interaction F(9,252) = 0.405, p = 0.53, NS). 
There were significant differences in cocaine-induced activity between 
genotypes, whereby α4-D1-KO mice showed enhanced cocaine induced 
locomotor activity over the first 3 sessions (Figure 5.11, significant session by 
genotype by treatment-drug interaction, F(9,252) = 4.13, p<0.05).  
To compare cocaine-sensitisation between genotypes we measured the 
difference in activity between session 1 and session 10. Comparison of this 
difference confirmed that both genotypes sensitised to cocaine by a similar 
magnitude (significant effect of treatment-drug, F(1,28) = 24.12, p < 0.001, non-
significant treatment-drug by genotype interaction, F(1,28) = 3.34, p = 0.079, 
NS). 
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Figure 5.11. Effect of repeated intermittent cocaine on locomotor activity in D1-
α4-D1-WT and α4-D1-KO mice (per genotype: saline n=8, cocaine n=8). 
Locomotor activity was increased over the course of 10 sessions of cocaine 
administration (p<0.001) however in D1-α4-KO mice exhibited more rapid 
sensitisation (p<0.05). In session 1 acute cocaine injection increased locomotor 
activity (p<0.001), to a greater extent in D1-α4-KO mice (p<0.001). Error bars 
represent SEM. 
 
5.3.7. Conditioned Activity in D1-α4-KO vs D1-α4-WT animals 
 
Following 10 days of repeated cocaine, but not saline, mice showed conditioned 
increases in activity following a saline injection in the cocaine-paired 
environment (Fig; significant main effect of treatment-drug, F(1,28) = 48.72, p < 
0.001). Conditioned activity was significantly greater in α4-D1-KO (n=8) 
compared to α4-D1-WT (n=8) mice (Figure 5.12, significant genotype by 
treatment-drug interaction F(1,28) = 4.77, p<0.05). 
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Figure 5.12.  Conditioned activity in cocaine-sensitised or saline-treated α4-D1-
WT and α4-D1-KO mice (n=8 per group). Locomotor activity following saline 
administration was significantly increased in cocaine-sensitised mice compared 
with saline-treated mice (p<0.001). α4-D1-KO mice showed significantly greater 
conditioned activity (p<0.05*). Error bars represent SEM. 
 
5.3.8. Response to 20mg/kg cocaine challenge in sensitised and non-
sensitised D1-α4-KO vs D1-α4-WT animals 
Compared with saline, cocaine challenge (20mg/kg) significantly increased 
locomotor activity in saline-treated mice (significant main effect of challenge-
drug F(1,16) = 74.9, p<0.001), to a greater extent in saline-treated α4-D1-KO 
(n=4) than α4-D1-WT (n=4) mice (Figure 5.13, significant challenge-drug by 
genotype interaction, F(1,16) = 9.8, p<0.01).  
Compared with saline, cocaine challenge (20mg/kg) significantly increased 
locomotor activity in cocaine-sensitised mice (Figure 5.13, significant main effect 
of challenge-drug F(1,16) = 120.95, p<0.001), and this was not significantly 
different between cocaine-sensitised α4-D1-KO (n=4) and α4-D1-WT (n=4) mice 
(non-significant challenge-drug by genotype interaction, F(1,16) = 1.25, p = 0.29, 
NS).  
Cocaine-induced locomotor activity was significantly greater in cocaine-
sensitised than non-sensitised mice (Figure 5.13, significant main effect of 
treatment-drug F(1,16) = 18.81, p < 0.001, NS) and this was not significantly 
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different between α4-WT (n=4) and α4-KO (n=4) mice (non-significant 
treatment-drug by genotype interaction F(1,16) = 0.18, p = 0.68, NS). 
 
 
Figure 5.13. Effect of challenge dose of 20mg/kg cocaine on saline-treated and 
cocaine-sensitised α4-D1-WT vs α4-D1-KO mice (n=8 per group). Cocaine 
significantly increased locomotor activity (p<0.001), to a greater extent in D1-
α4-KO mice (p<0.001). Cocaine-sensitisation increased response to the cocaine 
challenge (p<0.001) similarly in both genotypes. Error bars represent SEM. 
 
5.3.9. cFos induced by cocaine in sensitised and non-sensitised α4-D1-
KO vs α4-D1-WT animals 
To analyse the effects of acute cocaine in sensitised and non-sensitised animals 
we compared cFos expression in the Dorsal Striatum and Nucleus Accumbens 
following an acute challenge of either saline or cocaine (20mg/kg) in cocaine-
sensitised vs saline-treated animals. 
Compared with saline, cocaine challenge (20mg/kg) significantly increased cFos 
expression in the NAc Core of saline-treated mice (Figure 5.14, significant main 
effect of challenge-drug F(1,16) = 51.66, p<0.001), to a greater extent in α4-D1-
KO (n=4) than α4-D1-WT (n=4) mice (Figure 5.14, significant challenge-drug by 
genotype interaction, F(1,16) = 11.91, p<0.01).  
Compared with saline, cocaine challenge (20mg/kg) significantly increased cFos 
expression in the NAc Core of cocaine-sensitised mice (Figure 5.14, significant 
main effect of challenge-drug F(1,16) = 25.29, p<0.001), to a greater extent in 
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α4-D1-KO (n=4) than α4-D1-WT (n=4) mice (Figure 5.14, significant challenge-
drug by genotype interaction, F(1,16) = 6.77, p < 0.05, non-significant main effect 
of genotype F= 2.52, p = 0.138, NS). 
Cocaine-induced cFos in the NAc core was significantly greater in cocaine-
sensitised than saline-treated mice (Figure 5.14, significant main effect of 
treatment-drug F(1,16) = 12.37, p < 0.001, NS) and this was not significantly 
different between α4-D1-WT (n=4) and α4-D1-KO (n=4) mice (Figure 5.14, non-
significant treatment-drug by genotype interaction F(1,16) = 0.288, p = 0.6, NS).  
Compared with saline, cocaine challenge (20mg/kg) significantly increased cFos 
expression in the NAc shell of saline-treated mice (Figure 5.14, significant main 
effect of challenge-drug F(1,16) = 177.3, p<0.001), and this was not significantly 
different between α4-D1-KO (n=4) and α4-D1-WT (n=4) mice (Figure 5.14, non-
significant challenge-drug by genotype interaction, F(1,16) = 0.14, p = 0.71, NS, 
non-significant main effect of genotype F(1,16) = 1.08, p=0.319, NS). 
Compared with saline, cocaine challenge (20mg/kg) significantly increased cFos 
expression in the NAc shell of cocaine-sensitised mice (Figure 5.14, significant 
main effect of challenge-drug F(1,16) = 67.55, p<0.001), to a greater extent in 
α4-D1-KO (n=4) than α4-D1-WT (n=4) mice (Figure 5.14, significant challenge-
drug by genotype interaction, F(1,16) = 4.96, p <0.05). 
Cocaine-induced cFos in the NAc shell was significantly greater in cocaine-
sensitised than saline-treated mice (Figure 5.14, significant main effect of 
treatment-drug F(1,16) = 36.34, p < 0.001, NS) and this was not significantly 
different between α4-D1-WT (n=4) and α4-D1-KO (n=4) mice (Figure 5.14, non-
significant treatment-drug by genotype interaction F(1,16) = 3.38, p = 0.091, NS). 
Compared with saline, cocaine challenge (20mg/kg) significantly increased cFos 
expression in the Dorsal Striatum of saline-treated mice (Figure 5.14, significant 
main effect of challenge-drug F(1,16) = 154.03, p<0.001), and this was not 
significantly different between α4-D1-KO (n=4) and α4-D1-WT (n=4) mice 
(Figure 5.14, non-significant challenge-drug by genotype interaction, F(1,16) = 
0.15, p = 0.71, NS, non-significant main effect of genotype F(1,16) = 0.041, 
p=0.843, NS). 
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Compared with saline, cocaine challenge (20mg/kg) significantly increased cFos 
expression in the Dorsal Striatum of cocaine-sensitised mice (Figure 5.14, 
significant main effect of challenge-drug F(1,16) = 68.15, p<0.001), and this was 
not significantly different between α4-D1-KO (n=4) and α4-D1-WT (n=4) mice 
(Figure 5.14, non-significant challenge-drug by genotype interaction, F(1,16) = 
0.086, p = 0.774, NS). 
Cocaine-induced cFos in the Dorsal Striatum was significantly greater in cocaine-
sensitised than saline-treated mice (Figure 5.14, significant main effect of 
treatment-drug F(1,16) = 4.83, p < 0.05) and this was not significantly different 
between α4-D1-WT (n=4) and α4-D1-KO (n=4) mice (Figure 5.14, non-
significant treatment-drug by genotype interaction F(1,16) = 0.16, p = 0.69, NS).  
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Figure 5.14. Effect of IP saline or cocaine (20mg/kg) injection on cFos 
expression the NAc Core and Shell of cocaine-sensitised or saline-treated α4-D1-
WT and α4-D1-KO mice (n=8 per group). In saline-treated mice acute cocaine 
challenge increased cFos expression in the NAc Core (p<0.001), to a greater 
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extent in α4-D1-KO mice (p<0.01*). In saline-treated mice acute cocaine 
challenge increased cFos expression in the NAc Shell (p<0.001) and this was not 
different between genotypes. In cocaine-sensitised mice cocaine challenge 
increased cFos expression in the NAc Core (p<0.001), to a greater extent in α4-
D1-KO mice (p<0.05*). In cocaine-sensitised mice acute cocaine challenge 
increased cFos expression in the NAc Shell (p<0.001) to a greater extent in α4-
D1-KO mice (p<0.05*). Cocaine challenge induced greater cFos expression in 
the NAc Core of cocaine-sensitised than saline-treated mice (p<0.001) and this 
was not different between genotypes. Cocaine challenge induced greater cFos 
expression in the NAc shell of cocaine-sensitised than saline-treated mice 
(p<0.001) and this was not different between genotypes. Cocaine challenge 
induced greater cFos expression in the Dorsal Striatum of saline-treated 
(p<0.001) and cocaine-sensitised mice (p<0.001) and this was not different 
bwetween genotypes. Error bars represent SEM. 
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Figure 5.15. Representative images NAc Core and Shell following cocaine 
(20mg/kg) and saline challenge in cocaine-sensitised and saline-treated α4-D1-WT 
and α4-D1-KO mice. 
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5.3.10. Behavioural Sensitisation to Cocaine in α4-D2-KO vs α4-D2-WT 
animals 
Locomotor activity during the initial habituation session (following IP saline 
injection) revealed no significant differences in baseline locomotor activity 
between α4-D2-WT (n=16) and α4-D2-KO (n=16) mice (Figure 5.16, non-
significant effect of genotype F(1,28) = 0.91, p = 0.348, NS). 
Comparison of activity in session 1 revealed that, relative to saline, acute-
cocaine injection (10mg/kg) significantly increased locomotor activity (Figure 
5.16, significant main effect of treatment-drug F(1,28) = 35.02, p<0.001), to a 
similar extent in D2-α4-KO (n=8) and D2-α4-WT (n=8) mice (Figure 5.16, non-
significant genotype by treatment-drug interaction F(1,28) = 0.365, p = 0.55, 
NS). 
Repeated, intermittent injections of cocaine, but not saline, induced an increase 
in locomotor activity over the course of 10 sessions (Figure 5.16, significant 
main effect of treatment-drug, F(1,28) = 32.7, p<0.001;  significant session by 
treatment-drug interaction, F(9,252) = 8.6, p < 0.01). Saline-treated α4-D2-WT 
and α4-D2-KO mice showed a similar locomotor activity over 10 sessions (Figure 
5.16, non-significant session by genotype interaction F(9,25) = 2.89, p = 0.329, 
NS). Cocaine-induced activity was similar in both genotypes (Figure 5.16, non-
significant session by genotype by treatment-drug interaction, F(9,124) = 1.57, p 
= 0.22, NS).  
To compare cocaine-sensitisation between genotypes we measured the 
difference in activity between session 1 and session 10. Comparison of this 
difference confirmed that both genotypes sensitised to cocaine by a similar 
magnitude (Figure 5.16, significant effect of treatment-drug, F(1,28) = 8.57, 
p<0.01, non-significant treatment-drug by genotype interaction, F(1,28) = 0.05, p 
= 0.819, NS). 
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Figure 5.16. Effect of repeated intermittent cocaine on locomotor activity in α4-
D2-WT and α4-D2-KO mice (per genotype; saline n=8, cocaine n=8). Locomotor 
activity was increased over the course of 10 sessions of cocaine administration 
(p<0.001) similarly in both genotypes. In session 1 acute cocaine injection 
increased locomotor activity similarly in both genotypes. Error bars represent 
SEM. 
 
5.3.11. Conditioned Activity in α4-D2-KO vs α4-D2-WT animals 
Following 10 days of repeated cocaine, but not saline, mice showed increases in 
activity following a saline injection in the cocaine-paired environment (Figure 
5.17, significant main effect of treatment-drug, F(1,28) = 12.98, p < 0.001). 
Conditioned activity was similar in α4-D2-KO (n=8) and α4-D2-WT (n=8) mice 
(non-significant genotype by treatment-drug interaction F(1,28) = 0.199, p = 
0.659). 
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Figure 5.17. Conditioned activity in cocaine-sensitised or saline-treated α4-D2-
WT and α4-D2-KO mice (n=8 per group). Locomotor activity following saline 
administration was significantly increased in cocaine-sensitised mice than saline-
treated mice (p<0.001), and this was not different between genotypes. Error 
bars represent SEM. 
 
5.3.12. Response to 20mg/kg cocaine challenge in sensitised and non-
sensitised α4-D2-KO vs α4-D2-WT animals 
Compared with saline, cocaine challenge (20mg/kg) significantly increased 
locomotor activity in saline-treated mice (Figure 5.18, significant main effect of 
challenge-drug F(1,16) = 189.01, p<0.001), and this was not significantly different 
between in α4-D2-KO (n=4) and α4-D2-WT (n=4) mice (Figure 5.18, non-
significant challenge-drug by genotype interaction, F(1,16) = 2.868, p=0.116, NS; 
non-significant main effect of genotype, F(1,16) = 1.28, p = 0.281, NS).  
Compared with saline, cocaine challenge (20mg/kg) significantly increased 
locomotor activity in cocaine-sensitised mice (Figure 5.18, significant main effect 
of challenge-drug F(1,16) = 123.84, p<0.001), and this was not significantly 
different between in α4-D2-KO (n=4) and α4-D2-WT (n=4) mice (Figure 5.18, 
non-significant challenge-drug by genotype interaction, F(1,16) = 0.002, p = 
0.968, NS; non-significant main effect of genotype, F(1,16) = 0.12, p = 0.73, NS).  
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Cocaine-induced locomotor activity was significantly greater in cocaine-
sensitised than non-sensitised mice (Figure 5.18, significant main effect of 
treatment-drug F(1,16) = 18.81, p < 0.001, NS) and this was not significantly 
different between in α4-D2-KO (n=4) and α4-D2-WT (n=4) mice (Figure 5.18, 
non-significant treatment-drug by genotype interaction F(1,16) = 0.18, p = 0.68, 
NS). 
 
 
Figure 5.18. Effect of challenge dose of 20mg/kg cocaine on saline-treated and 
cocaine-sensitised α4-D2-WT and α4-D2-KO mice (n=8 per group). Cocaine 
significantly increased locomotor activity (p<0.001) to a greater extent in 
cocaine-sensitised mice than saline-treated mice (p<0.001) and this was not 
different between. Error bars represent SEM. 
 
5.3.13. cFos induced by cocaine in sensitised and non-sensitised D2-α4-
KO vs D2-α4-WT animals 
To analyse the effects of acute cocaine in sensitised and non-sensitised animals 
we compared cFos expression in the NAc Core and Shell following an acute 
challenge of either saline or cocaine (20mg/kg) in cocaine-sensitised vs saline-
treated animals. 
Compared with saline, cocaine challenge (20mg/kg) significantly increased cFos 
expression in the NAc Core of saline-treated mice (Figure 5.19, significant main 
effect of challenge-drug F(1,16) = 35.5, p<0.001), and this was not significantly 
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different between in α4-D2-KO (n=4) and α4-D2-WT (n=4) mice (Figure 5.19, 
non-significant challenge-drug by genotype interaction, F(1,16) = 1.57, p = 0.23, 
NS; non-significant main effect of genotype F= 0.04, p = 0.84, NS). 
Compared with saline, cocaine challenge (20mg/kg) significantly increased cFos 
expression in the NAc Core of cocaine-sensitised mice (Figure 5.19, significant 
main effect of challenge-drug F(1,16) = 45.24, p<0.001), and this was not 
significantly different between in α4-D2-KO (n=4) and α4-D2-WT (n=4) mice 
(Figure 5.19, non-significant challenge-drug by genotype interaction, F(1,16) = 
2.71, p = 0.13, NS; non-significant main effect of genotype F(1,16) = 0.086, p = 
0.78, NS). 
Cocaine-induced cFos in the NAc core was significantly greater in cocaine-
sensitised than saline-treated mice (Figure 5.19, significant main effect of 
treatment-drug F(1,16) = 11.31, p < 0.01) and this was not significantly different 
between in α4-D2-KO (n=4) and α4-D2-WT (n=4) mice (Figure 5.19, non-
significant treatment-drug by genotype interaction F(1,16) = 3.26, p = 0.096, NS; 
non-significant main effect of genotype F(1,16) = 0.16, p = 0.7, NS). 
Compared with saline, cocaine challenge (20mg/kg) significantly increased cFos 
expression in the NAc shell of saline-treated mice (significant main effect of 
challenge-drug F(1,16) = 59.4, p<0.001), and this was not significantly different 
between in α4-D2-KO (n=4) and α4-D2-WT (n=4) mice (Figure 5.19, non-
significant challenge-drug by genotype interaction, F(1,16) = 0.033, p = 0.86, NS; 
non-significant main effect of genotype F(1,16) = 0.38, p=0.55, NS). 
Compared with saline, cocaine challenge (20mg/kg) significantly increased cFos 
expression in the NAc shell of cocaine-sensitised mice (Figure 5.19, significant 
main effect of challenge-drug F(1,16) = 4.65, p<0.05), and this was not 
significantly different between in α4-D2-KO (n=4) and α4-D2-WT (n=4) mice 
(non-significant challenge-drug by genotype interaction, F(1,16) = 0.11, p = 0.75, 
NS; non-significant main effect of genotype F(1,16) = 0.17, p = 0.69, NS). 
Cocaine-induced cFos in the NAc shell was significantly greater in cocaine-
sensitised than saline-treated mice (Figure 5.19, significant main effect of 
treatment-drug F(1,16) = 10.58, p < 0.01) and this was not significantly different 
between in α4-D2-KO (n=4) and α4-D2-WT (n=4) mice (Figure 5.19, non-
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significant treatment-drug by genotype interaction F(1,16) = 0.056, p = 0.82, NS; 
non-significant main effect of genotype F(1,16) = 0.022, p = 0.86, NS). 
Compared with saline, cocaine challenge (20mg/kg) significantly increased cFos 
expression in the Dorsal Striatum of saline-treated mice (Figure 5.19, significant 
main effect of challenge-drug F(1,16) = 91.95, p<0.001), and this was not 
significantly different between α4-D2-KO (n=4) and α4-D2-WT (n=4) mice 
(Figure 5.19, non-significant challenge-drug by genotype interaction, F(1,16) = 
0.021, p = 0.89, NS; non-significant main effect of genotype F(1,16) = 0.14, p = 
0.715, NS). 
Compared with saline, cocaine challenge (20mg/kg) significantly increased cFos 
expression in the Dorsal Striatum of cocaine-sensitised mice (Figure 5.14, 
significant main effect of challenge-drug F(1,16) = 101.41, p<0.001), and this was 
not significantly different between α4-D2-KO (n=4) and α4-D2-WT (n=4) mice 
(Figure 5.19, non-significant challenge-drug by genotype interaction, F(1,16) = 
0.686, p = 0.424, NS). 
Cocaine-induced cFos in the Dorsal Striatum was not-significantly different 
between cocaine-sensitised than saline-treated mice, although there was a trend 
towards increased cFos in cocaine-induced cFos in cocaine-sensitised mice 
(Figure 5.14, significant main effect of treatment-drug F(1,16) = 4.07, p = 0.067) 
and this was not significantly different between α4-D2-WT (n=4) and α4-D2-KO 
(n=4) mice (Figure 5.14, non-significant treatment-drug by genotype interaction 
F(1,16) = 0.117, p = 0.738, NS).  
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Figure 5.19. Effect of IP saline or cocaine (20mg/kg) injection on cFos 
expression the NAc Core and Shell of cocaine-sensitised or saline-treated α4-D2-
WT and α4-D2-KO mice (n=8 per group). In saline-treated mice acute cocaine 
challenge increased cFos expression in the NAc Core (p<0.001) and this was not 
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different between genotypes. In saline-treated mice acute cocaine challenge 
increased cFos expression in the NAc Shell (p<0.001) and this was not different 
between genotypes. In cocaine-sensitised mice cocaine challenge increased cFos 
expression in the NAc Core (p<0.001 and this was not different between 
genotypes (p<0.001). In cocaine-sensitised mice acute cocaine challenge 
increased cFos expression in the NAc Shell (p<0.001) and this was not different 
between genotypes (p<0.001). Cocaine challenge induced greater cFos 
expression in the NAc Core of cocaine-sensitised than saline-treated mice 
(p<0.01) and this was not different between genotypes. Cocaine challenge 
induced greater cFos expression in the NAc shell of cocaine-sensitised than 
saline-treated mice (p<0.01) and this was not different between genotypes. 
Cocaine challenge induced greater cFos expression in the Dorsal Striatum of 
saline-treated (p<0.001) and cocaine-sensitised mice (p<0.001) and this was 
not different between genotypes. Error bars represent SEM. 
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Figure 5.20. Representative images NAc Core and Shell following cocaine 
(20mg/kg) and saline challenge in cocaine-sensitised and saline-treated α4-D2-WT 
and α4-D2-KO mice. 
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5.3.14. Behavioural Sensitisation to Cocaine in α4-KO and α4-WT mice  
Locomotor activity during the initial habituation session (following IP saline 
injection) revealed no significant differences in baseline locomotor activity 
between α4-WT (n=16) and α4-KO (n=16) mice (Figure 5.21, non-significant 
effect of genotype F(1,28) = 0.51, p = 0.48, NS). 
Comparison of activity in session 1 revealed that acute-cocaine injection 
(10mg/kg) significantly increased locomotor activity (Figure 5.21, significant 
main effect of treatment-drug F(1,28) = 25.7, p<0.001), to a similar extent in α4-
KO (n=8) and α4-WT (n=8) mice (Figure 5.21, non-significant genotype by 
treatment-drug interaction F(1,28) = 0.58, p = 0.45, NS). 
Repeated, intermittent injections of cocaine, but not saline, induced an increase 
in locomotor activity over the course of 10 sessions (Figure 5.21, significant 
main effect of treatment-drug, F(1,28) = 79.95, p<0.001;  significant session by 
treatment-drug interaction, F(1,28) = 6.88, p < 0.01). Saline-treated α4-WT and 
α4-KO mice showed a similar locomotor activity over 10 sessions (Figure 5.21, 
non-significant session by genotype interaction F(9,25)  0.006, p = 0.94, NS). 
Cocaine-induced activity was similar in both genotypes (Figure 5.21, non-
significant session by genotype by treatment-drug interaction, F(9,124) = 0.12, p 
= 0.74, NS).  
To compare cocaine-sensitisation between genotypes we measured the 
difference in activity between session 1 and session 10. Comparison of this 
difference confirmed that both genotypes sensitised to cocaine by a similar 
magnitude (Figure 5.21, significant effect of treatment-drug, F(1,28) = 19.22, 
p<0.001, non-significant treatment-drug by genotype interaction, F(1,28) = 0.58, 
p = 0.45, NS). 
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Figure 5.21. Effect of repeated intermittent cocaine on locomotor activity in α4-
WT and α4-KO mice (per genotype; saline n=8, cocaine n=8). Locomotor 
activity was increased over the course of 10 sessions of cocaine administration 
(p<0.001) similarly in both genotypes. In session 1 acute cocaine injection 
increased locomotor activity similarly in both genotypes. Error bars represent 
SEM. 
 
5.3.15. Conditioned Activity in α4-KO vs α4-WT animals 
Following 10 days of repeated cocaine, but not saline, mice showed increases in 
activity following a saline injection in the cocaine-paired environment (Figure 
5.22, significant main effect of treatment-drug, F(1,28) = 9.63, p < 0.001). 
Conditioned activity was similar in α4-KO (n=8) and α4-WT (n=8) mice (Figure 
5.22, non-significant genotype by treatment-drug interaction F(1,28) = 0.005, p = 
0.942, NS). 
 
186 
 
 
 
Figure 5.22. Conditioned activity in cocaine-sensitised or saline-treated α4-WT 
and α4-KO mice (n=8 per group). Locomotor activity following saline 
administration was significantly increased in cocaine-sensitised mice, compared 
with saline-treated mice (p<0.001), and this was not different between 
genotypes. Error bars represent SEM. 
 
5.3.16. Response to 20mg/kg cocaine challenge in sensitised and non-
sensitised α4-KO vs α4-WT animals 
Compared with saline, cocaine challenge (20mg/kg) significantly increased 
locomotor activity in saline-treated mice (Figure 5.23, significant main effect of 
challenge-drug F(1,16) = 88.4, p<0.001), and this was not significantly different 
between in α4-KO (n=4) and α4-WT (n=4) mice (Figure 5.23, non-significant 
challenge-drug by genotype interaction, F(1,16) = 0.31, p=0.59, NS; non-
significant main effect of genotype, F(1,16) = 0.11, p = 0.75, NS).  
Compared with saline, cocaine challenge (20mg/kg) significantly increased 
locomotor activity in cocaine-sensitised mice (Figure 5.23, significant main effect 
of challenge-drug F(1,16) = 98.78, p<0.001), and this was not significantly 
different between in α4-KO (n=4) and α4-WT (n=4) mice (Figure 5.23, non-
significant challenge-drug by genotype interaction, F(1,16) = 0.063, p = 0.81, NS; 
non-significant main effect of genotype, F(1,16) = 0.13, p = 0.72, NS).  
Cocaine-induced locomotor activity was significantly greater in cocaine-
sensitised than non-sensitised mice (Figure 5.23, significant main effect of 
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treatment-drug F(1,16) = 19.66, p < 0.001, NS) and this was not significantly 
different between in α4-KO (n=4) and α4-WT (n=4) mice (Figure 5.23, non-
significant treatment-drug by genotype interaction F(1,16) = 0.27, p = 0.61, NS; 
non-significant main effect of genotype, F(1,16) = 0.001, p = 0.99, NS). 
 
 
Figure 5.23. Effect of challenge dose of 20mg/kg cocaine on saline-treated and 
cocaine-sensitised α4-WT and α4-KO mice (n=8 per group). Cocaine significantly 
increased locomotor activity (p<0.001) to a greater extent in cocaine-sensitised 
mice than saline-treated mice (p<0.01) similarly in both genotypes. Error bars 
represent SEM. 
 
5.3.17. In Situ Hybridisation to examine cFos in D1/D2 neurons of 
saline-treated vs cocaine-sensitised α4-WT and α4-KO mice  
To analyse the effects of acute cocaine in sensitised and non-sensitised animals 
we compared cFos expression in D1 and D2 neurons in the NAc Core and Shell 
following an acute challenge of either saline or cocaine (20mg/kg) in cocaine-
sensitised vs saline-treated animals. 
Compared with saline, cocaine challenge (20mg/kg) significantly increased cFos 
expression in the NAc Core of saline-treated mice (Figure 5.24, significant main 
effect of challenge-drug F(1,16) = 200.01, p<0.001) to a greater extent in α4-KO 
(n=4) than α4-WT (n=4) mice (Figure 5.24, significant challenge-drug by 
genotype interaction, F(1,16) = 5.72, p < 0.05). There was no significant 
difference in cocaine induced cFos between D1 and D2 neurons in the NAc core 
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(Figure 5.24, non-significant neuron-type by challenge drug interaction, F(1,16) = 
0.68, p = 0.68, NS) and this was not significantly different between α4-KO and 
α4-WT mice (Figure 5.24, non-significant neuron-type by genotype by challenge 
drug interaction, F(1,10) = 0.015, p = 0.9, NS). 
Compared with saline, cocaine challenge (20mg/kg) significantly increased cFos 
expression in the NAc Core of cocaine-sensitised mice (Figure 5.24, significant 
main effect of challenge-drug F(1,16) = 63.05, p<0.001). Cocaine-induced cFos 
was greater in D1 than D2 neurons in the cocaine-sensitised NAc Core (Figure 
5.24, significant neuron-type by challenge-drug interaction, F(1,10) = 14.64, 
p<0.01), and this was increased in α4-KO (n=4) compared with α4-WT (n=4) 
mice (Figure 5.24, significant neuron-type by challenge-drug by genotype 
interaction, F(1,16) = 18.73, p < 0.001).  
Cocaine-induced cFos in the NAc core was significantly greater in cocaine-
sensitised than saline-treated mice (Figure 5.24, significant main effect of 
treatment-drug F(1,16) = 5.39, p < 0.05) and this was not significantly different 
between α4-KO (n=4) and α4-WT (n=4) mice (Figure 5.24, non-significant 
treatment-drug by genotype interaction F(1,16) = 0.031, p = 0.86, NS). Cocaine-
induced cFos was increased to a greater extent in D1 neurons of cocaine-
sensitised than saline-treated mice (Figure 5.24, significant neuron-type by 
treatment-drug interaction, F(1,16) = 21.85, p<0.001) and this effect was greater 
in α4-KO mice (Figure 5.24, significant neuron-type by treatment-drug by 
genotype interaction, F(1,16) = 12.87, p<0.01). 
Compared with saline, cocaine challenge (20mg/kg) significantly increased cFos 
expression in the NAc shell of saline-treated mice (Figure 5.24, significant main 
effect of challenge-drug F(1,16) = 74.05, p<0.001) and this was not significantly 
different between α4-KO (n=4) and α4-WT (n=4) mice (Figure 5.24, non-
significant challenge-drug by genotype interaction, F(1,16) = 2.83, p = 0.12, NS). 
There was no significant difference in cocaine induced cFos between D1 and D2 
neurons in the NAc shell of saline-treated mice (Figure 5.24, non-significant 
neuron-type by challenge drug interaction, F(1,16) = 0.82, p = 0.38, NS) and this 
was not significantly different between α4-KO and α4-WT mice (Figure 5.24, 
non-significant neuron-type by genotype by challenge drug interaction, F(1,10) = 
1.21, p = 0.3, NS). 
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Compared with saline, cocaine challenge (20mg/kg) significantly increased cFos 
expression in the NAc shell of cocaine-sensitised mice (Figure 5.24, significant 
main effect of challenge-drug F(1,16) = 220.04, p<0.001) to a greater extent in 
α4-KO than α4-WT mice (Figure 5.24, significant challenge-drug by genotype 
interaction, F(1,10) = 7.43, p<0.05). Cocaine-induced cFos was greater in D1 than 
D2 neurons in the cocaine-sensitised NAc shell (Figure 5.24, significant neuron-
type by challenge-drug interaction, F(1,10) = 29.65, p<0.001), and this was not 
significantly different between α4-KO (n=4) and α4-WT (n=4) mice (Figure 5.24, 
non-significant neuron-type by challenge-drug by genotype interaction, F(1,16) = 
0.001, p = 0.99).  
Cocaine-induced cFos in the NAc shell was significantly greater in cocaine-
sensitised than saline-treated mice (Figure 5.24, significant main effect of 
treatment-drug F(1,16) = 73.38, p < 0.001) to a greater extent in α4-KO (n=4) 
than α4-WT (n=4) mice (Figure 5.24, significant treatment-drug by genotype 
interaction F(1,16) = 9.89, p < 0.01, NS). Cocaine-induced cFos was increased to 
a greater extent in D1 neurons of cocaine-sensitised than saline-treated mice 
(Figure 5.24, significant neuron-type by treatment-drug interaction, F(1,16) = 
13.7, p<0.001), and this was not significantly different between α4-KO and α4-
WT mice (Figure 5.24, non-significant neuron-type by treatment-drug by 
genotype interaction, F(1,16) = 2.09, p = 0.12, NS). 
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Figure 5.24. Effect of IP saline or cocaine (20mg/kg) injection on cFos 
expression the NAc Core and Shell of cocaine-sensitised or saline-treated α4-D1-
WT and α4-D1-KO mice (n=8 per group). In saline-treated mice acute cocaine 
challenge increased cFos expression in D1 and D2 neurons in the NAc Core 
(p<0.001) and this was increased in α4-KO mice (p<0.05*). In saline-treated 
mice acute cocaine challenge increased cFos expression in D1 and D2 neurons in 
the NAc Shell (p<0.001) and this was not different between genotypes. In 
cocaine-sensitised mice acute cocaine challenge increased cFos expression, 
preferentially in D1 neurons, in the NAc Core (p<0.01) and this was increased in 
α4-KO mice (p<0.001*). In cocaine-sensitised mice acute cocaine challenge 
increased cFos expression in the NAc Shell, preferentially in D1 neurons 
(p<0.001) and cFos expression was increased in α4-KO mice (p<0.001). Cocaine 
challenge induced greater cFos expression in the NAc Core of cocaine-sensitised 
than saline-treated mice, preferentially in D1 neurons (p<0.001) and this was 
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increased in α4-KO mice (p<0.01). Cocaine challenge induced greater cFos 
expression in the NAc shell of cocaine-sensitised than saline-treated mice, to a 
greater extent in α4-KO mice (p < 0.01*) and preferentially in D1 neurons 
(p<0.001) which was not different between genotypes. Error bars represent 
SEM. 
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Figure 5.25. Representative images NAc Core and Shell following cocaine 
(20mg/kg) and saline challenge in cocaine-sensitised and saline-treated α4-WT 
and α4-KO mice. Green =D1, Red = D2, Blue = cFos. 
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5.4. Discussion 
To investigate whether acute or chronic cocaine had different effects on NAc 
neuronal populations depending on α4-GABAAR expression we examined cFos 
expression following acute cocaine administration in naïve or cocaine-sensitised 
α4-KO and α4-WT mice. We replicated previous findings that mice with a 
constitutive deletion of GABAAR α4-subunit do not show a significant difference 
from their wildtype counterparts in their locomotor response to acute cocaine at 
various doses. Furthermore, we confirmed that repeated intermittent cocaine 
was able to dose-dependently increase locomotor activity equally in both 
wildtype and GABAAR α4-subunit knockout mice (Macpherson, 2013). 
However, despite a lack of behavioural deficits in α4 KO mice we identified 
several differences in cocaine-related cFos expression compared to wild type 
mice. Acute cocaine administration induced greater cFos expression in the NAc 
core of naïve α4-KO mice than α4-WT controls whilst cocaine induced cFos in the 
NAc shell was similar in both genotypes. These differences are only present 
following cocaine administration indicating that α4-GABAARs are modulating 
neuron ensembles responsive to both acute cocaine administration. 
Subsequently, we found that this pattern was altered by chronic cocaine 
treatment, whereby cocaine-induced cFos was elevated in both the NAc Core and 
Shell of cocaine-sensitised α4-KO mice compared with α4-WT controls. This 
suggests that α4 is expressed in neural ensembles within the NAc Shell that 
increase their cFos expression as animals become sensitised to cocaine. When 
compared with results from acute administration this represents a transition of 
cocaine dependant activity from the NAc Core to NAc Shell in α4-GABAAR 
expressing neurons that is due to sensitisation. Cocaine challenge also increased 
cFos expression in the Dorsal striatm; however, the difference between 
genotypes was ony present in the NAc. This may be due to relative greater 
expression of α4-GABAARs in the NAc (Pirker et al., 2000; Schwarzer et al., 
2001; Wisden et al., 1991). 
By combining acute and chronic cocaine manipulations into a single experiment 
and using a multi-probe fluorescent-in-situ-hybridisation we were further able to 
identify the neuronal subpopulations involved in this effect. The increased cFos 
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induced by cocaine, in the NAc Core of naïve α4-KO mice and both NAc Core and 
Shell of cocaine-sensitised α4-KO mice compared with their α4-WT controls, is 
localised predominantly in D1 expressing neurons (Fig). Cocaine is known to 
preferentially induced cFos expression in D1 neurons where it facilitates 
expression of behavioural sensitisation (Zhang et al., 2006). According, relief of 
tonic inhibition on D1 neurons appears to facilitate this cFos expression. We may 
therefore have expected an accompanying increase in behavioural sensitisation 
which is not present in α4-KO mice. Our results indicate that there must be a 
mechanism outside of D1 expressing neurons that is preventing this.  
Previously we have suggested that lack of effects on behavioural sensitisation in 
α4-KO mice may be due to neural compensatory mechanism such as the 
upregulation of a2 subunits (Macpherson, 2013). However, electrophysiological 
evidence indicates that deletion of GABAARs α4-subunits has no impact on the 
kinetics of the phase currents mediated by synaptic receptors within the NAc 
(Maguire et al., 2014). Furthermore, our cFos data demonstrate that α4 
positively affects cocaine induced activity and signalling in D1 neurons.  
We therefore suggest that disinhibition of D2 expressing neurons, either on 
cholinergic interneurons or MSNs, opposes the behavioural effects of disinhibited 
D1 MSNs and that if both populations are disinhibited concurrently then any 
resulting effects may be opposing and cancel each other out. This would be the 
reverse of the effect observed when deletion of NMDARs in D2 MSNs normalized 
sensitization in mice already lacking NMDARs in D1 receptors (Beutler et al., 
2011).  
This hypothesis is supported by our finding that specific deletion of α4-GABAARs 
in D1 expressing neurons alone had identical effects on patterns of overall cFos 
expression under the same experimental conditions. Furthermore, this was 
accompanied by an accelerated acquisition of behavioural sensitisation in α4-D1-
KO mice compared with α4-D1-WT controls. A further experiment using the 
multi-probe fluorescent-in-situ-hybridisation method in α4-D1-KO animals 
following the same behavioural tests is required to verify that increased cFos in 
D1 neurons underlies these effects in both genotypes. Conversely, following 
inactivation of D2-MSNs in the NAc using conditionally expressed Tetanus toxin 
mice exhibit a delayed acquisition of cocaine-sensitisation (Hikida et al., 2010). 
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This suggests that either disinhibition of D1 MSNs or inhibition of opposing D2 
MSNs results in a preference of behaviours associated with direct pathway 
activation i.e. cocaine potentiated activity. 
Conditional deletion of α4-GABAARs in D1 neurons does not affect baseline 
locomotor behaviour or cFos expression in the NAc Core or Shell. This may be 
because although α4 is slightly expressed throughout the striatum it is most 
highly expressed in the NAc which is known to modulate drug potentiated, rather 
than more general locomotor behaviour (Costall et al., 1977; Campbell et al., 
1997). This is also reflected in similar baseline levels of cFos in α4-KO and α4-
D1-KO and their wildtype controls, suggesting that α4-GABAARs oppose neural 
activity induced by cocaine without affecting baseline activity. Accordingly, intra-
NAc THIP attenuated cocaine potentiation of behaviours (locomotor activity, CPP 
and CRf) but not baseline behaviour (Macpherson, 2013). 
Previous studies of cocaine-induced adaptation of neuronal spine-density have 
observed a transition of neuroplasticity from NAc Core to Shell (Marie et al., 
2012). The investigators blocked increases in spine density on neurons in the 
NAc Core by using a protein synthesis inhibitor directly following cocaine 
injection, which was sufficient to abolish cocaine CPP. Administering the inhibitor 
in the NAc Shell immediately after cocaine injection had no effect but at 4h after 
cocaine injection it reduced spine density. Importantly, cocaine-induced spine 
density in the NAc Shell was blocked by inhibition of the NAc Core indicating that 
plasticity in the NAc core is essential to induce plasticity in the shell, necessary 
for cocaine reward. We may therefore suggest that increased cFos plasticity in 
the NAc core of α4-KO and α4-D1-KO mice is subsequently transferred to the 
NAc Shell during sensitisation. 
Compared with wildtype controls α4-D1-KO mice exhibited increased conditioned 
activity following a saline injection in the previously cocaine paired environment. 
Unlike locomotor activity and sensitisation, this was not reflected in cFos 
expression which was similar in cocaine-sensitised α4-D1-KO mice and wildtype 
controls following a saline challenge. It has been demonstrated that cocaine 
induced cFos is increased following sensitisation only when cocaine was 
administered in the conditioned environment (Mattson et al., 2007). Accordingly, 
selective inactivation of these neurons with the ‘Duan02 inactivation method’ 
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attenuated cocaine-induced locomotor sensitisation in animals receiving cocaine 
in the drug-paired but not non-paired environment (Koya et al., 2009). It is 
therefore possible that the increased cFos in D1 neurons we observe in the NAc 
Shell of α4-D1-KO mice reflects this environmental association and underlies 
both conditioned locomotor activity and accelerated acquisition of cocaine 
sensitisation. Cocaine CPP experiments have implicated the NAc Shell in 
mediating learned associations between the effects of the drug and the 
environment while the core might be involved in pharmacological effects of 
cocaine (Liao et al., 2000; Sellings, McQuade and Clarke, 2006). This increase in 
cFos is also present in the NAc Shell of α4-KO mice, although they do not show 
enhanced conditioned locomotor activity. Therefore, we may also suggest that 
D2 expressing neurons oppose conditioned activity which may underlie their 
opposition to increases in behavioural sensitisation when D1-MSNs are 
disinhibited.  
In contrast to constitutive and D1 specific α4 knockouts, D2-α4-KO mice appear 
similar to wildtype controls in both in behaviour and cFos expression. This also 
suggests that differences in constitutive α4-KO’s are be mediated entirely by 
increased activation of D1 neurons. This may be expected as previous 
experiments have demonstrated that cocaine induces cFos in striatal neurons via 
action at D1 but not D2 receptors, and in fact D2 antagonists increase cFos 
expression (Robertson et al., 1991). Thus, it is possible that changes in activity 
occur in D2 neurons which are not reflected in cFos activation. As D2 MSNs 
appear to oppose behavioural sensitisation (Ferguson et al., 2011) we may have 
expected disinhibition of D2-MSNs by deletion of α4-GABAARs to attenuate 
sensitisation to cocaine. Optogenetic stimulation of D2 MSNs had no effect of 
sensitisation (Lobo et al., 2010) indicating that D2 neuron modulation of 
sensitisation is one-directional and does not directly oppose sensitisation. These 
data support a model in which D2 neuron activity counterbalances D1 
hyperactivity but does not affect sensitisation directly.  
In conclusion our data demonstrate that α4-GABAARs mediate tonic inhibition of 
D1-MSNs in the NAc which are responsive to cocaine. Removal of this tonic 
inhibition accelerates acquisition of behavioural sensitisation to cocaine and 
increased conditioned activity, but only if D2 expressing neurons are not-
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concurrently disinhibited. We also observe a transfer of potentiated neuronal 
activity in disinhibited D1 neurons from the NAc Core to NAc Shell following 
cocaine sensitisation. This may underlie strengthening of environment-drug 
associations mediated by the NAc Shell. 
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Chapter 6 
General Discussion   
 
6.1. Introduction 
The data presented within this thesis have investigated roles for α4-GABAARs in 
mediating binge-like alcohol consumption and behaviours associated with 
addiction to psychostimulants. We have found that α4βδ-GABAARs in the NAc are 
necessary for high levels of alcohol consumption observed in DID experiments. 
In addition, α4-GABAARs on D1 expressing neurons modulate the potentiation of 
several behaviours by cocaine and cocaine-associated environments. Here we 
will discuss the physiological mechanisms underlying these findings, and their 
wider implications. 
6.2. Summary of Results 
6.2.1. Characterising transgenic-mice and viral-vectors used to 
manipulate GABAA α4 receptor subunits 
Genotyping and qRT-PCR analysis of NAc and Dorsal Striatum tissue samples 
confirmed the absence of GABAAR α4-subunit DNA and mRNA expression in α4-
KO mice, and a reduction of approximately 50% in α4-Het mice when compared 
to α4-WT controls. These data confirm previous findings that the cre/loxp 
cleavage of the intended sequence produced a functional effect, blocking the 
ability of the Gabrα4 gene to produce intact α4-subunit mRNA in α4-KO mice 
(Chandra et al., 2006). 
To visualise the expression pattern of GABAAR α4 subunits, to enable 
investigation of colocalistation with other neural markers in subsequent analysis, 
we used a recently developed fluorescent in-situ-hybridisation method 
(RNAscope). This method has been useful in other studies of low expressing 
genes as it amplifies mRNA signal for clear visualisation. Unexpectedly, we 
appeared to detect signal from the probe targeting the Gabrα4 gene in α4-KO 
animals where it should be absent. We therefore suggest that α4 signal observed 
in α4-KO mice results from either non-specific binding of the probe or that that 
following deletion of exon-3 in α4-KO mice there remains a truncated mRNA 
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transcript which does not lead to expression of functional α4 protein but is able 
to bind the RNAscope probe. The RNAscope probe targets a 1316 base-pair 
region surrounding the deleted exon-3 but encompassing upstream and 
downstream which are not deleting in the α4-KO mouse. If a truncated mRNA is 
present it could therefore have a large amount of sequence homology with the 
α4 probe. Despite this problematic ‘background’ signal we observed higher levels 
of α4 mRNA specific signal in α4-WT mice and are therefore able to distinguish 
α4-WT and α4-KO neurons using this method. 
To confirm the D1- and D2-specific knockout of α4 in our conditional knockout 
α4-D1-KO and α4-D2-KO mice we performed an in-situ-hybridisation using 
probes targeting Cre-recombinase, Gabrα4, and either Drd or Drd2. No Cre was 
detected in ‘Floxed’-α4 mice which serve as controls for the conditional α4 
knockout mice. In α4-D1-KO mice Cre was colocalized with D1 but not D2 
whereas in α4-D2-KO mice Cre colocalized with D2 and was negatively 
correlated with D1. We have therefore confirmed that Cre is correctly expressed 
in the expected neural populations according to the original driver lines. Overall, 
Cre expression was higher in the NAc of α4-D2-KO mice than α4-D1-KO mice. 
This is also expected as Cre expression was higher in the D2- than D1- BAC-Cre 
founder line used to breed our conditional knockouts (Gong et al., 2007). In 
‘Floxed-α4’, α4-D1-KO and α4-D2-KO mice α4 was colocalized with both D1 and 
D2.  
Our analysis revealed that in ‘Floxed’-α4 mice this correlation was equal in D1 
and D2 neurons. In contrast, we found that in α4-D1-KO mice α4 was more 
strongly correlated with D2 and less with D1, whereas in α4-D2-KO mice the 
reverse was true; α4 was more strongly correlated with D1 and less with D2. We 
therefore conclude that the presence α4 probe signal in both populations is due 
to the background signal (discussed above) and populations of D1 and D2 
neurons not expressing Cre in α4-D1-KO and α4-D2-KO mice respectively. Thus, 
converging data evidences a reduction of the α4 mRNA specific signal in D1 or 
D2 neurons of α4-D1-KO and α4-D2-KO mice respectively.  
In addition, we used an AAV viral vector to deliver Cre to the NAc of ‘Floxed’-α4 
mice and demonstrated its ability to reduce α4 subunit mRNA. Expression of the 
AAV-Cre virus in the NAc was confirmed by immunohistochemistry for the 
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mCherry marker. We were able to visualise mCherry expression within the 
targeted region of the NAc core to confirm localisation of the virus. Further qRT-
PCR analysis demonstrated substantial knockdown (~60%) of GABAAR α4 
subunit mRNA in the NAc but not in a nearby control region (Dorsal Striatum) 
when compared with the control AAV-GFP virus or untreated mice. Importantly, 
we also demonstrated similar levels of α4 expression in ‘Floxed’-α4 animals 
compared with α4-WT mice which verifies them as equally ecologically 
representative controls in experiments using manipulations of α4.  
The presented data, in addition to previous studies, demonstrate that the 
GABAAR α4 subunit is functionally deleted in α4-KO mice. Further, in D1- and 
D2- specific conditional knockout mice Cre/loxp deletion has reduced α4 
expression in D1 or D2 expressing neural populations respectively. We have also 
produced an AAV-Cre virus which can be used to locally knockdown α4 
expression when surgically injected into a region of interest, the NAc.   
6.2.2. The role of α4-GABAARs in mediating binge-like alcohol drinking 
(Drinking in the Dark) 
We have demonstrated a role of α4-GABAARs in mediating binge-like alcohol 
consumption in mice during ‘Drinking in the Dark’ experiments. Our data indicate 
that α4-GABAARs are necessary for the high level of alcohol consumption seen in 
C57-BL/6J mice as constitutive deletion of α4 was sufficient to reduce alcohol 
consumption in DID. We have further anatomically refined this result be 
demonstrating that reducing α4 expression specifically within the NAc is 
sufficient to reduce binge-like alcohol drinking. Our results agree with multiple 
studies in which RNAi mediated downregulation of α4 in the NAc reduced ethanol 
consumption by rats during intermittent access in tests of ‘Two-bottle choice’ or 
operant self-administration (Rewal et al., 2009, 2012). At present our results do 
not suggest α4-GABAAR modulation of binge-like alcohol consumption is D1 or 
D2 dependent and indicate that a combined reduction of α4-GABAARs on D1 and 
D2 neurons is required to reduce drinking (Table 6.1). 
Despite this we were unable to demonstrate robust pharmacological 
manipulations of drinking via selective α4-GABAAR super-agonists. Systemic 
THIP injections did not reduce ethanol consumption, except at doses which also 
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reduced water consumption due to sedation. Similarly, we were unable to reduce 
ethanol drinking by delivering THIP directly to the NAc. This avoids the sedative 
effect of THIP as intra-NAc THIP at the same dose did not affect baseline 
locomotor activity (Macpherson, 2013).  The highly selective α4-GABAAR 
receptor agonist DS2 also failed to have a significant effect on drinking when 
delivered to the NAc.  
Our experiments identify α4-GABAARs as a potential therapeutic target for 
treatments of alcoholism. We propose that if partial antagonists with high 
specificity for α4-GABAAR receptors are developed they should be tested in 
further pre-clinical studies of ethanol consumption such as Drinking in the Dark.  
6.2.3. The role of α4-GABAARs in locomotor behaviour and its 
potentiation by cocaine 
The locomotor experiments in this thesis discovered that conditionally deleting 
α4-GABAARs, thereby relieving tonic inhibition, on D1 MSNs facilitates cocaine-
potentiation of locomotor activity at various doses (significantly at 10, 20 and 30 
mg/kg). This agrees with multiple studies in which genetic or pharmacological 
methods to activate D1 MSNs increased cocaine-induced locomotion (Schindler 
and Carmona, 2002; Bachtell et al., 2005b; A. V Kravitz et al., 2010). We did 
not observe any differences in baseline locomotor activity following this 
manipulation, suggesting that α4-GABAARs on D1 MSNs specifically modulate the 
locomotor activating effects of psychostimulants but not normal initiation of 
locomotor activity (Table 6.1).  
Further, we identified a dissociation between the effects of α4βδ receptors on D1 
and D2 MSNs on cocaine-induced locomotor activity since deletion of α4 in D2 
MSNs had no such effect. Based on previous studies using injections of D2 
agonists in the NAc we may also have expected an increase in cocaine 
potentiated locomotor activity (Bachtell et al., 2005b) however those effects 
were smaller than those produced by D1 agonists therefore deletion of α4-
GABAARs may not have a sufficiently strong effect on D2 MSNs to replicate such 
findings. 
Previously, deletion of either GABAAR α4-subunits or δ-subunits, often paired in 
extrasynaptic α4βδ GABAARs, had no influence on baseline locomotion (Herd et 
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al., 2009; Macpherson, 2013) and constitutive GABAAR α4-subunit knockout 
mice showed no difference from wildtype mice in locomotor activity following 
various doses of cocaine. There is however evidence that when 
pharmacologically activated α4βδ receptors oppose the locomotor stimulating 
effects of cocaine as intra-NAc injections of the agonist THIP attenuated cocaine-
induced locomotor activity and this effect was abolished in α4-KO (Macpherson, 
2013). This may be due to the relatively high expression of α4 in the NAc, 
relative to the rest of the striatum, which is known to mediate the locomotor 
activating properties of cocaine (Costall et al., 1977; Robinson and Berridge, 
1993; Campbell et al., 1997; Schwarzer et al., 2001).  
These data suggest that α4-GABAARs in the NAc do not modulate baseline 
locomotion, but their activation is able to attenuate cocaine-potentiated 
locomotor activity. Our results indicate that this is most likely mediated by 
activation of α4-GABAARs on D1 MSNs. This could be fully confirmed by intra-
NAc administration of THIP to D1/D2 α4 conditional knockout mice in larger 
cocaine-dose-response study of locomotor activity. We hypothesise that intra-
NAc THIP would not attenuate cocaine-induced locomotor activity in α4-D1-KO 
mice, but would in WT or α4-D2-KO mice. 
6.2.4. The role of α4-GABAARs in instrumental responding and its 
potentiation by cocaine 
We have also demonstrated that conditionally deleting α4-GABAA receptors on 
D1 MSNs facilitates cocaine-potentiation of instrumental responding for natural 
rewards under a PR schedule (Table 6.1). Again, we did not observe any 
differences in baseline instrumental responding following this manipulation. 
Whilst α4-D1-KO show greater enhancement of PR breakpoints following 
10mg/kg cocaine they are more severely impaired following 30mg/kg indicating 
that they are more prone to stereotypy at high doses due to hypersensitivity to 
the stimulant effects of cocaine. In contrast, deletion of α4 in D2 MSNs had no 
such effect on cocaine-potentiation of instrumental responding while it similarly 
had no effect on baseline responding. This contrasts with previous studies where 
activation of D1 or D2 MSNs systemically or in the NAc facilitated responding 
under PR schedules reinforced by food or sucrose (Aberman, Ward and 
Salamone, 1998; Barbano, Le Saux and Cador, 2009). This implies that α4-
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GABAARs on MSNs are a oppose effects of psychostimulants but do not alter 
behaviour under normal conditions.  
This dissociated pattern of effects in D1 and D2 specific α4 knockout mice is 
strikingly similar to those we observed in tests of locomotor activity (outlined 
above, Table 6.1). These results suggest that α4-D1-KO  mice exhibit ‘general 
increase in approach-investigation’ behaviour which is the common underlying 
mechanism of cocaine-potentiated behaviour in both tests (Ikemoto and 
Panksepp, 1999). We conclude that increased cocaine potentiation of PR 
responding in α4-D1-KO mice is likely due to the enhanced locomotor stimulant 
effects of cocaine. 
We have also identified a behavioural dissociation in the pattern of effects 
displayed by D1 specific and D2 specific or constitutive α4 knockout mice in tests 
of locomotor activity/instrumental responding experiments when compared with 
tests of Conditioned reinforcement (CRf). α4-D1-KO mice show facilitation of 
locomotor activity and instrumental responding which was absent in constitutive 
α4-KO or α4-D2-KO mice. Conversely, α4-KO or α4-D2-KO mice show 
enhancement baseline and cocaine potentiated CRf which is absent in α4-D1-KO 
mice (Macpherson, 2013). This supports the hypothesis that removal of tonic 
inhibition of D2 MSNs enhances efficacy of secondary reinforcers and further 
enhances cocaine’s potentiation of CRf independently of its locomotor activating 
properties or of effects on primary reward value.  
6.2.5. The role of α4-GABAARs on D1 and D2 expressing neurons in 
behavioural sensitisation to cocaine 
To investigate whether acute or chronic cocaine had different effects on NAc 
neuronal populations depending on α4-GABAAR expression we examined cFos 
expression following acute cocaine administration in naïve or cocaine-sensitised 
α4-KO and α4-WT mice. To investigate the role of α4-GABAARs on either D1 or 
D2 expressing neurons we used D1/D2 specific α4 knockout mice in a standard 
behavioural sensitisation experiment and performed similar analysis of cFos 
expression. 
We replicated previous findings that mice with a constitutive deletion of GABAAR 
α4-subunit do not show a significant difference from their wildtype counterparts 
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in their locomotor response to acute cocaine at various doses. Furthermore, we 
confirmed that repeated intermittent cocaine was able to dose-dependently 
increase locomotor activity equally in both wildtype and GABAAR α4-subunit 
knockout mice (Macpherson, 2013). However, despite a lack of behavioural 
deficits in α4 KO mice we identified several differences in cocaine-related cFos 
expression compared to wild type mice. Acute cocaine administration induced 
greater cFos expression in the NAc core of naïve α4-KO mice than α4-WT 
controls whilst cocaine induced cFos in the NAc shell was similar in both 
genotypes. Subsequently, we found that this pattern was altered by chronic 
cocaine treatment, whereby cocaine-induced cFos was elevated in both the NAc 
Core and Shell of cocaine sensitised α4-KO mice compared with α4-WT controls 
(Table 6.1).  
This suggests that α4 is expressed in neural ensembles within the NAc Shell that 
increase their cFos expression as animals become sensitised to cocaine. When 
compared with results from acute administration this represents a transition of 
cocaine dependent activity from the NAc Core to NAc Shell in α4-GABAAR 
expressing neurons that is due to sensitisation. Further analysis of cFos 
expression in cocaine sensitised vs non-sensitised α4-WT and α4-KO mice 
revealed that these effects were predominantly mediated by expression of cFos 
in D1 MSNs in the NAc. 
Conditional deletion of α4-GABAARs in D1 neurons did not affect baseline 
locomotor behaviour or cFos expression in the NAc Core or Shell. This may be 
because although α4 is slightly expressed throughout the striatum it is most 
highly expressed in the NAc which is known to modulate drug potentiated, rather 
than more general, locomotor behaviour (Costall et al., 1977; Campbell et al., 
1997). Deletion of α4-GABAARs in D1 neurons resulted in an increased acute 
response to cocaine and more rapid behavioural sensitisation to cocaine. The α4-
D1-KO mice showed increased locomotor activity in early sessions although they 
sensitised to a similar endpoint as α4-D1-WT controls. Furthermore, specific 
deletion of α4-GABAARs in D1 expressing neurons alone had identical effects on 
patterns of overall cFos expression under the same experimental conditions 
(Table 6.1). 
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In contrast, deletion of α4-GABAARs in D2 expressing neurons had no effect on 
behavioural sensitisation. This may be expected as previous experiments have 
demonstrated that cocaine induces cFos in striatal neurons via action at D1 but 
not D2 receptors, and in fact D2 antagonists increase cFos expression 
(Robertson et al., 1991). These data support a model in which D2 neuron 
activity counterbalances D1 hyperactivity but does not affect sensitisation 
directly.  
Compared with wildtype controls α4-D1-KO mice also exhibited increased 
conditioned activity following a saline injection in the previously cocaine-paired 
environment. These results indicate that the increased cFos in D1 neurons we 
observe in the NAc Shell of α4-D1-KO mice reflects this environmental 
association and underlies both conditioned locomotor activity and accelerated 
acquisition of cocaine sensitisation. As this is not behaviourally reflected in the 
constitutive α4 knockout we suggest that the concurrent disinhibition of D2 
expressing neurons opposes conditioned activity. 
These data demonstrate that α4-GABAARs mediate tonic inhibition of D1-MSNs in 
the NAc which are responsive to cocaine. Removal of this tonic inhibition 
accelerates acquisition of behavioural sensitisation to cocaine and increased 
conditioned activity, but only if D2 expressing neurons are not-concurrently 
disinhibited. We also observe a transfer of potentiated neuronal activity in 
disinhibited D1 neurons from the NAc Core to NAc Shell following cocaine 
sensitisation. This may underlie strengthening of environment-drug associations 
mediated by the NAc Shell. 
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Behaviour α4-KO α4-D1-KO α4-D2-KO 
Drinking in the Dark Reduced Normal Normal 
Baseline Locomotor Activity 
cFos in NAc Core 
cFos in NAc Shell 
cFos in Dorsal Striatum 
Normal 
Normal 
Normal 
Normal 
Normal 
Normal 
Normal 
Normal 
Normal 
Normal 
Normal 
Normal 
Cocaine-induced locomotor activity 
cFos in NAc Core 
cFos in NAc Shell 
cFos in Dorsal Striatum 
Normal 
Enhanced 
Normal 
Normal 
Enhanced 
Enhanced 
Normal 
Normal 
Normal 
Normal 
Normal 
Normal 
Behavioural sensitisation to cocaine 
cFos in NAc Core 
cFos in NAc Shell 
cFos in Dorsal Striatum 
+THIP 
Normal 
Enhanced 
Enhanced 
Normal 
Not Blocked 
Accelerated 
Enhanced 
Enhanced 
Normal 
? 
Normal 
Normal 
Normal 
Normal 
? 
Fixed Ratio responding Normal Normal Normal 
Progressive Ratio responding Normal Normal Normal 
Cocaine potentiation of Progressive 
Ratio responding 
Enhanced Normal Normal 
Cocaine-CPP 
(MacPherson, 2013) 
Normal Enhanced Normal 
Cocaine-enhanced Cocaine-CPP  
+ THIP 
(MacPherson, 2013) 
Normal 
Not Blocked 
Normal 
Not Blocked 
Absent 
- 
CRf 
(MacPherson, 2013) 
Enhanced Normal Enhanced 
Cocaine potentiated CRf 
+ THIP 
(MacPherson, 2013) 
Normal 
Not Blocked 
Normal 
Blocked 
Normal 
Not Blocked 
Table 6.1. Summary of the consequences of constitutive or dopamine D1-/D2-
expressing neuron specific GABAAR α4-subunit knockout mice, and 
pharmacological activation of α4βδ-GABAARs by THIP. 
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6.3. By what mechanism do α4-GABAARs modulate alcohol consumption? 
Given the role of α4-GABAARs we have identified in CRf for natural rewards and 
cocaine-conditioned behaviours we may have speculated that their role in 
alcohol consumption involves similar reward processing mechanisms. However, 
effects on CRf, CPP, operant responding, locomotor behaviour and sensitisation 
were all mediated by α4-GABAARs separately on D1 or D2 neuronal populations 
(Macpherson, 2013). In contrast knockout of α4 in both cell types, either 
globally or in the NAc, was required to reduce drinking.  
Using DID experiments we are unable to examine the motivational/appetitive 
aspects of α4-GABAARs role in binge-like drinking. We therefore consider two 
opposing hypotheses; increased tonic inhibition mediated by α4-GABAARs either 
reduces the “reward” value of ethanol or it enhances satiation such that mice are 
sated after drinking less alcohol. As reviewed earlier downregulation of α4 or δ 
reduced operant ethanol self-administration (Rewal et al., 2012) however there 
was no difference between genotypes in the first 5 minutes of drinking sessions, 
following several reinforcers, which indicates that this is a difference in 
consummatory rather than appetitive behaviour. Conversely, mice carrying a 
mutation of the β1 subunit which potentiates GABAA receptor activity maintained 
high rates of responding throughout sessions whilst wild-types slowed their rate 
of as the session progressed consistent with them satiating on alcohol (Anstee et 
al., 2013).  
Alcohol is likely to activate GABAARs via upregulation of neurosteroids (Lambert 
et al., 2003; Finn et al., 2004). At a moderate dose of 50ng the neurosteroid 
allopregnanolone delivered intracranially (to the lateral ventricle thereby 
targeting the whole brain) increased alcohol drinking but not appetitive 
behaviour in mice (Ford et al., 2007). Notably, the investigators used 
lickometers to observe that allopregnanolone increased drinking bouts in the first 
10 minutes, following which drinking was similar to untreated levels. This is in 
accordance with our hypothesis that activation of α4-GABAARs by neurosteroids 
opposes satiation and affects consummatory behaviour rather than the 
reinforcing effects of alcohol. Together these results suggest that tonic inhibition 
by extrasynaptic GABAAR receptors opposes ethanol satiation while disinhibition 
promotes satiation. Under this model the upregulation of α4 following chronic 
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ethanol administration (Liang et al., 2007) is likely a maladaptive change 
contributing to maintained ethanol consumption. This may however be opposed 
by reduced synaptic GABA transmission in MSNs (Wilcox et al., 2014) acting as a 
homeostatic mechanism. Whilst we have established α4-GABAARs control 
consummatory behaviour, further experiments are required to investigate 
alcohol conditioned behaviours (see section 6.8.). 
6.4. Does deletion of α4-GABAARs on D1 neurons facilitate cocaine-
potentiation of general exploratory behaviours by disinhibition of D1 
MSNs within the NAc? 
It has been suggested that potentiated locomotor responses following intra-NAc 
infusions of dopamine agonists may result from a general facilitation of 
approach-investigation behaviour which is subsequently directed by 
environmental conditions (Ikemoto and Panksepp, 1999). In a standard 
locomotor activity chamber increased NAc dopamine transmission may simply 
stimulate exploratory locomotor activity, whilst in other situations it can facilitate 
other approach behaviours such as instrumental responding or conditioned 
activity in operant tasks (Taylor and Robbins, 1986; Cador, Taylor and Robbins, 
1991; Kelley and Delfs, 1991). 
Under a proposed ‘prepare and select’ model D1 neurons are involved in 
preparing several responses whilst D2 neurons are involved in more specific 
selection based on biological needs (Keeler, Pretsell and Robbins, 2014). Under 
this model increasing activity in D1 neurons will increases the likelihood of 
multiple responses whereas increasing activity in D2 neurons will lead to more 
selective responses. Deletion of α4 from D1 neurons specifically facilitates 
cocaine’s potentiation of locomotor activity, operant responding and behavioural 
sensitisation, as well as conditioned locomotor activity and CPP. Thus, it appears 
that α4βδ GABAAR inhibition of D1 neurons play a critical role opposing the 
general behaviour-enhancing properties of psychostimulants. In contrast, 
deletion of α4 from D2 neurons did not facilitate such a variety of exploratory 
behaviours but enhanced CRf which requires selective responses to specific cues. 
 
210 
 
 
6.5. Does deletion of α4-GABAARs on D1 neurons facilitate 
environmental conditioning associated with neural ensembles in the NAc 
Shell? 
It is thought that projections from the hippocampus to the NAc , particularly the 
Shell sub-region, may provide information about environmental cues associated 
with drugs (Ferbinteanu and McDonald, 2001; Britt et al., 2012). This suggests 
that the enhanced cocaine-CPP and conditioned locomotor activity seen in α4-
D1-KO mice may result from increased ability of glutamatergic inputs from the 
hippocampus to excite D1-MSNs within the NAc in the absence of α4-mediated 
inhibition. Accordingly, inactivation of NMDA conductance specifically in D1-MSNs 
decreased acquisition of cocaine-CPP (Heusner and Palmiter, 2005). 
Drug associated environmental contexts have been found to promote 
reinstatement of drug-seeking following extinction which may contribute to 
relapse in drug addicts (Crombag et al., 2008). Recently, neural ensembles in 
the NAc Shell have been implicated in the reinstatement of cocaine seeking by 
cocaine-paired environments. Re-exposure to a cocaine associated context 
reinstated cocaine seeking and increased cFos expression to a greater extent in 
the NAc Shell than Core (Cruz et al., 2014). Importantly, inactivation of those 
neural ensembles by the Daun02 inactivation method in the NAc Shell, but not 
Core, prevented neuronal activation and the reinstatement of cocaine seeking by 
the cocaine-associated environment.  
Increased cFos in the NAc Shell was associated with conditioned activity in our 
behavioural sensitisation experiments. Whilst α4-D1-KO mice showed increased 
conditioned activity, cFos levels in their NAc Shell were similar to other 
genotypes. As yet, we do not know if the balance of D1 vs D2 expressing 
neuronal activation was similar in these mice however this may be elucidated in 
further experiments (see section 6.8). 
6.6. Implications for Drug Abuse 
6.6.1. Compounds acting at α4-GABAARs as a treatment for alcoholism? 
Drugs which enhance GABAAR inhibition have been used to treat alcohol use 
disorders, primarily during withdrawal. Gamma-Hydroxybutyrate (GHB) 
enhances inhibition by both GABAA and GABAB receptors and has been found to 
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be effective in treating alcoholism in a clinical trial, most likely as an alcohol 
replacement preventing withdrawal symptoms (Addolorato et al., 1996). GHB 
has abuse potential and therefore must be carefully prescribed and monitored. 
Similarly, benzodiazepines have been suggested as an alcohol substitute and are 
used during withdrawal detoxification, but continued use is rare as they may 
enhances risk of relapse (Mayo-Smith, 1997; Zack, Poulos and Woodford, 2006). 
If α4-GABAARs are the subtype primarily affected by alcohol THIP may be able to 
have similar effects on withdrawal symptoms with fewer side effects due to their 
specificity. When administered systemically THIP also has sedative properties 
and, although we did not find a significant effect of intra-NAC THIP on DID, it 
has been found to enhance drinking in some pre-clinical studies (Boyle et al., 
1993), indicating it likely has similar drawbacks to benzodiazepines for this use. 
DS2 is unlikely to be of therapeutic use due to its limited solubility and ability to 
cross the blood brain barrier (Jensen et al., 2013). 
Electrophysiological evidence indicates that alcohol activates α4-GABAARs 
indirectly via upregulated neurosteroids (Lambert et al., 2003; Finn et al., 
2004). Agents that block the synthesis or action of neurosteroids reduce alcohol 
consumption in animals (Simms et al., 2012). Finasteride, which blocks the 
synthesis of neurosteroids including allopregnanolone, was recently reported to 
reduce alcohol consumption in humans  (Irwig, 2014), although it also caused 
persistent sexual side-effects. The testing of mifepristone in human subjects 
with alcohol use disorders is in early stages and clinical trials are not yet 
published (Swift and Aston, 2015). If discovered/developed, compounds that 
block interaction between neurosteroids and α4-GABAARs may have similar 
effects on drinking behaviour without off-target effects associated with the 
depletion of steroids. 
6.6.2. Compounds acting at α4-GABAARs as a treatment for cocaine 
abuse? 
In previous studies, systemic or intra-NAc administration of THIP was not able to 
reduce cocaine-CPP and CRf responding under drug-free (baseline) test 
conditions (Macpherson, 2013). However, THIP did reduce cocaine-enhancement 
of cocaine-CPP, CRf responding and locomotor activity, as well as behavioural 
sensitisation to cocaine. These results indicate that THIP is able to block the 
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energising effects of cocaine. The present data suggest this is primarily mediated 
by α4-GABAARs on D1 neurons and may, in part, result from attenuated drug-
environment associations. Thus, THIP has potential therapeutic value in blocking 
the hyperlocomotor of cocaine and its potentiation of drug-seeking, although it is 
yet unclear what the effects may be in humans. 
Unfortunately, when administered systemically, THIP also has sedative 
properties and therefore may have limited therapeutic use in treating cocaine 
abuse. Furthermore, our results implicate α4-GABAARs in promoting alcohol 
consumption, as do several other studies (Rewal et al., 2009, 2012). Although 
our data do not demonstrate that THIP or DS2 increase alcohol drinking, 
published studies did find that THIP increased drinking and we observed trends 
towards increased drinking following intra-NAc THIP and DS2. We would 
therefore suggest caution in clinically administering THIP, or other α4-GABAAR 
agonists, especially to poly-drug abusers who drink alcohol. 
6.6.3. Investigation of the GABRΑ4 gene in humans 
A linkage and association analysis indicated that the ‘16-cM’ region of 
chromosome 4p, which contains a cluster of genes encoding GABAAR subunits 
such as GABRΑ2 and GABRΑ4, was associated with an increased risk of drug 
dependence (Reich et al., 1998; Edenberg et al., 2004; Enoch, 2008, 2013). 
Furthermore, single nucleotide polymorphisms (SNPs) of the GABRΑ2 gene have 
been associated with alcohol dependence and cocaine addiction in humans 
(Edenberg et al., 2004; Dixon et al., 2010). In contrast, six GABRΑ4 SNPs 
investigated were not significantly correlated with risk for alcohol dependence 
(Edenberg et al., 2004). Similarly, post-mortem analysis of GABAergic gene 
expression revealed that the GABRΑ2 gene was altered in hippocampus of 
alcohol and cocaine addicts, whereas GABRΑ4 expression was unaltered (Enoch, 
2013).  
Given the various effects of α4-GABAARs manipulations on alcohol and cocaine 
related behaviour described in this thesis we may have expected SNPs or altered 
expression of the GABRΑ4 gene in humans to be associated with drug addiction. 
It is possible that compensatory changes in other genes may mask the 
behavioural effects of different α4 subunit expression in humans, as has been 
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observed in α4-KO mice (Chandra et al., 2006). Based on our data it is possible 
that only α4-GABAARs within the NAc are involved in alcohol and cocaine related 
behaviours therefore analysis of tissue from the Striatum and NAc of people with 
addiction may be more relevant. 
6.7. Considerations 
6.7.1. The use of THIP/DS2 to target α4-GABAARs 
In our DID experiments the GABAAR agonist THIP was used due to its preferred 
action at δ-subunit containing GABAARs, which within the NAc are largely co-
assembled with α4-subunits in extrasynaptic locations (Pirker et al., 2000; 
Stephen G. Brickley and Mody, 2012). However, it has been reported that THIP 
doses over 3µM may begin to act at γ2-containing synaptic GABAARs in addition 
to its action at δ-containing extrasynaptic receptors (Ebert et al., 1994; 
Mortensen et al., 2004, 2010). We therefore also used DS2, a novel positive 
allosteric modulator of δ-containing GABAARs which more specifically targets 
extrasynaptic α4βδ receptors. An in-vitro concentration-response study indicated 
that DS2 produces a similar peak stimulated inhibitory current as THIP in α4βδ 
receptors, but, unlike THIP, does not produce any response in α4βγ2 or α1βγ2 
receptors even at high concentrations (up to 10µm) (Mortensen et al., 2010; 
Jensen et al., 2013).  
When tested in-vivo systemic administration of DS2 demonstrates a poor 
brain/plasma ratio, indicating DS2 does not readily cross the blood-brain barrier 
(Jensen et al., 2013). Accordingly, systemic administration of DS2, even at high 
doses (up to 100mg/kg), fail to produce the effects in animal models seen with 
relevant doses of THIP, including reduced locomotor activity and rotarod 
performance (Wafford and Ebert, 2006; Herd et al., 2009). Furthermore, DS2 is 
not readily soluble in saline solution. We were able to dilute DS2 in sterile saline 
containing 2% Tween-20 and 2% DMSO and our results indicate that this buffer 
did not produce effects on its own when infused intracranially. Based on 
preliminary studies in WT mice we used a dose of 0.03mM administered 
intracranially, directly to the NAc (Dixon, Stephens, King, unpublished data).    
Immunohistochemical analysis revealed that the expression pattern of the 
GABAAR α4-subunit within the NAc is indistinguishable from that of GABAAR δ-
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subunits, and distinct from expression of the cell adhesion molecule neuroligin2 
(NL2), which is selectively expressed in inhibitory synapses (Maguire et al., 
2014). Thus, there appear to be few or no synaptic α4-GABAARs within the NAc, 
indicating that the effects of THIP or DS2 at α4-GABAARs in the NAc are highly 
likely to be due to an action at extrasynaptic α4βδ receptors. 
6.7.2. cFos 
Firstly, because cFos expression is activated by a wide variety of signalling 
pathways its expression alone cannot provide much information about the 
mechanisms behind cFos activation in our experiments (Chung, 2015). However, 
many studies have characterised the mechanisms by which psychostimulants 
activate cFos activation in MSNs via transmission at D1 dopamine receptors 
(reviewed, Xu, 2008). This may mean our experiments are insensitive to 
differences of activity in D2-MSNs. 
Secondly, cFos expression does not indicate whether the neurons are activated 
directly, for example by increased dopamine transmission, or indirectly due to 
upstream, circuit-level changes. This is particularly problematic when studying 
effects of systemic drug administration and the basal ganglia where sub-regions 
receive many different inputs (Robertson et al., 1991). 
Third, activity-dependent genes are differentially regulated in different cell types 
and in distinct brain areas and immediate early gene expression does not always 
result correlate with neuronal firing (Kawashima, Okuno and Bito, 2014). It is 
also possible that a stimulus activates a neuron without activating cFos.  
Finally, cFos expression is useful for measuring only activation, not inhibition, of 
neurons. Thus, it can be used to measure disinhibition, as in our sensitisation 
experiments, but not inhibition mediated by GABAARs. This is not necessarily 
prohibitive to examining the effects of α4-GABAAR activation on cFos as THIP or 
DS2 treated mice could be compared with saline treated controls. Activation of 
D2Rs by dopamine results in inhibition of neurons, therefore measures of cFos 
will not provide evidence of increased activation of D2Rs which likely occurs due 
to increased dopamine release during behavioural sensitisation.  
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6.7.3. The use of mouse behavioural paradigms to model addiction-
associated behaviours 
6.7.3.1. Drinking in the Dark 
The principal disadvantage of Drinking in the Dark is that no choice is offered. 
However, a 4-hour period of voluntary fluid deprivation is not sufficient to 
greatly challenge mice (Lyons et al., 2008), and many genotypes drink very little 
in DID (Rhodes et al., 2007). The motivation for ethanol consumption in DID is 
not known, although it is unlikely to be due to calorie seeking and probably not 
caused by postprandial thirst stemming from feeding (Lyons et al., 2008). 
The DID procedure takes advantage of a time-period in the animal’s circadian 
rhythm which is associated with high levels of ingestive behaviour to produce 
high level of ethanol intake (Rhodes et al., 2005). When C57BL/6J mice were 
given access to 20% ethanol beginning 3 hours into the light cycle consumption 
of ethanol was and associated BECs were reduced to ~20% relative to 3 hours 
into the dark cycle (Lowery-Gionta et al., 2012). Experiments may be affected 
by circadian fluctuations in neurophysiological activity, including in 
neurochemical systems, that have been implicated in binge-like ethanol drinking 
(Mitchell, Prévot and Beauvillain, 1998; Vidal and Lugo, 2006; Sprow and Thiele, 
2012), and yield results that are specific only to that portion of the dark cycle.  
In DID experiments mice consume binge-like levels of ethanol during the time of 
day that they also consume most of their food, therefore it is possible that DID 
procedures may interfere with normal feeding (or vice versa). This may be more 
apparent in experiments involving repeated use of DID procedures over days or 
weeks, as in our intra-NAc drug delivery experiments. Although short-term food 
restriction did not alter the level of binge-like ethanol drinking with DID 
procedures (Lyons et al., 2008), it is possible over many sessions this could 
impact ethanol consumption. 
Observations generated with DID procedures in mice may not generalize to 
other strains or species. Out of a panel of 12 strains tested only C57BL/6J mice 
achieved BECs above 100 mg/dL (Rhodes et al., 2007). Different ethanol 
drinking in DID procedures could be attributed to taste reactivity to ethanol. 
Some strains might develop reduced sensitivity to the aversive taste of ethanol 
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and thus be willing to consume more. However, C57BL/6J mice show relatively 
stable ethanol intake over the 4-day DID procedure (Rhodes et al., 2005) and, 
while repeated episodes of DID promoted significant increases of subsequent 
continuous 2-bottle-choice ethanol intake, the level of binge-like ethanol 
drinking did not increase following 40 sessions (Cox et al., 2013). 
6.7.3.2. Behavioural Sensitisation 
Although neural and behavioural sensitisation is well established in animals it 
has been questioned whether such sensitisation also occurs in humans. Some 
studies have reported that repeated intermittent administration of amphetamine 
resulted in sensitisation of striatal dopamine release (Boileau et al., 2006), 
whereas others have found that detoxified cocaine addicts exhibit a decrease in 
methylphenidate or amphetamine evoked dopamine release in the striatum 
following administration, rather than a sensitised increase  (Volkow et al., 1997; 
Martinez et al., 2007). These studies may be confounded by congenital or 
otherwise pre-existing differences in dopamine release in people with addiction 
(Melis, Spiga and Diana, 2005). Similarly, behavioural evidence for progressive 
drug effects in humans is mixed. Subjects reported increased subjective effects 
of amphetamine following repeated administration (Strakowski et al., 2001; 
Boileau et al., 2006), and clinician-rated levels of energy and motor activity were 
also reported to be increased (Strakowski et al., 1996, 1998). In contrast, other 
studies found no evidence of increased subjective effects following repeated 
amphetamine administration (Johanson and Uhlenhuth, 1981; Kelly, Foltin and 
Fischman, 1991). This may be attributed to the conditions during drug 
administration in these studies. The expression of sensitisation is modulated by 
the environmental context of drug administration (Robinson & Berridge, 2008), 
therefore a drug challenge in the test environment may not result in the 
expression of behavioural sensitisation as it would in a previously drug-paired 
context. Further investigation, including environmental manipulations, is 
required to investigate behavioural sensitisation in humans 
6.7.4. Genetic limitations 
A major limitation to the use of transgenic mice is that genetic deletion or 
altered expression of a gene often results in compensatory changes in 
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expression of other genes and their products. Indeed, previous qRT-PCR analysis 
of NAc tissue samples revealed that mRNA expression levels of two other 
GABAAR subunits were altered following deletion of Gabra4 either constitutively 
or specifically or in D1/D2 neurons. Expression of the GABAAR δ-subunit was 
reduced, likely due to a lack of α4-subunits with which δ-subunits would 
ordinarily co-assemble to form extrasynaptic α4-GABAARs. 
In contrast, expression of the GABAAR α2-subunit was increased. It is possible 
that regulation of the Gabrα2 gene was perturbed due to deletion of Gabrα4 as 
they are located adjacently on chromosome 4. However, electrophysiological 
evidence demonstrated that deletion of the α4-subunit did not affect the kinetics 
of phase currents mediated by synaptic receptors within the NAc (Maguire et al, 
2013). This indicates that the increase in α2-subunit mRNA in the NAc is not 
translated into α2-subunit proteins in functional receptors. This could be further 
confirmed by western blot or immunohistochemical analysis of α2-subunit 
protein expression in α4-KO mice. 
Viral vectors have been proposed as a way of altering gene regulation while 
avoiding compensatory changes as they can be expressed in adult animals 
(Hommel et al., 2003). However, it is known that GABAARs can be rapidly up- or 
down-regulated under certain physiological conditions, such as following cocaine 
or alcohol administration (Liang et al., 2007). We used a Cre virus to delete α4-
GABAARs specifically within the NAc of ‘floxed-α4 mice, which resulted in reduced 
alcohol consumption in our DID experiments. Whilst we used qRT-PCR analysis 
to confirm the knockdown we did not analyse the expression of other GABAARs. 
This should be carried out in further experiments to ensure that compensatory 
changes in other GABAAR subunits are not the cause of this effect. For example, 
GABAAR α2 subunit, which has been implicated in the acute and reinforcing 
effects of alcohol (Dixon et al., 2012; Edenberg et al., 2004). Furthermore, if 
any GABAAR α4 subunit mRNA is differently regulated protein analysis (Western 
blot or immunohistochemistry) should be used to detect whether this results in 
changes in expression of functional receptors. 
We have previously used qRT-PCR analysis to demonstrate changes in 
expression of GABAARs in the NAc of D1/D2 specific α4 knockout mice, including 
upregulation of α2 mRNA (Macpherson, 2013). However, expression within the 
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individual D1/D2 cell populations has not been examined. This could be 
examined using immunohistochemistry or multi-probe in-situ-hybridisation to 
colocalise D1/D2 markers with various GABAAR subunits. These methods are 
typically less quantitative and, at present, are limited by the number of 
antibodies/probes that can be co-labelled simultaneously. It may be possible to 
use Fluorescence-activated cell sorting (FACS) to separate D1 and D2 cell 
populations for qRT-PCR and Western Blot analysis. Methods have been 
developed which allow FACS based on immunolabelled cell types (Guez-Barber 
et al., 2011). This would rely on antibodies for D1/D2 neuron markers which at 
present show problems with effective application and cross-reactivity in brain 
tissue. Alternatively, α4-D1/D2-KO mice could be bred with BAC-mice expressing 
different fluorochromes under the Drd1 and Drd2 promoters, e.g. GFP and td-
Tomato as previously demonstrated (Shuen et al., 2008). This would be 
confounded by additional BAC disruption and expression of fluorochromes 
although cross-bred, BAC-XFP and WT control mice could be compared to 
investigate global effects on GABAAR subunit expression.  
6.8. Future Work 
6.8.1. Role of α4 in alcohol consumption and reinforcement 
In the presented experiments knockdown of α4 in the NAc, using a Cre virus in 
‘floxed’-α4 mice, was sufficient to reduce drinking under DID conditions. In 
further experiments we could we do this prior to operant self-administration 
experiments to investigate the role of α4-GABAARs in motivation for alcohol as 
well as consumption. If this reduces self-administration, we would replicate 
findings of Rewal and colleagues (2012) who used RNAi to knockdown α4 in the 
NAc of rats. Additionally, time-course data obtained in such experiments may 
indicate whether reduced consumption in α4-KOs is a result of faster satiation. 
This would be indicated if levels of drinking are similar early drinking sessions 
but more rapidly decline (as observed by Rewal et al. 2012). 
It may be of interest to investigate other regions in which α4 is expressed using 
similar methods. The thalamus is a good candidate as it is where α4 is most 
highly expressed (Sur et al., 1999b; Schwarzer et al., 2001) and ethanol is 
known to potentiate GABAergic tonic inhibition there in wild-type but not α4-KO 
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mice (Jia et al. 2007). If depression of the thalamus is necessary to promote 
ethanol consumption α4 knockdown may result in reduced drinking. 
It would be highly useful to examine pharmacological inactivation of α4-GABAARs 
on alcohol consumption; however, at present there are no antagonists that are 
specific for α4βδ receptors. Based on electrophysiological evidence it is likely 
that alcohol activates α4-GABAARs indirectly via upregulated neurosteroids 
(Lambert et al., 2003; Finn et al., 2004). We could test this hypothesis in future 
experiments by investigating whether administration of neurosteroids, for 
example allopregnanolone, is able to increase alcohol drinking and operant self-
administration in α4-KO mice as it does in WT mice (Janak, et al., 1998; Sinnott 
et al. 2002).  
Finally, to establish whether α4-GABAARs promote alcohol reinforcement it is 
necessary to use similar genetic manipulations of α4 in ethanol conditioning 
experiments. Although they often are less robust that when performed using 
psychostimulants, protocols have been developed to establish responding for 
ethanol associated cues, ethanol CPP and ethanol sensitisation (Kelley et al., 
1997; Phillips et al., 1994; Shahan & Jimenez-Gomez, 2006).  
6.8.2. Role of α4 in Cocaine-related behaviours 
Following our demonstration that D1 neurons are the primary mediator of cFos 
differences in cocaine-sensitised α4-KO it is of immediate interest to conduct 
similar experiments in D1/D2 specific α4-GABAAR knockout mice. We 
hypothesise that the similar patterns of overall cFos expression observed in α4-
D1-KO mice as in α4-KO mice are also highly likely to be mediated by D1 
neurons following cocaine sensitisation. 
Previously we have demonstrated that systemic THIP administration blocks 
cocaine potentiation of locomotor activity and behavioural sensitisation in WT 
but not α4-KO mice (Macpherson, 2013). We could use the same manipulation in 
D1/D2 specific α4-GABAAR knockout mice to identify whether either one or both 
populations mediates this effect. Outcomes of THIP activating D1 and D2 were 
dissociated in other behaviours, including cocaine potentiated CPP and CRf 
(Macpherson, 2013). We hypothesise that THIP would not affect cocaine-
potentiated locomotor activity or sensitisation in α4-D1-KO mice which would 
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provide secondary confirmation that α4-GABAARs on D1 neurons appear to 
oppose those behaviours. 
As D1 and D2 receptors are widespread throughout the striatum and other 
regions (Gerfen et al., 1990) it would be useful to provide anatomical specificity 
to behavioural effects in D1/D2 specific α4-GABAAR knockout mice. Previous 
studies have demonstrated knockdown of α4-GABAARs in the NAc of rats using 
viral vector mediated RNAi (Rewal et al., 2009). Viral vectors have been 
developed which conditionally express RNAi sequences in the presence of Cre 
recombinase (Saunders et al., 2012). This technique could be used in 
combination with BAC mice expressing Cre under the D1- or D2-promotor to 
conditionally knockdown Gabrα4 in those populations and within specified brain 
regions such as the NAc. We hypothesise that this would result in similar effects 
on cocaine-related behaviour observed in our D1/D2 conditional knockout mice 
due to the established role of the NAc in those behaviours, the high expression 
of α4-GABAARs there, and its further implication by our cFos analysis of cocaine 
treated mice. 
In our experiments cocaine was continually administered in the cocaine-paired 
environment during behavioural sensitisation and challenge dosing for cFos 
analysis. It has been established that cocaine induces greater cFos expression in 
a cocaine environment (Mattson et al., 2007) and our results suggest that α4-
GABAARs on D1 neurons modulate neural ensembles which mediate this 
environmental effect. It would therefore be of interest to observe the effects of 
cocaine on cFos expression in a non-cocaine paired environment to see if α4-
GABAARs mediated differences are still apparent. If so this would indicate 
whether α4-GABAARs are directly involved in behavioural sensitisation or that 
they encode drug-environment association which contributes to increased 
locomotor activity.   
Operant self-administration of drugs is often considered the gold-standard for 
examining treatments for addiction pre-clinically. It may therefore be of interest 
to examine constitutive α4-KO and α4-D1/D2-KO mice in such experiments. 
However, the increases in cocaine potentiated locomotor activity and responding 
for natural rewards observed in α4-D1-KO mice would likely confound our 
interpretation of operant self-administration experiments. Drug-associated cues 
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powerfully drive drug-seeking behaviour (Di Ciano and Everitt, 2004) therefore 
the role of α4 in conditioned behaviours may important regardless of its effect on 
operant self-administration. While we have previously examined the constitutive 
and D1/D2 specific α4 knockout mice in CRf using food rewards it would be 
useful extend these results using cocaine rewarded CRf experiments. This may 
further indicate whether α4-GABAARs are a useful target to reduce drug seeking 
following conditioned cues. 
6.9. Conclusion 
In conclusion α4-GABAARs are modulators of the excitability of NAc MSNs, and 
therefore play an important role in controlling consummatory, locomotor and 
conditioned behaviours. Deletion of α4-GABAARs globally or within the NAc is 
sufficient to dramatically reduce binge-like alcohol drinking. In contrast deletion 
of α4-GABAARs specifically from D1 expressing neurons is required to facilitate 
cocaine-potentiation of locomotor activity, operant responding cocaine-
sensitisation and conditioned locomotor activity. These behavioural differences 
are accompanied by increased cFos expression in the NAc, acutely in the Core 
then in the Shell following sensitisation. These data indicate α4-GABAARs within 
the NAc play different roles controlling alcohol consummatory behaviour and 
cocaine conditioned behaviours, both of which are associated with addiction. 
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